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Abstract 
Electrospinning is a technique which has been widely studied to fabricate 
fibrous polymeric membranes. More recent work has demonstrated the 
preparation of composite fibres by incorporation of ceramic or glass particles 
in the spinning process. However, the incorporation of strontium-substituted 
bioactive glasses (Sr-BGs) into electrospun membranes has not yet been 
studied with detail. This is perhaps surprising, as Sr-BGs have been reported 
to exhibit superior osteogenic activity compared to conventional bioactive 
glasses. Therefore, the aim of this project was to fabricate electrospun 
composite materials combining poly(caprolactone) (PCL) and Sr-BG 
particles, and to study their potential use as scaffolds for bone tissue 
engineering. Here, three Sr-BGs in which calcium was substituted by 
strontium in molar proportions of 0, 50 and 100% were prepared and 
characterised. Glass particles with sizes <45 μm were prepared by milling 
and sieving, and added to PCL solutions before electrospinning. The 
resulting composite materials were then examined using scanning electron 
microscopy, energy dispersive X-ray spectroscopy (EDS), and by performing 
solubility and cytotoxicity studies. Two methods to add Sr-BG particles to the 
surface of the fibres were also investigated. The effect of Sr-BG dissolution 
on mesenchymal stromal cells (MSCs) was studied by assessing cytotoxicity 
and the expression of six genes associated with osteoblastic differentiation. 
Strontium substitution resulted in a reduction of glass transition temperature, 
increased density and increased solubility of the glasses. EDS confirmed the 
presence of Sr-BG particles within the electrospun fibres. Solubility studies 
suggested an accelerated degradation of PCL due to Sr-BG dissolution in 
the composite fibres, with an apparent effect on medium pH. All the materials 
generally presented good levels of in vitro biocompatibility, although the 
addition of particles to the surface of the fibres increased their apparent 
cytotoxicity in some cases. Sr-BG dissolution was associated with an up-
regulation of genes involved in the process of osteoblastic differentiation. It 
was concluded that Sr-BGs may indeed enhance osteogenic differentiation in 
MSC populations, and electrospun PCL/Sr-BG showed great potential for 
use as a versatile medical device or scaffold for bone tissue regeneration. 
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1 Introduction 
The regenerative capacity of bone tissue means that many injuries are able 
to heal without the need of surgical intervention. However, large defects may 
lack the conditions required for the regeneration process to occur and, if left 
untreated, may cause pain, loss of function, disability and disfigurement, 
affecting the quality of life of patients worldwide (Bueno and Glowacki, 2011). 
Therefore, these injuries will necessitate medical treatment to support the 
healing process, especially in older patients. 
The ‘gold standard’ treatment for those defects is the transplantation of 
autogenous bone grafts obtained from other sites in the skeleton. This 
method generally presents good clinical outcomes due to the good 
integration of the graft into the defect site and virtually non-existent risks of 
rejection and disease transmission compared to grafts obtained from other 
sources. However, severe limitations in the amount of bone which can be 
harvested from the patient and increased risks of morbidity and pain in the 
donor sites led to the pursuit of suitable alternatives (Moore, 2001; Myeroff 
and Archdeacon, 2011). 
Historically, a wide range of biomaterials have been investigated as potential 
substitutes for bone grafts, with varying degrees of success (Hench and 
Polak, 2002). Bioinert materials, such as steel alloys, were initially selected 
due to showing good mechanical properties and biocompatibility, and 
because they elicited minimal reactions from the body. However, this 
biological inertness meant that the materials were unrecognised by the body 
and did not bond with the surrounding tissues, leading to encapsulation, 
isolation and final deterioration of the implant. 
Degradable and bioactive materials later received considerable attention due 
to their improved biological properties. Degradable materials, such as 
bioresorbable polymers (Pulapura and Kohn, 1992; Middleton and Tipton, 
2001), exhibit controlled degradation and resorption in the body, eliminating 
the need of a second surgical intervention to remove the implant. Bioactive 
materials, such as bioactive glasses (Hench, 1998; Jones, 2013), are able to 
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stimulate specific cellular responses that may encourage the production of 
new bone tissue and will result in generally stronger biomaterial-tissue 
interfaces. Additionally, the composition of both degradable and bioactive 
materials may be tailored to modify their properties. For example, co-
polymerisation may be used to modify the degradation rates of bioresorbable 
polymers. It is also possible to substitute certain chemical elements in the 
composition of bioactive glasses in order to alter their physical properties and 
bioactivity. Strontium is a particular element which has received attention in 
the last few years as it has been reported to encourage the formation of new 
bone tissue, both as a component of the drug strontium ranelate (Marie et 
al., 2001; Marie, 2005; Bonnelye et al., 2008) and as part of bioactive 
glasses (Lao et al., 2009; Gentleman et al., 2010; Gorustovich et al., 2010; 
O’Donnell et al., 2010; Isaac et al., 2011). Finally, novel alternative 
approaches to bone grafts have been developed which combine the 
concepts of degradable and bioactive materials in order to elicit specific 
responses at the molecular level. 
Bone tissue engineering is a discipline that aims to create healing responses 
in precise anatomic regions of the skeleton to encourage the formation of 
new bone tissue that is structurally integrated with the surrounding tissues 
and which is durable and effective (Langer and Vacanti, 1993; Kakar and 
Einhorn, 2005). For this purpose porous scaffolds with the appropriate 
characteristics to support the development of the new tissues need to be 
designed and fabricated. Various biomaterials have been investigated for the 
production of these scaffolds, including demineralised bone matrix, natural 
and synthetic polymers, ceramics and bioactive glasses. However, as no 
single material is able to fulfil all the requirements for bone tissue 
engineering applications, the use of composite biomaterials that attempt to 
mimic the composite nature of bone tissue have been explored because they 
offer the possibility of combining the material and biological properties of the 
different components into a single structure (Barone et al., 2010). 
Several manufacturing methods have been historically employed to process 
biomaterials into porous structures to be used as scaffolds (Chan and Leong; 
2008; Moroni et al., 2008). Among them, electrospinning has been widely 
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investigated due to its versatility and ease of use. Electrospun fibres with 
diameters of a few micrometres down to tens of nanometres may be 
produced from a polymer solution through the application of electrostatic 
forces, resulting in the fabrication of non-woven porous membranes after the 
fibres are deposited on a collecting plate (Doshi and Reneker, 1995; Huang 
et al., 2003; Martins et al., 2008). Composite materials may also be 
fabricated using this technique by adding particles of a different biomaterial, 
such as ceramics or glasses, to the initial polymer solution. This particulate 
will then be incorporated within the electrospun fibres, creating a structure 
that may present enhanced properties compared to the non-composite fibres 
(Holzwarth and Ma, 2011). 
To summarise, the incorporation of bioactive glass particles into electrospun 
membranes is technically feasible and it is possible that a strontium-
substituted bioactive glass may stimulate the formation of new bone tissue, if 
incorporated into this structure. Surprisingly, relatively little work studying this 
topic has been reported. Therefore, the aim of this research was to 
investigate the development of novel electrospun composite materials 
combining poly(caprolactone), a bioresorbable polymer, and particles of 
strontium-substituted bioactive glass, and to investigate their potential use as 
a scaffold for bone tissue engineering. Additionally, the materials may be 
used as fillers of bone voids in non-load bearing sites of the skeleton or as 
bioresorbable components in barrier membranes for guided bone 
regeneration applications, where it may encourage bone growth in structures 
affected by periodontal disease. 
The relevant scientific literature and principles supporting this project will be 
reviewed in the following section of this report, before presenting the 
research work performed and the conclusions drawn from it. 
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2 Literature review 
2.1 Biomaterials and bone tissue 
The use of materials to replace missing or damaged parts of the body can be 
traced to centuries ago. For example, the Mayans used artificial teeth made 
of nacre obtained from sea shells and ancient Greek literature mentions the 
use of metallic sutures (Ratner, 2013). However, it was only after the 
development of aseptic surgical techniques and of an adequate 
understanding of the immune system that their use became more frequent 
and efficient. Previous to that, surgical procedures involving implanted 
materials were generally unsuccessful due to infection and to the presence 
of a region created by the implant which was inaccessible to the immune 
system. 
2.1.1 Classification of biomaterials 
A biomaterial can be defined as a ‘nonviable material used in a medical 
device, intended to interact with biological systems’ (Ratner et al., 2013). 
Hench and Polak (2002) outlined three generations in the historical 
development of modern biomaterials. 
Initially, the principle applied to select a biomaterial was its biological 
inertness in order to minimise the response of the immune system to the 
presence of the implanted material. Although this approach proved to be very 
successful, enhancing the quality of life of many patients worldwide, the 
biological inertness of the implant meant that it would be unrecognised by the 
body and would not bond with the surrounding tissues, leading to their 
isolation from the host by encapsulation in fibrous connective tissue and 
chronic inflammation. This process may also lead to material deterioration, 
loosening of the implant and final clinical failure (Barone et al., 2010). In 
response to this, second generation biomaterials were developed. The focus 
shifted towards creating implants that could elicit controlled reactions in the 
physiological environment using bioactive components and that, therefore, 
would improve the interface between the implant and the surrounding 
tissues. Additionally, degradable materials exhibiting controlled chemical 
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degradation and resorption in the body and which would be eventually 
replaced by the regenerating tissues were investigated. Examples of second 
generation biomaterials are bioactive glasses, ceramics, glass-ceramics, 
bioresorbable polymers and composites, which were soon successfully used 
in a wide variety of clinical applications. Finally, third generation biomaterials 
emerged as a result of the convergence of bioactive and degradable 
biomaterials, in such a way that ‘bioactive materials are being made 
resorbable and resorbable polymers are being made bioactive’, as Hench 
and Polak (2002) described it. 
Two alternative routes to repair damaged tissues arose from this 
convergence: tissue engineering and in situ tissue regeneration. The main 
advantage offered by these two is the potential to elicit specific cellular 
responses at the molecular level that will stimulate cell differentiation or the 
activation of certain genes (Hench and Polak, 2002; Hench and Thompson, 
2010). For example, it has been reported that bioactive glasses are able to 
upregulate seven families of genes in primary human osteoblasts after their 
exposition to the glass ionic dissolution products (Xynos et al., 2001; Hench, 
2009). There is growing scientific evidence supporting the use of these 
advanced biomaterials and approaches in the regeneration of damaged 
tissues, exhibiting promising results and many potential benefits, especially 
for an ageing population. 
The success of an implanted biomaterial will depend on its biocompatibility 
and its ability to achieve a stable attachment to the surrounding tissues. 
Biocompatibility can be defined as ‘the ability of a material to perform with an 
appropriate host response in a specific application’ (Ratner et al., 2013). 
Depending on the type of host response elicited, four categories of 
biomaterials have been described (Hench et al., 2013; Woesz and Best, 
2008): 
1) Bioinert materials are those that elicit minimal interaction and minimal 
chemical reactions at the biomaterial-tissue interface. This results in 
the production of a fibrous capsule covering the implant in order to 
prevent further interactions with the host.  
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2) Bioresorbable materials are those that are either dissolved or 
resorbed by the body, in such a way that the implant can be 
eventually replaced by the surrounding tissues. 
3) Bioactive materials are those that can trigger a chemical reaction with 
the environment, undergoing time-dependent changes as a 
consequence. These changes result in the formation of a layer of 
hydroxy-carbonate apatite on the surface of the implant, providing 
binding sites for cells and tissues. 
4) Toxic materials are those that cause cellular death due to their 
composition, locally or remotely. 
The mechanism of attachment is directly related to the type of host response 
at the implant-tissue interface (Hench and Best, 2013). In the case of bioinert 
materials, which do not bond chemically or biologically to tissues, the 
thickness of the fibrous capsule will vary depending on the nature of the 
material and on the motion and fit at the implant-tissue interface. The 
presence of movement will usually lead to an eventual deterioration of the 
implant, possibly requiring additional surgery to remove it. On the other hand, 
bioresorbable and bioactive materials are more suitable alternatives for the 
fabrication of implants because bioresorbable materials can be replaced by 
the surrounding tissues as they degrade, resulting in thin or nonexistant 
interfacial regions, and bioactive materials are able to elicit specific biological 
responses at the implant-tissue interface that may result in the formation of 
stronger bonds with the surrounding tissues. 
2.1.2 Bone tissue structure and biology 
A bone is a complex organ which fulfils important functions in the body, 
including the protection of internal organs from damage, the provision of 
structural support for soft tissues and of attachment points for muscles and 
ligaments, and the storage of minerals and energy in the form of fat. 
Depending on their shape, bones can be classified into five categories: long, 
short, flat, irregular and sesamoid bones (Table 2.1).  
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Table 2.1. Types of bone by shape, functions and examples. 
Type of bone Function Example 
Long Movement of body Femur 
Short Shock absorption Carpals 
Flat Protection of internal organs Cranium 
Irregular Support and protection Vertebrae 
Sesamoid Protection of tendons Patella 
The anatomy of a bone can be analysed by considering the parts that form a 
long bone such as the humerus (Figure 2.1). The external parts are the 
diaphysis, forming the main body of the bone; the epiphyses, which are the 
distal and proximal ends of the bone; the metaphyses, which are the regions 
in a mature bone where the diaphysis joins the epiphyses; the articular 
cartilage, formed by a thin layer of hyaline cartilage where the bone forms an 
articulation; and the periosteum, which is a cover of connective tissue 
surrounding the whole bone, except on the cartilaginous surfaces. The 
internal parts are the medullary cavity, which is the space within the 
diaphysis containing the bone marrow; and the endosteum, formed by a thin 
membrane of connective tissue lining the medullary cavity. 
 
Figure 2.1. Schematic diagram of a humerus, identifying the main parts that form it. 
The main tissue in bone is osseous (bone) tissue, which can be described as 
a composite material made of a matrix possessing an organic and an 
inorganic component (Boskey, 2005). The organic component of the matrix 
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represents approximately 30% of the total bone tissue and is mainly 
composed by proteins, of which type I collagen is the most abundant. The 
collagen fibres assemble in an organised manner parallel to the long axis of 
bone, creating bone calcification sites in a region known as the ‘hole zone’ 
(Figure 2.2). Other organic molecules are present in the organic phase, 
participating in signalling processes related to tissue remodelling, 
mineralization and turnover. These include structural and biologically active 
proteins, proteoglycans, glycoproteins, peptides, lipids and adsorbed serum 
proteins (Bueno and Glowacki, 2011). The inorganic component of the matrix 
provides strength and rigidity to bone tissue and is mainly composed of an 
analog of the mineral hydroxyapatite (HA) with chemical composition 
Ca10(PO4)6(OH)2 and a Ca:P molar ratio ranging from 1.3:1 to 1.9:1. The size 
of the HA crystals are in the range of 2 to 7 nm in thickness, 15 to 200 nm in 
length and 10 to 80 nm in width (Katsanevakis et al., 2012), and are 
deposited parallel to the collagen fibres and in direct contact with them. This 
occurs through a cell-mediated process of nucleation: ions or ion clusters in 
solution collide to generate a stable nucleus from which the crystal grows as 
more ions or ion clusters are added over time (Boskey, 2005; Bueno and 
Glowacki, 2011). 
 
Figure 2.2. Schematic diagram of a) the microstructure of bone, showing the arrangement of 
collagen molecules creating ‘hole zones’ where hydroxyapatite crystals are nucleated; and of 
b) the lowest level of the hierarchical structure of bone, showing the parallel alignment and 
elongation of the mineral particles formed with hydroxyapatite crystals. Adapted from 
Katsanevakis et al. (2012). 
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The way in which the mineral is deposited maximises the resistance to 
external mechanical forces applied to the bone. The HA crystals provide high 
strength and fracture toughness while the collagen fibres maintain its load-
bearing and viscoelasticity, allowing bone tissue to absorb shock (Safadi et 
al., 2009; Katsanevakis et al., 2012). When the collagen fibres are 
abnormally produced, as it occurs in osteogenesis imperfecta, the HA 
crystals are smaller in size and may be deposited apart from the collagen 
fibres, resulting in a weaker bone matrix and a reduced ability to withstand 
mechanical forces (Boskey, 2005). 
Macroscopically, bone tissue can be organised in two different architectures: 
cortical (lamellar) bone and trabecular (woven) bone. Cortical bone 
represents approximately 80% of the total mass of the skeleton. It is a dense 
structure made up by circumferential lamellae, woven tissue or plexiform 
tissue. The circumferential lamellae are arranged parallel to the bone 
surface. Located within these are osteons (Haversian systems) with an 
average diameter of 200 μm and enclosing a central cavity (Haversian canal) 
which contains blood and lymphatic vessels. The external boundary of each 
osteon is the cement line, which separates it from the surrounding interstitial 
tissues. Woven tissue and plexiform tissue are usually found in the bones of 
large or fast growing animals, and may also be formed at fracture healing 
sites. Also within cortical bone are cavities known as lacunae, where the 
osteocytes are located. Trabecular bone, making up the remaining 20% of 
the total mass of the skeleton, is found in the metaphysis, epiphyses and 
medullary cavity of long bones. It consists of an interconnected lattice of 
trabeculae with approximate thickness of 200 μm (Wang et al., 2010).  
The main cell types present in bone tissue are osteoblasts, osteocytes and 
osteoclasts (Table 2.2; Figure 2.3). Bones in the axial and appendicular 
skeleton are formed by one of two processes: intramembranous bone 
formation or endochondral bone formation. In intramembranous bone 
formation the osteoprogenitor cells in the mesenchyme aggregate in the 
areas where a new bone is to be formed and differentiate into osteoblasts, 
which will then synthesise new bone matrix. Growth occurs by the deposition 
of new bone tissue by osteoblasts on previously existing bone. On the other 
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hand, endochondral bone formation involves the initial formation of cartilage 
tissue through the differentiation of mesenchymal cells into chondrocytes and 
its subsequent replacement by bone tissue through a process of chondrocyte 
hypertrophy, invasion of the cartilage by blood vessels, chondrocyte 
apoptosis, and final differentiation of osteoprogenitor cells into osteoblasts, 
which will deposit new bone matrix on the cartilage remains (Safadi et al., 
2009). 
Table 2.2. Main cell types present in bone tissue, including their origin, location and function. 
Adapted from Boskey (2005), Safadi et al. (2009) and Wang et al. (2010). 
Cell type Origin Location Function 
Osteoblasts Mesenchymal 
stromal cells 
Line bone surfaces at 
sites of active bone 
formation. 
Production of type I 
collagen; Mineralisation of 
matrix by deposition of 
calcium and phosphate. 
Osteocytes Osteoblasts 
trapped within 
bone matrix 
In cavities within the 
bone matrix known as 
lacunae. 
Extend long cellular 
processes through 
canaliculi, joined by gap 
junctions to enable cellular 
communication, possibly to 
maintain bone metabolism. 
Osteoclasts Multinucleated 
cells created 
by the fusion 
of several 
monocytes 
In pits or cavities of 
active bone resorption 
known as Howship’s 
lacunae. 
Bone resorption during 
bone remodelling. 
 
Figure 2.3. Schematic diagram of bone tissue structure at a cellular level, showing the main cell 
types present in bone tissue. Adapted from Jang et al. (2009). 
An important characteristic of bone tissue is that it has the ability to remodel 
itself (e.g. in response to external mechanical forces) and to repair itself after 
injury. The remodelling of bone tissue is a process which occurs in temporary 
locations known as basic multicellular units (BMU). An active BMU consists 
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of a leading front of osteoclasts, which will resorb the bone tissue and form a 
defect. Reversal cells will follow the osteoclasts, covering the defect and 
preparing it for the deposition of new bone tissue. Osteoblasts will then 
occupy the area and deposit new unmineralised bone matrix, directing its 
formation into lamellar bone. Following mineralisation, osteoblasts will 
become embedded into the new matrix and differentiate into osteocytes 
(Raggatt and Partridge, 2010). 
The mechanical properties of bone tissue have generally been well 
documented, using various approaches to measure them at the micro and 
macroscopic levels (Rho et al., 1998; Currey, 2009; Wang et al., 2010). 
Cortical bone shows a high degree of anisotropy and the measured values of 
different mechanical properties may vary depending on the species, age, 
health, location in the bone and testing conditions. The case of trabecular 
bone is more complex due to the small dimensions of the individual 
trabeculae. Table 2.3 presents typical values for some mechanical properties 
of human cortical and trabecular bone. 
Table 2.3. Values of the mechanical properties of human cortical and trabecular bone. Adapted 
from Katsanevakis et al (2012). 
Bone Mechanical property Value 
Cortical 
Yield stress (Tension) 78-151 MPa 
Yield stress (Compression) 131-224 MPa 
Elasticity modulus 17-20 GPa 
Trabecular 
Yield stress 5-10 MPa 
Elasticity modulus 50-100 MPa 
2.1.3 Response of bone tissue to injury 
Bone tissue usually fails when the loads applied to a bone exceed the range 
of forces to which it has adapted. Fractures are then formed, resulting in the 
disruption of the continuity of the tissue and affecting cellular viability, 
vascular connections and the structural integrity of the bone. In the strict 
clinical sense, the term includes a whole range of potential defects affecting 
bone, from microscopic fractures to the rupture of a bone into many 
fragments (McRae and Esser, 2008; Bueno and Glowacki, 2011) 
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As any other material, cyclic loading may lead to the failure of bone tissue 
through a process known as fatigue. This involves the accumulation of 
microstructural cracks, also known as microdamage, resulting in an increase 
in bone fragility (Schaffler, 2003; Bueno and Glowacki, 2011). These defects 
were first described by Frost in human rib samples as small cracks with 
linear morphology and lengths between 30 and 100 μm, and he was also the 
first to propose that these cracks may be targeted by the remodelling 
process of bone tissue in order to maintain the mechanical integrity of the 
skeleton (Schaffler, 2003). Since then, this idea has been supported by 
significant experimental studies. For example, Mashiba et al. (2001) reported 
an increase in the number of microstructural cracks and decreased 
mechanical properties in the bones of dogs treated with drugs that 
suppressed the remodelling process. There is also evidence that the 
presence of the cracks can initiate targeted remodelling of bone tissue, as 
reviewed by Burr (2002). Verborgt et al. (2000) reported that microdamage is 
translated into osteocyte death through apoptosis, which may then play a 
significant role in the remodelling process due to the strong associations that 
exist between osteocyte apoptosis and subsequent bone remodelling. In 
summary, this continuous cycle of microdamage due to wear and tear and 
bone tissue remodelling has the benefit of providing bone the ability to 
regenerate and heal injuries. Most other tissues lack a similar regenerative 
capacity and usually heal by scar formation (Bueno and Glowacki, 2011). 
The causes of larger fractures are varied. Trauma is the most frequent cause 
and it may occur both directly and indirectly. Fatigue fractures may develop 
due to excessive cyclic loading of a bone, generating damage at a faster rate 
than the healing process and leading to eventual failure. Pathological 
fractures occur in abnormal or diseased bone, where a particular condition 
weakens the tissue and the force required to produce the fracture is reduced 
(McRae and Esser, 2008). Fractures may also be classified depending on 
the mechanism of injury, the strength of the force causing them, the direction 
of the fracture lines and the degree of associated soft tissue damage (Bueno 
and Glowacki, 2011). 
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In order for proper healing to occur in bone there must be enough vascularity 
and viable cells available to facilitate each phase of the repair process. This 
may occur by one of two mechanisms: primary healing or secondary healing. 
Primary healing occurs in fractures which are partial or stable and that are 
aligned so that the surfaces are very closely positioned. Osteons close to the 
fracture will die due to the lack of blood supply and then osteoclasts will 
begin to cut cones at the ends of the Haversian canals, resorbing the bone 
and allowing for the expansion of the capillary network around the fracture 
site. Osteoblasts then will follow the osteoclasts, depositing new woven bone 
tissue and creating osteons that connect with the other surface (Bueno and 
Glowacki, 2011). Secondary healing is a more complex mechanism, 
involving four stages: inflammation, soft callus formation, hard callus 
formation and remodelling. These are summarised in Table 2.4. 
Table 2.4. Description of the four stages in the secondary healing mechanism in bone tissue. 
Adapted from Bueno and Glowacki (2011). 
Stage Length Actions 
Inflammation 3 – 4 
days 
Formation of hematoma and fibrin clot; Arrival on 
immune, mesenchymal and osteoprogenitor cells; 
Bone at the edges become necrotic and degrades due 
to release of lysosomal enzymes by osteocytes; 
Macrophages phagocytose debris and osteoclasts 
resorb fragments of necrotic bone. 
Soft callus 
formation 
3 – 4 
weeks 
Rapid proliferation of osteoprogenitor cells in the 
periosteum; Differentiation into chondrocytes and 
osteoblasts; Formation of cartilaginous callus, 
immobilising fracture fragments. 
Hard callus 
formation 
3 – 4 
months 
Vascularisation of soft callus and replacement with 
woven bone, through endochondral bone formation 
and intramembranous bone formation; Osteoclasts 
continue resorbing dead bone. 
Remodelling Several 
years 
Reorganisation of woven bone into lamellar bone and 
formation of medullary cavity 
2.1.4 Bone graft substitutes 
Although many fractures have the ability to regenerate without the need of 
surgical intervention, there may be situations when the results of the healing 
process may not be optimal due to systemic problems, such as poor health 
or advanced age; diseases, such as diabetes; and the use of medications, 
such as glucocorticoids. Poor results can also occur due to issues 
associated with the defect site, such as the fracture of bone tissue into many 
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fragments, infection, inadequate immobilisation and anatomical problems 
(Bueno and Glowacki, 2011). 
Bone grafts are generally used to promote bone formation in defect sites 
derived from congenital or acquired conditions (Bueno and Glowacki, 2011). 
Currently, the transplantation of autogenous bone grafts obtained from non-
load bearing sites in the skeleton is the treatment that presents the best 
clinical outcomes in the replacement of damaged bone tissue. The iliac crest 
is the most commonly used donor site, although alternatives such as the 
proximal part of the tibia, the distal end of the radius or the greater trochanter 
have also been investigated (Myeroff and Archdeacon, 2011). The 
transplanted bone tissue tends to integrate well into the defect site and the 
risks of immune rejection and disease transmission are practically 
eliminated, in contrast to what may occur with grafts obtained from other 
donors (allografts) or from animal sources (xenografts). Despite these 
benefits, autogenous bone grafts present important challenges such as the 
limited amount of bone which can be obtained and the variable quality of the 
grafts depending on the conditions of the patient. There are also associated 
issues such as increased risks of bleeding, hematoma, infection, chronic 
pain and morbidity in the donor sites (Moore, 2001; Myeroff and Archdeacon, 
2011). 
A wide range of materials have been investigated as alternatives for bone 
grafts: metals, ceramics and polymers of synthetic and natural origin (Table 
2.5). Metals have usually been used in orthopaedic and dental applications 
due to their good mechanical properties. However, as they are bioinert 
materials, metals will form a bond with bone which is simply mechanical and 
cannot adapt to varying conditions, potentially leading to a loosening of the 
implant. An approach used to improve their performance is to coat the 
metallic surface with a bioactive material such as HA, which may promote 
the formation of a strong bond with bone. However, this presents certain 
limitations, such as potential chemical reactions occurring between the metal 
and the coating which may weaken the implant at the proximity of the 
interface and may reduce the strength of the coated system (Barone et al., 
2010). 
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Table 2.5. Materials investigated to be used as bone substitutes and their potential applications 
Adapted from Barone et al. (2010) and Bohner (2010). 
Type of 
material 
Material Applications 
Metals Stainless steel 
Titanium 
Titanium alloys 
Joint replacement 
Bone plates 
Dental implants 
Ceramics Alumina 
Zirconia 
Calcium sulphates 
Calcium carbonates 
Calcium phosphates 
Hydroxyapatite 
Bioactive glasses 
Bioactive glass-ceramics 
Joint replacement 
Dental implants 
Bone screws 
Maxillofacial reconstruction 
Ossicular bone substitutes 
Kerato-prostheses 
 
Polymers Poly(lactic acid) 
Poly(glycolic acid) 
Poly(caprolactone) 
Cellulose 
Hyaluronic acid 
Fibrin 
Collagen 
Chitosan 
Joint replacements 
Bone fixation devices 
Drug delivery systems 
 
Ceramics were proposed as bone graft substitutes due to good resistance to 
corrosion, good biocompatibility levels, low friction, high resistance to wear, 
and stability in physiological environments (Barone et al., 2010). Alumina 
(Al2O3) was the first ceramic widely used clinically with great success, usually 
in dental applications and in total joint prostheses. Zirconia (ZrO2) has also 
been successfully used in total joint prostheses due to high fracture 
toughness and tensile stress values. However, both alumina and zirconia are 
bioinert and only form a mechanical bond with bone. 
Polymers are very attractive materials to be used as bone graft substitutes 
because their composition and structure can be tailored to suit specific needs 
depending on the method of polymerisation, processing and 
functionalization, making it possible to create devices with predictable 
chemical and physical characteristics (Barone et al. 2010). A group of 
polymers which has received considerable attention for this purpose is the 
family of poly(α-hydroxy esters). These polymers can be processed using a 
wide range of techniques, including electrospinning, exhibit good levels of 
biocompatibility and are bioresorbable. Bioresorbable polymers are those 
that will degrade after implantation, usually through a non-biological process 
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such as hydrolysis, and will be safely removed from the body through cellular 
activity (Treiser et al., 2013). The most frequently used poly(α-hydroxy 
esters) for tissue regeneration applications are poly(glycolic acid) (PGA), 
poly(lactic acid) (PLA) and poly(caprolactone) (PCL). The properties of these 
polymers, as well as their mechanisms of degradation and resorption, will be 
discussed with detail in the following sections of this Literature Review. 
However, despite these advantageous characteristics, polymers are 
preferentially used in non-load bearing sites in the skeleton due to their weak 
mechanical properties compared to metals and ceramics. 
A common characteristic of most of the previously mentioned materials is 
that they are bioinert. However, bioactive materials offer the potential to 
improve the attachment between the implant and bone tissue as a result of a 
series of physical and chemical reactions that occur at the implant-tissue 
interface. Bioactive ceramics, such as hydroxyapatite and tricalcium 
phosphate, have been used in several clinical applications because they are 
biocompatible, biodegradable, osteoconductive and can bond directly to 
bone. Bioactive glasses, capable of forming a layer of hydroxy-carbonate 
apatite which leads to the formation of a bond with soft and hard tissues, 
have been used in prostheses, bone fillers and scaffolds. Bioactive glass-
ceramics, made through the application of appropriate thermal treatments to 
glass that result in the growth of crystal phases within the amorphous 
vitreous matrix, have shown improved mechanical properties and moderate 
bioactivity compared with the bioactive glass compositions from which they 
were derived. One of the most clinically successful glass-ceramic 
compositions is the denominated A/W, constituted by two crystalline phases 
(i.e. an apatite phase and a wollastonite phase) and a residual vitreous 
phase (De Aza et al., 2007). Despite the beneficial characteristics of 
bioactive materials, they do not usually provide good support in load-bearing 
applications and it may be difficult to process them into specific shapes for 
particular clinical applications (Barone et al., 2010). 
Finally, an approach which has received considerable attention is the 
production of composite bone graft substitutes through the combination of 
two or more biomaterials. This has usually been achieved by embedding a 
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ceramic or bioactive glass within a polymer matrix, creating structures which 
may retain key characteristics of both biomaterials. For example, it may be 
possible to mould structures with shapes fitting specific bone defects using 
polymers presenting resorption rates that match the rate of new bone tissue 
formation (Barone et al., 2010). Additionally, it may be possible to mimic the 
composite nature of bone matrix by adding ceramics which may enhance the 
mechanical properties of the polymer. Bonfield (1988) reported that a 
composite material made of synthetic HA embedded within a matrix of 
polyethylene presented mechanical properties comparable to those of bone. 
The addition of 45S5 bioglass particles to a poly(lactic-co-glycolic acid) 
(PLGA) matrix by Lu et al. (2003) resulted in the creation of structures with 
higher compressive modulus than the polymer on its own and which 
supported the growth and mineralisation of osteoblast-like cells in vitro. 
The most frequent polymers chosen for the fabrication of composite 
materials are poly(α-hydroxy esters), mainly due to their bioresorbability. 
These polymers generate acidic degradation by-products as they degrade, 
reducing the local pH and potentially affecting negatively the surrounding 
tissues after implantation. It has been proposed that the alkalinity produced 
by the dissolution of embedded bioactive glass particles may be used to 
buffer the acidic effect of the polymer degradation (Suggs et al., 2007; Jones, 
2013). Another concern is the potential loss of structural integrity as the new 
bone tissue grows. Ideally, the composite biomaterial should maintain its 
structure for as long as necessary while the regeneration occurs. However, 
the potentially different rates of degradation of each phase may result in an 
unstable construct and an increased risk of some particles migrating within 
the body after implantation (Jones, 2013). 
2.1.5 Commercial bone graft substitutes 
About half a million bone graft operations are performed in the United States 
and around 300000 in Europe every year. The majority of those procedures 
involve the treatment of bone defects caused by trauma, the removal of 
tumours and non-union of fractures using a temporary template composed 
by the patient’s own bone (Jones, 2011). However, as previously discussed, 
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there are major issues associated with the use of autogenous bone grafts 
which will have a significant impact in the patient’s quality of life. Bone graft 
substitutes with appropriate characteristics may have a beneficial effect as 
the patient would require a smaller number of operations and may be able to 
return to a normal life more rapidly. From an economic perspective, bone 
graft substitutes may also reduce the costs involved in the operations. It is 
estimated that the market of bone graft substitutes is worth US$ 2 billion/year 
(Jones, 2011) and has been in continuous growth for several years. Many 
companies have produced their own designs and have commercialised them 
after strict control and approval by regulatory bodies such as the FDA and 
the EU. Table 2.6 and Table 2.7 present a summarised list of commercial 
products approved to be used as bone graft substitutes in the United States 
and Europe. 
Table 2.6. Summarised list of commercial products approved to be used as bone graft 
substitutes in the United States and Europe. Adapted from Finkemeier (2002) and Jones (2011).  
Product Company Source Type 
Grafton 
DBM 
Osteotech Human Demineralised bone matrix 
DynaGraft GenSci 
Regeneration 
Sciences 
Human Demineralised bone matrix 
OrthoBlast GenSci 
Regeneration 
Sciences 
Human Demineralised bone matrix and 
allograft cancellous bone 
Osteofil Sofamor Danek Human Demineralised bone matrix with 
gelatin carrier and water 
Opteform Exactech Human Compacted corticocancellous 
bone chips mixed with the 
same material as Osteofil 
DBX Synthes Human Demineralised bone matrix 
Allomatrix Wright Medical 
Technology 
Human/Synthetic Demineralised bone matrix in 
an Osteoset medium 
Endobon Merck KGaA Animal Sintered bovine cancellous 
bone 
Bio-Oss Osteohealth 
 
Animal Bovine bone 
Interpore Interpore 
International Inc 
Animal Coralline hydroxyapatite 
Pro-
Osteon 
Interpore 
International Inc 
Animal Coralline hydroxyapatite 
Collagraft Zimmer Animal/Synthetic Bovine collagen, 
hydroxyapatite, tricalcium 
phosphate 
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Table 2.7. (Continuation) Summarised list of commercial products approved to be used as bone 
graft substitutes in the United States and Europe. Adapted from Finkemeier (2002) and Jones 
(2011).  
Product Company Source Type 
NovaBone NovaBone 
Products LLC 
Synthetic Bioactive glass 
PerioGlas NovaBone 
Products LLC 
Synthetic Bioactive glass 
BonAlive BonAlive 
Biomaterials Ltd 
Synthetic Bioactive glass 
StronBone RepRegen Ltd Synthetic Bioactive glass 
Osteoset Wright Medical 
Technology 
Synthetic Calcium sulphate 
ApaPore Apatech Ltd Synthetic Hydroxyapatite 
Vitoss Orthovita Synthetic Ultraporous β-tricalcium 
phosphate 
SRS Norian Synthetic Calcium phosphate injectable 
cement 
2.2 Bone tissue engineering 
Two main approaches currently exist for the repair and regeneration of 
damaged tissues, driven by a desire to prevent the issues associated with 
the replacement of damaged tissues using grafts: tissue engineering and in 
situ tissue regeneration (Hench and Polak, 2002). 
Tissue engineering involves the isolation of specific cells and their seeding 
on a scaffold in vitro under controlled conditions that would encourage the 
synthesis of new extracellular matrix. The overall aim is to engineer a 
biological construct which may be implanted into a defect site in order to 
support the regeneration of the damaged tissues. Langer and Vacanti (1993) 
proposed that tissue engineering may be defined as: ‘an interdisciplinary field 
that applies the principles of engineering and the life sciences toward the 
development of biological substitutes that restore, maintain, or improve 
tissue function’. In situ tissue regeneration involves the implantation of cell-
free biomaterials into a defect site in order to stimulate and guide local cells 
in the surrounding tissues to repair the defect in vivo. Various bioactive 
materials and growth factors may be used to encourage the activation and 
recruitment of cells, which in turn would produce additional growth factors 
and would stimulate multiple generations of cells to form the new tissues. 
Figure 2.4 shows a schematic representation of both approaches. 
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Figure 2.4. Schematic diagram of two alternative approaches for tissue regeneration: a) Tissue 
engineering, involving the in vitro seeding of a porous scaffold, cellular infiltration, proliferation 
and production of extracellular matrix (ECM), followed by the implantation of the construct into 
a defect site; and b) in situ tissue regeneration, involving the implantation of a cell-free 
biomaterial into a defect site, followed by in vivo protein adsorption on the implant’s surface, 
cellular infiltration, proliferation and production of extracellular matrix. 
The main advantage of tissue engineering is the potential to deliver cells 
which are already differentiated and are capable of sustaining the 
regeneration process, directly into the defect site. Although in situ tissue 
regeneration is based on a similar fundamental idea, encouraging the 
surrounding cells to repair the defect, this approach may prove ineffective if 
the gap to be filled is too large. In those cases it may be more convenient to 
implant a tissue engineered construct in which the regeneration process has 
already started. Another advantage is the potential to produce large 
quantities of tissue on demand for specific applications, eliminating the 
problems of tissue shortages as a relatively small number of cells would 
need to be harvested from the patient and then expanded in vitro. The use of 
autologous cells may also prevent undesired potential risks such as immune 
rejection and disease transmission. Additionally, tissue engineering may 
allow for a high level of control of cell culture conditions, a situation which is 
not possible after implantation in the body. For example, it is possible to 
apply mechanical stimuli to cell-scaffold constructs during culture in order to 
encourage the formation of extracellular matrix, or control the supply of 
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nutrients and oxygens using techniques specifically developed for this 
purpose, such as dynamic cell cultures using fluid perfusion. This control 
becomes more difficult as the culture process progresses, as the 
extracellular matrix produced by the cells in the scaffolds may reduce the 
passage of nutrients and oxygen, reducing their availability to the cells 
residing in the core of the scaffold and resulting in their necrosis. The 
absence of a vascular network is a major drawback for tissue engineered 
constructs, especially if their dimensions are large (Ikada, 2006). Finally, the 
success of the tissue engineered construct will be strongly influenced by the 
age, health status, systemic conditions and genetic background of the donor. 
In situ tissue regeneration seems, in principle, simpler than tissue 
engineering as the cell seeding and culture steps are eliminated. The 
biological conditions required for the development of the new tissues are 
directly provided by the body, as it occurs for natural regeneration processes. 
However, the implanted biomaterial should be designed in such a way as to 
provide the surrounding tissues with a suitable environment for the 
regeneration process to successfully occur. For example, it may be possible 
to induce the formation of a vascular network supporting the growth of the 
new tissue if angiogenic factors are included and slowly released by the 
implant (Ikada, 2006). Additional advantages of in situ tissue regeneration is 
that there are fewer immunorejection and ethical concerns compared with 
tissue engineering, and it may be easier to fabricate devices which would be 
easily used in the surgical theatre. Despite these attractive characteristics of 
in situ tissue regeneration, the possibility of dealing with larger defects and 
the potential of greater control on the culture conditions make tissue 
engineering a discipline which has attracted great attention for the treatment 
of many defects. 
2.2.1 Design of scaffolds for tissue engineering 
Most cells reside in an environment called the extracellular matrix, which is 
essential for the healthy development of tissues in the body. The various 
functions of extracellular matrix are: the provision of support for cells to 
attach, proliferate, migrate and respond to signals; the contribution of 
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mechanical properties to the tissue; the provision of biological cues that 
regulate cellular activity; the formation of a reservoir of growth factors and 
other biological cues; and the provision of a dynamic environment that may 
change in response to tissue processes such as morphogenesis, 
homeostasis and wound healing (Chan and Leong, 2008). 
The native extracellular matrix is usually considered as the best possible 
scaffold for any particular tissue engineering application in terms of structure 
and function. All scaffolds should then attempt to mimic it as close as 
possible. The fundamental design criteria for any scaffold for tissue 
engineering should then take in account the following factors (Chan and 
Leong, 2008): 
1) Architecture: the scaffold should provide space for vascularisation, 
tissue growth and remodelling. The structure should be porous for the 
efficient transport of nutrients and other substances without 
compromising the mechanical stability of the scaffold. The scaffold 
should ideally be degradable after implantation, with a rate matching 
the rate of new matrix production. 
2) Cyto- and tissue compatibility: the scaffold should provide support for 
cells to attach, proliferate and differentiate both in vitro and in vivo. 
The biomaterials selected should be compatible with the cellular 
components in the tissue engineered construct and in the host. 
3) Bioactivity: the scaffold may interact with the cellular components of 
the tissue engineered construct, facilitating and regulating their 
activity. The biomaterials may include biological of physical cues to 
enhance attachment (i.e. cell-adhesive ligands) or to influence 
morphology and alignment (i.e. topography). The structure may also 
work as a delivery system of biochemical signals that may enhance 
tissue regeneration (i.e. growth factors). 
4) Mechanical properties: the scaffold should provide mechanical and 
shape stability to support the regeneration of the tissue in the defect 
site. If possible, the mechanical properties of the biomaterials used to 
fabricate the scaffold or their post-processing properties should match 
that of the host tissue. 
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Two main approaches have been investigated to fabricate porous scaffolds. 
The first approach involves the processing of synthetic (e.g. ceramics, 
polymers) or natural (e.g. chitosan, cellulose) materials in order to fabricate 
pre-made of artificial porous scaffolds. The second approach involves the 
removal of cellular elements from tissues and organs in order to produce 
collagenous porous scaffolds that retain the shape of the native tissues. 
These two approaches are schematically represented in Figure 2.5. 
 
Figure 2.5. Schematic diagram of two approaches for the production of porous scaffolds for 
tissue engineering applications. Adapted from Chan and Leong (2008). 
The fabrication of pre-made scaffolds using natural or synthetic materials 
presents various advantages over the use of decellularised tissues and 
organs: firstly, there is a wide range of biomaterials and manufacturing 
methods that may be used; and secondly, the properties of the scaffold may 
be more easily engineered in order to mimic the characteristics of the native 
extracellular matrix. This way, the resulting structures may be more easily 
sourced and more reproducible. The main disadvantage is the potentially 
inefficient seeding of the structure due to the limited penetration of cells into 
the scaffold. Various methods have been investigated to enhance 
penetrability, such as agitation or perfusion, but these are not free of 
problems and may increase the cost and complexity of the tissue 
engineering process. The manufacturing techniques used may be classified 
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within the following categories: processes using porogens in the 
biomaterials, solid free-form or additive manufacturing technologies, and 
techniques generating woven or non-woven fibres. Decellularised tissues 
and organs usually exhibit good levels of biocompatibility, mainly due to very 
closely mimicking the native structure of extracellular matrix. Specialized 
techniques are used to remove cellular components, usually through a 
combination of physical, chemical and enzymatic methods (Chan and Leong, 
2008). However, the structures may require a crosslinking treatment with 
glutaraldehyde (Tedder et al., 2009; Zhao et al., 2011) or other chemicals (Lu 
et al., 2010) to reinforce their mechanical properties and stabilise their shape 
(Chan and Leong, 2008). Additionally, cell seeding may also result in 
inhomogeneous cellular distributions while incomplete removal of cellular 
components may elicit immune reactions upon implantation. Examples of this 
approach include veins (Schaner et al., 2004), liver (Lin et al., 2004; 
Shirakigawa et al., 2012), or trachea (Baiguera et al., 2010; Remlinger et al., 
2010). 
The criterion used to select a biomaterial for the fabrication of artificial 
structures is also very important. As mentioned above, it should be 
biocompatible and, ideally, should degrade through a mechanism that does 
not generate toxic by-products. Any by-product should also be easily 
removed from the implantation site through metabolic routes in order to 
prevent a negative effect on the implant and the surrounding tissues. The 
degradation process should ideally occur at a rate matching the regeneration 
rate of the tissues to maximise the healing process. 
The mechanical properties of the scaffold and of the biomaterials selected to 
fabricate it will influence its application and the techniques used for its 
processing. Scaffolds with small pores exhibit greater strengths but the small 
size will greatly limit the penetration of cells and nutrients, and the 
vascularisation of the new tissues, while larger pores will reduce the overall 
strength of the structure. Additionally, the mechanical properties of the 
biomaterial will have an important influence on the seeded cells. Many 
mature cell types, such as epithelial cells, fibroblasts, muscle cells and 
neurons, are able to sense the stiffness of the substrate and may show 
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dissimilar morphology and adhesive characteristics as a result (Discher et 
al., 2005). Stem cells may also be influenced by this, as it was shown that 
MSCs may differentiate into different cell lineages in response to the 
elasticity of the matrix they attach to, depending on how similar it was to the 
elasticity of the native tissues (Engler et al., 2006). Natural materials, as 
mentioned above, may require treatments to improve their stability and 
mechanical properties. Synthetic materials may offer better controlled 
physical and mechanical properties, and may be used to tailor for both soft 
and hard tissues (Chan and Leong, 2008). 
The capacity of any particular biomaterial to withstand sterilisation is another 
crucial issue in the development of scaffolds as they will be implanted in the 
body and the risk of potential infection needs to be fundamentally reduced to 
zero. The sterilisation of biomaterials has usually been performed using 
various techniques such as dry heat sterilisation, autoclaving, ultraviolet light, 
radiation and treatment with various chemical agents. In the particular case 
of polymers, sterilisation is a complex issue because their thermal and 
chemical stability are lower than in other materials. Only some polymers (e.g. 
polytetrafluoroethylene, silicon rubber) can be safely dry-sterilised at 
temperatures between 160˚C and 190˚C, which are above the melting 
temperature of bioresorbable poly(α-hydroxy esters), such as poly(lactic-co-
glycolic acid). In general, poly(α-hydroxy esters) will also be affected if 
sterilised through autoclaving due to the presence of water in the process, as 
they degrade by hydrolysis. Radiation treatments at high dosages may result 
in the dissociation or cross-linkage of the polymer chains, altering the 
properties of the material. Chemical agents such as ethylene oxide gas and 
hypochloride solutions can be used to sterilise polymers at low temperatures 
if the exposure time is relatively short, although they may still suffer some 
damage if residual molecules are present (Khang, 2012). 
Besides the choice of material, the architecture given to the scaffold will play 
an essential role in the regeneration process. The structure should be porous 
without significantly compromising its mechanical stability (Chan and Leong, 
2008). Additionally, a large surface area will favour cell attachment and 
proliferation, while a large pore volume will be able to accommodate a mass 
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of cells large enough for tissue regeneration. In general, a high porosity and 
a good level of interconnectivity between the pores are desirable for the easy 
transport of materials and for the migration of cells into the structure, as well 
as to provide sufficient space for the synthesis of extracellular matrix and its 
vascularisation, which will be required for the long term viability of the 
construct (Yang et al., 2001). 
2.2.2 Bone tissue engineering 
The aim of bone tissue engineering is to create a healing response in a 
precise anatomic area of the skeleton so that the new tissue is structurally 
integrated with the surrounding tissues and has the appropriate 
biomechanical characteristics in order to be durable and effective (Kakar and 
Einhorn, 2005). 
This may be achieved by promoting, aiding and/or regulating the filling of the 
defect through new bone tissue formation by implanting cell-seeded 
scaffolds, or through the ingrowth of bone into the defect by implanting cell-
free scaffolds (Bueno and Glowacki, 2011). Cell-seeded scaffolds may be 
used when the implantation of bone cells or tissue in the defect site is 
desired. The in vitro cultivation of these scaffolds may also allow for the 
addition of physical or chemical cues in the structure that will guide cell 
proliferation and differentiation. Cell-free scaffolds may be used to fill the void 
created by a defect and to encourage the formation of new bone tissue as it 
grows from the implant-tissue interface (Bueno and Glowacki, 2011). 
Bone tissue engineering requires many of the same properties as other 
tissue engineering areas for scaffolds and the biomaterials used in their 
fabrication. This includes biocompatibility, biodegradability and high porosity. 
Ideally, the scaffold should degrade at a rate similar to the rate of bone 
growth but this will depend on the choice of biomaterials used and the 
architecture. For example, surgeons usually prefer to see regeneration of 
large bone defects over a period of approximately 12 months (Jones, 2013). 
With respect to the porosity, it has been suggested that the ideal pore size 
for bone tissue engineering is 200-500 μm, with smaller pores generally not 
being able to support the vascularisation of the new tissue (Gauthier et al., 
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1998; Yang, 2001; Bueno and Glowacki, 2011). Additionally, specific 
desirable characteristics of scaffolds for bone tissue engineering include: 
acting as substrate for osteoid deposition, supporting and promoting 
osteogenic differentiation, promoting osseointegration, prevention of soft 
tissue growth at bone-implant interface, being malleable and adaptable to 
irregular wound sites, being sterilisable without losing its properties and 
being available to surgeons on short notice (Katsanevakis et al., 2012). 
Materials frequently used in the fabrication of scaffolds for bone tissue 
engineering have been demineralised bone matrix, synthetic and natural 
polymers, ceramics and bioactive glasses. However, as no single material is 
able to fulfil all the requirements for bone tissue engineering applications, 
composite biomaterials that attempt to mimic the composite nature of bone 
tissue have generally been investigated. Several ceramics, glass-ceramics 
and bioactive glasses have been studied for this purpose, as reviewed in 
different publications (Hench, 1998; Barone et al., 2010; Holzwarth and Ma, 
2011). 
Ideally, the scaffolds used for bone tissue engineering should exhibit a 
strength and stiffness similar to that of the native bone tissue that is trying to 
regenerate. Bone strength can range from 20 MPa (trabecular) to 200 MPa 
(cortical). One advantage of synthetic polymers is the ability to tailor the 
mechanical properties to match the desired function, although there is a 
trade-off between strength and the ability to degrade. Generally, strong 
polymers degrade slowly while highly degradable polymers are weak. Also, 
polymers become stronger, stiffer, tougher and more resistant to wear with 
an increase in molecular weight and crystallinity. Crosslinking can also 
increase the strength and rigidity of polymers by reducing the ability of 
polymer chains to slide relative to each other (Wang et al., 2010). Ceramics 
like HA may be manufactured as dense structures, which show considerable 
compressive strength but are brittle and not suitable for load-bearing 
applications; and as porous structures, which possess poor mechanical 
properties. Bioactive glasses are considered to be weaker than most other 
bioactive materials, restricting their use to non-load bearing sites as well. 
However, bioactive glass-ceramics possess enhanced mechanical properties 
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while exhibiting moderate bioactivity (Barone et al., 2010). Table 2.8 
presents the mechanical properties of various biomaterials compared with 
those of cancellous and cortical bone. 
Table 2.8. Mechanical properties of various bioceramics compared with cancellous and cortical 
bone. Adapted from Middleton and Tipton (2000), Rezwan et al. (2006) and Barone et al. (2010). 
PGA=Poly(glycolic acid); P(L)LA=Poly(L-lactic acid); P(DL)LA=Poly(DL-lactic acid); 
PCL=Poly(caprolactone); PLGA=Poly(lactic-co-glycolic acid); HA=Hydroxyapatite; 
A/W=Apatite/Wollastonite glass-ceramic. 
Biomaterial 
Strength (MPa) 
Young’s 
modulus (GPa) 
Fracture 
toughness 
(MPa·m1/2) 
Compressive Bending 
Polymers 
PGA 
Fibre: 
340–920 
- 7.0 - 
P(L)LA 
Pellet: 
40–120 
Film or disk: 
28–50 
Fibre: 870–
2300 
- 2.7 - 
P(DL)LA 
Pellet: 
35–150 
Film or disk: 
29–35 
- 1.9 - 
PCL - - 0.4 - 
PLGA 41.4–55.2 - 2.0  
Bioceramics 
45S5 
bioglass 
- 42 35 - 
HA 500-1000 115-200 80-110 1.0 
A/W 1080 220 118 2.0 
Human bone 
Cancellous 2-12 - 0.05-0.5 - 
Cortical 100-230 50-150 7-30 2-12 
The approaches used in the fabrication of porous scaffolds for bone tissue 
engineering applications are various and include the use of wide range of 
techniques. Conventional methods to fabricate scaffolds, such as the 
production of fibre meshes through standard textile technologies, gas 
foaming, phase separation, freeze drying and particulate leaching, do not 
generally allow for a fine control over pore connectivity and the structures 
tend to lack structural stability (Moroni et al., 2008; Bueno and Glowacki, 
2011). Alternative approaches, such as additive manufacturing, 
electrospinning and surface-based technologies, allow for more precise 
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control over the structural characteristics of the scaffolds. Additive 
manufacturing employs a CAD/CAM approach to design and fabricate 
precise three-dimensional scaffolds layer by layer (Seitz et al., 2005; Wilson 
et al., 2011; Seol et al., 2013). Electrospinning, which will be explained with 
detail in section of this Literature Review, applies a high voltage electric 
current to a polymer solution to generate fibres with dimensions potentially 
similar to fibrils present in bone extracellular matrix (Jang et al., 2009; 
Holzwarth and Ma, 2011). Surface-based technologies include a range of 
lithographic tools used to fabricate bi-dimensional structures with specific 
surface topologies, which can then be stacked to form three-dimensional 
scaffolds (Moroni et al., 2008; Papenburg et al., 2007; Sellgren and Ma, 
2012). 
The cells most frequently used in bone tissue engineering have been 
sourced from the bone marrow. Mesenchymal stromal cells (MSCs) are a 
population of bone marrow cells which exhibit adherence to culture 
substrates in vitro and are able to differentiate into osteoblasts and form 
bone in vivo. With the appropriate stimulation they are able to differentiate 
into other cellular lineages including chondrocyte, adipocyte and fibroblast 
(Pittenger et al, 1999). The main issue with MSCs is that the number of cells 
found in bone marrow tends to be low, with estimations of one cell per fifty 
thousand nucleated cells in young individuals and even lower numbers in the 
elderly (Kakar and Einhorn, 2005). Therefore, alternative sources of MSCs 
with osteogenic potential have been investigated and isolated from adipose 
tissue, peripheral blood, the placenta and the umbilical cord (Hass, 2011). It 
has been suggested that allogeneic adult MSCs may be implanted without 
eliciting immune rejections in the host, especially when it was observed that 
the cells did not express cell-surface HLA-Class II antigens after expansion 
in vitro (Le Blanc et al., 2003) and that the expanded cells did not persist for 
long after implantation (Bueno and Glowacki, 2011). 
Finally, bone tissue engineering approaches often attempt to mimic the 
natural environment surrounding bone formation through the addition of 
bioactive components that may stimulate cell proliferation, migration, 
differentiation, osteogenesis and/or vascularisation. These may be 
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incorporated into the scaffold to be released after cultivation or implantation, 
and their effect will depend on dosage and release kinetics, which in turn are 
dependent on pore size and degradation rate. High doses may be necessary 
to obtain the desired effect due to the generally short half-lives of many of 
those components, potentially leading to undesirable bone formation outside 
the defect area (Bueno and Glowacki, 2011). Some of the bioactive 
components used are bone-morphogenetic proteins (e.g. BMP2), angiogenic 
factors (e.g. vascular endothelial growth factor), factors promoting cell 
adhesion (e.g. peptides containing Arg-Gly-Asp), protein mixtures (e.g. 
cocktail of enamel matrix proteins) and synthetic compounds (e.g. 
simvastatin). 
2.3 Electrospinning 
Electrospinning is a versatile method used to generate fibres with diameters 
from a few micrometres to tens of nanometres through the application of 
electrostatic forces to polymeric solutions or melts (Doshi and Reneker, 
1995; Huang et al., 2003; Martins et al., 2008). 
The history of electrospinning began in the late 16th century, when William 
Gilbert recorded the first observations of the electrostatic attraction of a liquid 
and the existence of what later would be known as the Taylor cone. 
Research on the science behind this phenomenon continued during the 
following centuries but it did not gain wide popularity until the beginning of 
the 20th century, when it began to be used in the fabrication of textiles and 
filters and when J. F. Cooley filed the first patent for the electrospinning 
method. Its introduction in the field of biomaterials occurred during the 
1990’s, when Doshi and Reneker (1995) successfully demonstrated that 
fibres with small diameters could be spun from solutions of different polymers 
and then suggested several potential applications for them. Since then, the 
number of publications about electrospinning has generally increased every 
year at an exponential rate (Tucker et al., 2012). 
The versatility of this method is due to the ability to tailor several properties 
of the electrospun fibres and membranes, such as diameter, morphology, 
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porosity and chemistry, by controlling the parameters and conditions of the 
process and by selecting appropriate starting materials. Electrospinning has 
been used for a broad range of purposes, including: biomedical applications, 
such as tissue engineering, drug delivery and wound dressing (Goh et al., 
2013); the development of electronic components and devices (Miao et al., 
2010); the creation of oil sorbents for environmental protection (Lin et al., 
2012); and the development of materials for energy-related applications, 
such as fuel cells or supercapacitors (Dong et al., 2011). 
2.3.1 The electrospinning process 
There are three basic elements that form an electrospinning system: a high 
voltage power supply, a capillary tube, and a grounded metal collecting plate 
(Figure 2.6). The system is usually placed inside a chemical hood to allow for 
the elimination of vapours originating from the organic solvents used to 
create the polymer solutions. Additionally, a closed environment with 
regulated temperature and humidity may be installed to prevent the 
interference of environmental factors in the process, such as air turbulence 
or the sudden variations of temperature (Martins et al., 2008). 
The electrospinning process involves the application of a high voltage 
electrical current to a capillary filled with a polymer solution, inducing a 
charge on the surface of the liquid. This results in the creation of mutual 
charge repulsions that generate forces directly opposite to the surface 
tension. As the intensity of the electric field increases, the hemispherical 
surface of the fluid at the tip of the capillary tube elongates to form a conical 
shape known as the ‘Taylor cone’. When the electric field reaches a critical 
value, at which the repulsive electric force overcomes the surface tension 
force, a charged jet is ejected from the tip of the Taylor cone and travels in 
the air towards the collecting plate. As long as the molecular cohesion in the 
liquid is sufficiently high, the jet will not break down. 
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Figure 2.6. Schematic diagram of an electrospinning system, identifying the main components 
that form it. Adapted from Martins et al. (2008). 
According to Reneker and Yarin (2008), the typical path of the jet is initially a 
stable and straight segment followed by a coil of increasing diameter. The 
coil is created by electrically driven bending instabilities generated by the 
repulsive interactions between the charges in the polymer solution. As it 
travels toward the collecting plate, the jet continues to coil and stretch while 
the solvent evaporates. When the jet finally reaches the plate it deposits, 
forming a non-woven mat of randomly distributed fibres. Since the generation 
of the fibre may occur uninterruptedly, it is theoretically possible to fabricate 
mats formed by very long fibres and exhibiting high levels of porosity (Doshi 
and Reneker, 1995; Huang et al., 2003; Martins et al., 2008). 
Several variations can be made to the basic system to allow for a more 
precise control on the results. For example, the capillary and the collecting 
plate can be arranged both vertically and horizontally. If arranged in a vertical 
orientation, with the collector placed directly above the capillary, then it will 
be possible to prevent drops of polymer solution from falling from the needle 
on the mat. A syringe pump may also be used to accurately control the flow 
rate of the polymer solution, which will play a significant role determining 
fibre diameter. Specially designed collector systems, such as rotating drum 
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collectors and static parallel electrodes, may be used to produce mats made 
of aligned fibres. Finally, it is known that the nature of the collector can have 
an influence in the density of the fibres per unit area and in arrangement of 
the fibres. Conductive collectors (i.e. aluminium foil) help dissipate the 
charges in the fibres upon deposition and reduce repulsion between them, 
resulting in the production of smooth and densely packed fibres. Conversely, 
non-conducting materials (i.e. paper) will not dissipate the charges, 
increasing repulsion between the fibres and will result in more loosely 
packed mats (Baji et al., 2010). 
 
Figure 2.7. Scanning electron microscopy micrograph of electrospun poly(caprolactone) 
showing the random distribution of fibres in the mat. 
The processing parameters governing the electrospinning method are 
multiple. In order of relative importance, from higher to lower impact in the 
results, these are: applied voltage, polymer flow rate, and distance from the 
capillary tip to the collecting plate. Additionally, a number of solution 
parameters play an important role in fibre formation and structure. In order of 
relative importance, from higher to lower impact, these are: polymer 
concentration, solvent volatility, and solvent conductivity (Sill and von 
Recum, 2008). The effects these have on the electrospinning process are 
presented in Table 2.9. 
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Table 2.9. Effects of the variation of processing and solution parameters on electrospun fibre 
diameter and morphology. Adapted from Sill and von Recum (2008). 
Parameter Effect on fibre diameter and morphology 
Increase of applied voltage 
Fibre diameter will initially decrease, but it will then 
increase after reaching a certain voltage value. 
Increase of flow rate 
Fibre diameter will generally increase. A beaded 
morphology may appear if the flow rate is too high. 
Increase of distance from 
capillary to collector 
Fibre diameter will generally decrease. A beaded 
morphology may appear if the distance is too short. 
Increase of polymer 
solution concentration 
Fibre diameter will generally increase if concentration 
is within an optimal range. 
Increase of solvent 
conductivity 
Fibre diameter will generally decrease. Fibres may 
present a broad diameter distribution. 
Increase of solvent volatility 
Fibres will generally exhibit pores on their surface, 
increasing surface area. 
Environmental parameters such as temperature and relative humidity also 
have an important effect on the electrospinning process (Tripatanasuwan et 
al., 2007; De Vrieze et al., 2009) and, as previously mentioned, it may be 
necessary to take special measures in order to produce fibres with regular 
diameters and morphologies. De Vrieze et al. (2009) reported that there were 
two main and opposing effects of the temperature on electrospun 
poly(vinylpyrrolidone) (PVP) and cellulose acetate (CA). The first effect was 
the evaporation rate of the solvent, which decreased at lower temperatures 
and, thus, it took longer for the jet to solidify. The second effect was the 
rigidity of the polymer chains, which had more freedom to move at higher 
temperatures and resulted in lower solution viscosity. At lower temperatures 
(i.e. 283 K) the first effect was dominant, while at higher temperatures (i.e. 
303 K) the second effect was dominant. Both resulted in decreased fibre 
diameters, but intermediate temperatures (i.e. 293 K) resulted in larger fibre 
diameters. With respect to humidity (i.e. concentration of water in the 
atmosphere), De Vrieze et al. (2009) reported that PVP fibre diameters 
generally decreased at higher humidity levels although this effect stopped at 
certain levels, when the fibres began to fuse upon deposition. Additionally, 
their observations suggested that these effects may vary depending on the 
polymer used. Although the effect of the temperature on CA was similar to 
what happened to PVP, CA fibres presented larger average diameters at 
high humidity levels. 
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2.3.2 Electrospinning for bone tissue engineering 
Electrospinning is a technique which has received considerable attention for 
the production of scaffolds for bone tissue engineering due to the wide range 
of polymers which can be processed and to the potential of producing fibrous 
materials which may mimic native bone matrix in terms of scale and structure 
(Goh et al., 2013). The diameter of electrospun fibres usually range from a 
few micrometers down to tens of nanometers, similar to the thickness of 
collagen fibres in bone tissue (i.e. 50 – 500 nm) (Holzwarth and Ma, 2011). 
Additionally, the materials produced can exhibit large surface area to volume 
ratio, high porosity and may be degradable if fabricated with appropriate 
biomaterials. Table 2.10 and Table 2.11 present a summarised list of 
electrospun systems fabricated and investigated for potential bone 
regeneration applications. 
Table 2.10. Summary of electrospun systems produced for potential bone regeneration 
applications. PLA=poly(lactic acid); PGA=poly(glycolic acid); PLGA=poly(lactic-co-glycolic 
acid); PCL=poly(caprolactone); PLCL=poly(lactic acid-co-caprolactone); PEO=poly(ethylene 
oxide); HA=hydroxyapatite; TCP=tricalcium phosphate. 
Material Composition Reference 
Inorganic 
materials 
Bioactive glass Kim et al., 2008 
Lu et al., 2009 
Silicates Sakai et al., 2006 
Yamaguchi et al., 2010 
Natural 
polymers 
Collagen Matthews et al., 2002 
Shih et al., 2006 
Chitosan Shin et al., 2005 
Silk fibroin Park et al., 2010 
Cellulose Li, K.N. et al., 2012 
Fibrin Sreerekha et al., 2013 
Gelatin Zhang et al., 2005 
Composite Gelatin and 
bioactive glass 
Gao et al., 2013 
Synthetic 
polymers 
 
PLA Li et al., 2006 
Schofer et al., 2008 
Prabhakaran et al., 2009 
PGA Li et al., 2006 
PLGA Li et al., 2006 
Xin et al., 2008 
PCL Yoshimoto et al., 2003 
Li et al., 2006 
Wutticharoenmongkol et al., 2006 
PLCL Kwon et al., 2005 
Bottino et al., 2011 
Composite PLA and HA Ngiam et al., 2009 
Prabhakaran et al., 2009 
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Table 2.11. (Continuation) Summary of electrospun systems produced for potential bone 
regeneration applications. PLA=poly(lactic acid); PGA=poly(glycolic acid); PLGA=poly(lactic-
co-glycolic acid); PCL=poly(caprolactone); PLCL=poly(lactic acid-co-caprolactone); 
PEO=poly(ethylene oxide); HA=hydroxyapatite; TCP=tricalcium phosphate. 
Material Composition Reference 
Synthetic 
polymers 
Composite PLA and HA Ngiam et al., 2009 
Prabhakaran et al., 2009 
Composite PLGA and 
amorphous TCP 
Schneider et al., 2008 
Composite PLA and HA Ngiam et al., 2009 
Prabhakaran et al., 2009 
Composite PLGA and 
amorphous TCP 
Schneider et al., 2008 
Composite PLGA and SiO2-
CaO gel 
Kim et al., 2010 
Composite PCL and HA Wutticharoenmongkol et al., 2006 
Yang et al., 2009 
Composite PCL and HA/TCP Patlolla et al., 2010 
Composite PCL and CaCO3 Fujihara et al., 2005 
Wutticharoenmongkol et al., 2006 
Composite PEO and silica Toskas et al., 2011 
Polymer 
blends 
PLGA/Collagen Liao et al., 2008 
PCL/Gelatin Zhang et al., 2005 
PCL/Collagen Chakrapani et al., 2012 
Collagen/Gelatin Jha et al., 2011 
Chitosan/PEO Desai et al., 2008 
Composite PLA/Collagen and 
HA 
Ngiam et al., 2009 
Prabhakaran et al., 2009 
The main issue with the application of electrospun materials for bone tissue 
engineering is associated with the difficulty in creating pores large enough to 
allow cellular migration and tissue perfusion, which may be particularly 
challenging for the treatment of large defects (Shin et al., 2012). Zhang et al. 
(2005) reported the enhanced infiltration of bone marrow MSCs into an mesh 
made of electrospun PCL and gelatin (i.e. 114 µm) compared with PCL on its 
own (i.e. 48 µm), suggesting that it may be possible to improve the situation 
by using natural polymers. However, achieving an adequate penetration of 
cells still remains a difficulty to be overcome. Another significant issue of the 
technique is limited reproducibility due to potential differences between 
electrospinning systems used by various research groups and laboratories. 
Many of those systems are custom built and may lack accurate humidity and 
temperature control, which would allow reducing variability introduced by 
environmental changes. 
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Among polymeric materials, bioresorbable poly(α-hydroxy esters) such as 
PGA, PLA, PCL and their copolymers have been the most extensively 
investigated for electrospinning. These polymers and their characteristics will 
be described with detail in section 2.4 of this review. Additionally, the 
fabrication of composite electrospun materials using bioresorbable polymers 
and bioceramics has received considerable attention due to the possibility of 
combining the properties of bioresorbable polymers with bioceramics in one 
single structure. This way, the inorganic phase may improve the biological 
properties of the polymeric fibres (i.e. enhancement of biocompatibility and 
osteogenetic potential of the biomaterial) while the polymeric phase may 
introduce some degree of flexibility that bioceramics lack. Also, as there is no 
need of thermal treatment because of the binding polymer phase, 
electrospun composite fibres may also be used in drug delivery applications. 
Finally, the addition of bioceramics in particulate form to electrospun fibres is 
considered a promising approach for bone tissue regeneration as it may 
make it possible to develop structures that mimic the composite nature of 
bone extracellular matrix (Jang et al., 2009). 
Potential problems of composite electrospun materials are similar to those 
that affect all composites. The main concern usually is the mechanical 
integrity of the material, especially if there is no interfacial bonding between 
the polymer and the bioceramic particles. This issue is particularly 
challenging when using poly(α-hydroxy esters), since the bioceramic phase 
tends to be highly hydrophilic and the polymers are hydrophobic. This may 
be solved by increasing the bonding at the interface using surfactants 
chemisorbed to the surface of the particles, but this may potentially affect the 
biocompatibility and degradation properties of the composite (Rezwan et al., 
2006). Additionally, both phases should ideally degrade at similar rates to 
maintain the mechanical properties of the structure and to match the rate of 
tissue regeneration. However, current polymer-bioceramic composites 
present different rates of degradation for each phase. The hydrolytic 
degradation of the ester bonds in bioresorbable polymers creates carboxylic 
groups, reducing the local pH and autocatalysing and accelerating its 
degradation. Natural polymers, which tend to degrade through enzymatic 
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activity, exhibit more linear degradation rates and may be adequate 
alternatives. However, it is usually more difficult to obtain reproducible 
sources than in the case of synthetic polymers (Jones, 2013). The production 
of composites with bioceramic nanoparticles also present a challenge as the 
particles tend to agglomerate and will not disperse homogeneously 
throughout the composite, which will result in the formation of beads in the 
electrospun fibres. Surfactants may be added to facilitate this step, by 
stabilising the interface of the nanoparticles and the polymer solution (Jang 
et al., 2009). However, this may present similar issues as those mentioned 
above for the increase of the interfacial bonding. 
2.4 Bioresorbable polymers 
Certain clinical circumstances may require the use of implants that will serve 
a temporary purpose rather than a permanent one. In those situations, 
degradable materials are of interest because the implants fabricated with 
these materials will not need to be surgically removed after they have fulfilled 
their purpose. The removal process can create new wounds, increasing the 
risk of surgical complications and infections, and, therefore, that is usually 
avoided if possible. Additionally, the use of degradable implants can prevent 
problems associated with the long-term safety of permanent implants, such 
as immune rejection, chronic inflammation at the implant-tissue interface, 
and final failure of the device. However, degradable implants are not exempt 
of safety concerns, such as the potential toxicity of degradation by-products, 
and the possible premature failure of the implant as the degradation process 
occurs. Therefore, the design of degradable implants will require the careful 
selection and testing of all the biomaterials used (Treiser et al., 2013). 
All biomaterials undergo some degree of degradation and, as a 
consequence, the strict differentiation between ‘degradable’ and ‘non-
degradable’ materials is often difficult. Gopferich (1996) suggested that this 
distinction may be based on the relation between the time-scale of the 
degradation and the time-scale of the desired application. Therefore, the 
term ‘degradable’ may be attributed to materials which degrade during their 
application or immediately after it, and ‘non-degradable’ may be attributed to 
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those materials that require a period of time to degrade substantially longer 
than the duration of the application. Several terms have generally been used 
in the literature to indicate that a material will eventually disappear after 
implantation into a living organism: biodegradation, bioerosion, bioabsorption 
and bioresorption (Treiser et al., 2013). ‘Biodegradation’ refers to the 
chemical breakdown of the material through a biologically-mediated process 
(i.e. enzymatic or cellular activity). If the breakdown occurs through non-
biological processes, such as hydrolysis, then the process is known as 
‘degradation’. ‘Bioerosion’ refers to the degradation process of a water-
insoluble material that is converted into a water-soluble material through 
physical and chemical mechanisms under physiological conditions. Finally, 
the terms ‘bioabsorption’ and ‘bioresorption’ are often used interchangeably 
and refer to the elimination of the material and its degradation by-products 
through cellular activity (i.e. phagocytosis). 
For the sake of consistency, the term ‘bioresorbable material’ will be used in 
this review for all those materials which are degradable and are bioresorbed 
by the body, leading to the total elimination of the implant and its degradation 
by-products with no residual side-effects. This process finally results in the 
replacement of the implant by the surrounding tissues, preventing additional 
surgical interventions to remove it and, thus, eliminating associated risks to 
the patient (Vert et al., 1992; Middleton and Tipton, 2000). 
2.4.1 Bioresorbable polymers 
Bioresorbable polymers may be of natural or synthetic origins. Natural 
polymers, such as collagen, polysaccharides (e.g. chitin, cellulose) and 
microbial polyesters (e.g. poly(hydroxybutyrate), poly(hydroxyvalerate)), 
have been investigated to be used as implantable materials (Pulapura and 
Kohn, 1992). However, synthetic polymers have generally been preferred 
because they offer several advantages over natural polymers as they can be 
produced under controlled conditions and can be tailored to provide a wider 
range of properties, offering less variability than natural materials. Also, they 
are a more reliable source of raw materials and are generally free of 
concerns of immunogenicity (Pulapura and Kohn, 1992; Middleton and 
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Tipton, 2000). A summary of several degradable polymers and their 
applications under investigation are presented in Table 2.12. 
Table 2.12. Summary of degradable polymers and their applications under investigation. 
Adapted from Treiser et al. (2013). 
Polymers Applications 
Synthetic degradable polymer 
Poly(glycolic acid), poly(lactic 
acid) and copolymers 
Barrier membranes, drug and hormone delivery, 
guided tissue regeneration, orthopaedic 
applications, vascular/urological stents, staples, 
sutures, injectable fillers, dura mater substitutes, 
skin replacement materials, tissue engineering 
Poly(caprolactone) Drug delivery, orthopaedic applications, staples, 
stents, tissue engineering 
Poly(dioxanone) Fracture fixation in non-load bearing bones, 
sutures, wound clips 
Other synthetic degradable polymers 
Poly(anhydrides) Drug delivery 
Poly(cyanoacrylates) Adhesives, drug delivery 
Poly(amino acids) and 
‘pseudo’ poly(amino acids) 
Drug delivery, tissue engineering, orthopaedic 
applications, stents, anti-adhesion barriers 
Poly(ortho esters) Drug delivery, stents 
Poly(phosphazenes) Blood containing devices, drug delivery, skeletal 
reconstruction, vaccine adjuvants 
Poly(propylene fumarate) Orthopaedic applications 
Poly(trimethylene carbonate) Sutures, orthopaedic applications 
Natural resorbable polymers 
Poly(hydroxybutyrate) and 
poly(hydroxyvalerate) 
Drug delivery, orthopaedic applications, stents, 
artificial skin, surgical patching materials for 
congenital heart defects, sutures 
Collagen Drug delivery, gene delivery, artificial skin, 
coatings to improve cellular adhesion, guided 
tissue regeneration, spinal dural repair, 
orthopaedic applications, soft tissue augmentation, 
tissue engineering, scaffold for blood vessel 
reconstruction, wound closure, haemostatic agents 
Fibrinogen and fibrin Tissue sealant, cell delivery 
Elastin-like peptides Drug delivery, coating of vascular grafts 
Natural resorbable polymers 
Gelatin Capsule coating for oral drug delivery, 
haemorrhage arrester 
Hyaluronic acid Wound dressing applications, drug delivery, tissue 
engineering, synthetic bone grafts, synovial fluid 
substitutes 
Cellulose Adhesion barrier, haemostat 
Various polysaccharides 
(e.g. chitosan, alginate) 
Drug/vaccine delivery, encapsulation of cells, 
sutures, wound dressings/healing 
Starch and amylose Oral drug delivery 
The most frequently used bioresorbable polymers for the production of 
scaffolds for bone tissue engineering are those in the group of poly(α-
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hydroxy esters), such as poly(glycolic acid) (PGA), poly(lactic acid) (PLA), 
poly(lactic-co-glycolic acid) (PLGA) and poly(caprolactone) (PCL). These 
polymers may be either semicrystalline (e.g. PGA, PCL) or amorphous (e.g. 
PLGA). Semicrystalline polymers have regular repeating units that allow the 
chains to fold into dense regions called crystallites, which act as crosslinks 
and give the polymer higher tensile strengths and higher modulus (i.e. 
stiffness) than the amorphous forms. However, as no polymer can 
completely organise into a crystalline material, many amorphous regions 
remain between the crystallites in semicrystalline polymers. When a 
semicrystalline polymer is heated to a temperature above its melting point it 
may be shaped into moulded parts. Amorphous polymers and the 
amorphous regions in semicrystalline polymers also exhibit a glass transition 
temperature. If they are heated above that temperature, the polymers will 
behave rubber-like, while below that point they will behave more like a glass. 
These properties will affect their mechanical and degradation characteristics 
(Middleton and Tipton, 2000). 
PGA is a highly crystalline, hydrophilic, linear aliphatic poly(ester) with a high 
melting point and relatively low solubility in most common organic solvents. 
PLA is also a linear poly(ester) which is usually easily dissolved in common 
organic solvents such as chloroform, methylene chloride, methanol, ethanol, 
benzene, acetone, dioxane, dimethylformamide and tetrahydrofuran. The 
presence of an extra methyl group in the molecule results in a more 
hydrophobic and amorphous character than PGA. That methyl group also 
creates a chiral centre, forming two enantiomeric forms of the polymer, 
P(D)LA and P(L)LA. The most frequently used form is P(L)LA. Through the 
co-polymerisation of PGA and PLA it is possible to control the physical and 
mechanical properties of the polymers formed, with most co-polymers 
exhibiting an amorphous character and degradation rates that depend on the 
relative amount of each co-monomer. Those with high or low PGA:PLA ratios 
are less sensitive to hydrolysis than those with more equal ratios, mainly due 
to their greater crystallinity. Finally, PCL is a linear, hydrophobic, semi-
crystalline polymer which is capable of forming blends and co-polymers with 
a wide range of molecules (Suggs et al., 2007). A detailed description of PCL 
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will be presented in section 2.4.2 of this review. Table 2.13 presents the 
thermal, mechanical and degradation characteristics of PGA, PLA, and PCL, 
as well as various enantiomers and co-polymers. Bone was included as a 
reference material. 
Table 2.13. Physical, mechanical and degradation properties of selected bioresorbable 
polymers from the poly(α-hydroxy ester) group and copolymers. PGA=Poly(glycolic acid); 
P(L)LA=Poly(L-lactic acid); P(DL)LA=Poly(DL-lactic acid); PCL=Poly(caprolactone); 
PLGA=Poly(lactic-co-glycolic acid). Adapted from Middleton and Tipton (2000) and Wang et al. 
(2010). 
Polymer 
Melting 
Point (°C) 
Glass 
transition 
temperature 
(°C) 
Tensile 
modulus 
(GPa) 
Elongation 
(%) 
Degradation 
time 
(months) 
PGA 225-230 35-40 7.0 15-20 6 to 12 
P(L)LA 173-178 60-65 2.7 5-10 > 24 
P(DL)LA Amorphous 55-60 1.9 3-10 12 to 16 
PCL 58-63 (-65)-(-60) 0.4 300-500 > 24 
85/15 
PLGA 
Amorphous 50-55 2.0 3-10 5 to 6 
75/25 
PLGA 
Amorphous 50-55 2.0 3-10 4 to 5 
65/35 
PLGA 
Amorphous 45-50 2.0 3-10 3 to 4 
85/15 
PLGA 
Amorphous 45-50 2.0 3-10 1 to 2 
2.4.2 Poly(Caprolactone) 
PCL is an aliphatic, hydrophobic, semi-crystalline polymer which is soluble in 
chloroform, dichloromethane, carbon tetrachloride, benzene, toluene, 
cyclohexanone and 2-nitropropane at room temperature. It has a low 
solubility in acetone, 2-butanone, ethyl acetate, dimethylformamide and 
acetonitrile and is insoluble in alcohol, petroleum ether and diethyl ether 
(Woodruff et al., 2010). It may also be mixed with various other polymers, 
such as poly(vinyl chloride), poly(styrene–acrylonitrile) and nitrocellulose; 
and is mechanically compatible with others, such as poly(ethylene), 
poly(propylene) and natural rubber (Labet and Thielemans, 2009). 
PCL degrades within several months to several years depending on the 
molecular weight, the degree of crystallinity and the conditions of 
degradation. The amorphous phase is degraded first, resulting in an increase 
in the degree of crystallinity while the molecular weight remains constant. 
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This is followed by the cleavage of ester bonds, resulting in mass loss. The 
degradation process is autocatalysed by the carboxylic acids liberated during 
hydrolysis and by enzymes, resulting in faster decomposition (Labet and 
Thielemans, 2009).  
The low glass transition temperature of PCL (i.e. -65°C - -60°C) means that it 
always exists in a rubbery state at room temperature, making it a highly 
permeable polymer (Suggs et al., 2007). This, along with its biocompatibility 
and controlled degradability, makes it a very useful polymer for biomedical 
applications such as scaffolds for tissue engineering, sutures, drug-delivery 
systems, wound dressings, contraceptive devices, internal fixation devices 
for bone fractures and dental treatments. Other applications where PCL has 
been frequently used include microelectronics, adhesives and packaging 
(Labet and Thielemans, 2009; Woodruff et al., 2010). 
The main method used to synthesise PCL is the ring opening polymerisation 
of ε-caprolactone (Figure 2.8). This can be achieved through four 
mechanisms which depend on the catalyst employed: anionic, cationic, 
monomer-activated and coordination-insertion ring opening polymerisation 
(Labet and Thielemans, 2009). Each mechanism affects the resulting 
molecular weight, molecular weight distribution, end group composition and 
chemical structure of the co-polymers (Woodruff et al., 2010) The alternative 
method to synthesise PCL is the polycondensation of 6-hydroxycaproic (6-
hydroxyhexanoic) acid. However, the ring opening polymerisation of ε-
caprolactone is usually the preferred route as it gives polymers with higher 
molecular weight and lower polydispersity (Labet and Thielemans, 2009). 
 
Figure 2.8. Schematic diagram of the synthesis of poly(caprolactone) from the ring form of ε-
caprolactone to the polymerised form. 
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PCL may be processed using a wide range of techniques, including 
electrospinning (Woodruff et al., 2010). The vast majority of the research 
work involving the electrospinning of PCL has been done using polymers 
with average molecular weight ranging from 65000 Da to above 80000 Da, 
providing the viscosity necessary for the electrospun jet to be formed. 
Solvents regularly used are DMF, DCM, chloroform, methanol, 
hexafluoroisopropanol and tetrahydrofuran (Cipitria et al., 2011).  
2.4.3 Mechanisms of degradation and resorption 
There are two main mechanisms through which polymer bonds can be 
broken: passively, by hydrolysis; and actively, by enzymatic reaction 
(Gopferich, 1996). The main mode of degradation for most synthetic 
polymers is through hydrolysis, while the enzymatic reaction is generally only 
available for naturally occurring polymers such as poly(saccharides) and 
proteins.  
The factors determining the rate of the hydrolytic reaction are the type of 
bond within the polymer backbone, pH of the environment, copolymer 
composition, and water uptake (Gopferich, 1996). Anhydrides and ortho-
ester bonds are the most reactive, followed by esters and amides. 
Environmental pH can promote degradation through acid or base catalysis, 
resulting in the fastest degradation rates at low and high pH values. The 
introduction of other type of monomer into the polymer chain can influence 
material properties such as crystallinity and glass transition temperature, 
causing indirect effects on the degradation rates which depend on the 
prevailing type of bond. Finally, with respect to water uptake, hydrophilic 
polymers can take up larger amounts of water than hydrophobic polymers 
and, thus, their degradation rates may increase. As hydrolysis is a 
bimolecular reaction, the reaction velocity will be determined by the 
‘concentration’ of the reagents and a larger content of water will result in a 
faster reaction. 
In semicrystalline bioresorbable polymers the hydrolytic process occurs in 
two phases (Middleton and Tipton, 2000). In the first phase water penetrates 
the bulk of the material, preferentially attacking the chemical bonds in the 
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amorphous regions. This results in the conversion of long polymer chains 
into shorter, water-soluble fragments, as represented in Figure 2.9. Because 
this occurs in the amorphous regions, the molecular weight of the polymer 
will be reduced without incurring into significant losses of physical properties 
since the matrix is held together by the crystalline regions. However, the 
physical properties of the structure will eventually be negatively affected as 
water begins to fragment the crystalline regions as well. 
 
Figure 2.9. Schematic diagram of hydrolytic degradation of poly(α-hydroxy ester) polymers 
from insoluble, long polymer chains to soluble polymer monomers. 
In the second phase, the metabolising of the smaller fragments results in a 
rapid loss of polymer mass. The degradation by-products of bioresorbable 
polymers such as poly(glycolic acid), poly(lactic acid) and poly(caprolactone) 
are metabolised through the citric acid cycle (Figure 2.10).  
 
Figure 2.10. Routes of degradation and excretion of some poly(α-hydroxy ester) polymers: 
poly(glycolic acid) (PGA), poly(lactic acid) (PLA) and poly(caprolactone) (PCL). Adapted from 
Santos Jr (2010) and Woodruff and Hutmacher (2010). 
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Therin et al. (1992) reported that the degradation process at the surface of 
poly(lactic-co-glycolic acid) implants initially occurs more rapidly due to a 
greater availability of water. The degradation by-products at the surface are 
then dissolved in the surrounding fluid. In the interior of the material, 
however, the inability of degradation by-products to diffuse away results in 
the development of a local acidic environment that further catalyses polymer 
degradation and accelerates hydrolysis. 
The location of the device plays an important role in the degradation rate of 
implants as well, as large devices implanted in areas with poor 
vascularization may degrade and overwhelm the body's ability to eliminate 
degradation by-products. This may lead to a build-up of acidic by-products 
and the development of an acidic environment that will catalyse the further 
degradation and cause further reduction in pH. The local reduction in pH may 
also be responsible for adverse tissue reactions. The metabolical routes 
through which the degradation products of some poly(α-hydroxy esters) are 
eliminated are shown in Figure 2.10. 
All bioresorbable polymers suffer erosion when degrading. Depending on the 
way this process occurs, it may be possible to differentiate between surface 
(heterogeneous) and bulk (homogeneous) eroding polymers (Gopferich, 
1996). Surface eroding polymers will gradually lose material from their 
surface, decreasing in size while maintaining the original shape of the device 
and its structural integrity. In the case of bulk eroding polymers, the process 
will occur throughout the whole structure and, as a result, the size of the 
device will be maintained while its structural integrity is diminished. Figure 
2.11 shows a schematic representation of how these two processes affect a 
polymeric device. 
The distinction between a surface eroding and a bulk eroding polymer will 
depend on several factors (Treiser et al., 2013). The chemistry of the 
polymer will determine the rate at which water is transported into the device. 
In bulk eroding polymers water penetrates the device at a faster rate than the 
rate at which the material is degraded into water-soluble fragments, resulting 
in the formation of cracks throughout the whole structure and in its final 
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disintegration into small fragments. In surface eroding polymers the material 
severely limits the rapid penetration of water and the rate at which the 
material is degraded into water-soluble fragments is fast, limiting the erosion 
process to the surface of the device. The architecture will also play a 
significant role, as sizes above certain critical thickness, specific for each 
polymer, will result in surface erosion, while sizes below that will result in 
bulk erosion (Von Burkersroda et al., 2002). The main advantage of surface 
erosion is that, knowing the characteristics of the polymer used, it may be 
possible to predict the outcomes of the erosion process, which may be 
interesting for applications such as drug delivery. 
  
Figure 2.11. Schematic diagram of surface erosion and bulk erosion processes on a polymeric 
device. Adapted from Gopferich (1996). 
Finally, it is known that the degradation process of synthetic polymers may 
also be influenced by biological activity (Williams and Zhong, 1995; Azevedo 
and Reis, 2004). Inflammation is usually observed in the region where a 
biomaterial has been implanted, especially at the implant-tissue interface, 
resulting in the release of elevated concentrations of hydrolytic enzymes 
which may potentially accelerate the degradation of the implant. For 
example, cholesterol esterase presents a high level of activity towards 
polyurethanes, proteinase K is able to accelerate the degradation of poly(L-
lactic acid) and lipase is able to catalyse the hydrolysis of poly(caprolactone). 
Additionally, chemical and enzymatic oxidation may play an important role in 
the degradation of various polymers. Leukocytes and macrophages are able 
to produce highly reactive oxygen species during inflammation, such as 
superoxide (O2
-) and hydrogen peroxide (H2O2), which may induce polymer 
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chain cleavage and thus contribute to the degradation of the implant. Many 
oxidative enzymes use dioxygen (O2) as a substrate, incorporating it into 
other substrates during the reaction (i.e. oxygenase) or using it as an 
acceptor of electrons (i.e. oxidase), and may play an important role in the 
degradation of implanted polymeric devices (Williams and Zhong, 1995). For 
example, Beranova et al. (1990) discovered that a multi-enzyme 
monoxygenase system with cytochrome P450 in the microsomal fraction of 
mouse and rat livers had a significant effect on the degradation of 
poly(ethylene). Santerre et al. (1994) and Labow (1999) investigated the 
effect of horseradish peroxidase, catalase and xanthine oxidase on 
poly(urethanes) but these oxidative systems were not able to induce the 
polymer degradation (Azevedo and Reis, 2004). 
2.4.4 Cell-polymer interactions 
Cell adhesion to a substrate is necessary for good implant-cell interaction. 
Several factors associated with the characteristics of the polymer surface will 
play an essential role in the ability of cells to attach, proliferate and 
differentiate (Santos JR, 2010). Additionally, any material implanted in the 
body will become quickly coated with proteins from the surrounding fluids. 
Many of the subsequent implant-cell interactions will depend on, or derive 
from, the composition of that layer of proteins (Saltzman and Kyriakides, 
2007).  
Factors such as the presence of polar groups on the surface of the polymer 
and its wettability have an effect on the adsorption of proteins and cell 
adhesion. Cell adhesion appears to be maximised on surfaces with 
intermediate wettability. For most surfaces, adhesion requires the presence 
of tissue culture serum, which indicates that this is probably associated with 
the ability of proteins in the serum to adsorb to the surface. In the absence of 
serum, cell adhesion is enhanced on positively charged surfaces (Saltzman 
and Kyriakides, 2007). 
It is also possible to generate polymer surfaces more suitable for cell 
adhesion and proliferation by surface modification. For example, polystyrene 
substrates used in tissue culture applications are usually treated by glow 
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discharge or exposure to chemicals to increase the number of charged 
groups, improving cell attachment and growth. Again, the effect of these 
modifications seems to be also associated with the ability of proteins to 
adsorb on the surface, providing points of cell attachment. However, certain 
chemical groups at the polymer surface, such as hydroxyl (-OH) or surface 
C-O functionalities, may play important roles in modulating the fate of 
attached cells and it may influence cell interactions in vivo. For example, the 
ability of macrophages to form multinucleated cells on the surface varies 
depending on the chemical groups present (Saltzman and Kyriakides, 2007). 
The use of bioresorbable polymers increases the complexity of these issues 
in vivo, as the presence of degradation by-products may cause additional 
and prolonged consequences on attached cells and surrounding tissues. The 
effects will mainly depend on the chemical properties of the polymer and are 
not difficult to determine, especially in the case of those by-products released 
through hydrolysis or enzymatic digestion. However, the effects of by-
products released due to cellular activity are more difficult to predict because 
all the chemical and biological mechanisms have not been clearly described 
(Saltzman and Kyriakides, 2007). 
2.5 Bioactive glasses 
A bioactive material can be defined as a biomaterial ‘that elicits a specific 
response at the interface of the material, which results in the formation of a 
bond between the tissues and the implant’ (Hench, 1998) 
Bioactive materials include ceramics, glasses and glass-ceramics. Once a 
bioactive material is implanted in the body, a series of biophysical and 
biochemical reactions occur at the implant-tissue interface, resulting in the 
formation of a bond via the formation of a biologically active layer of hydroxy-
carbonate apatite. This layer provides the interfacial bonding and is 
chemically and structurally equivalent to the mineral phase of bone (Barone 
et al., 2010). 
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2.5.1 Bioactive glasses 
Bioactive glasses were introduced in the late 1960s by Larry Hench (2006), 
when he developed a degradable glass with a composition close to a ternary 
eutectic in the Na2O-CaO-SiO2 diagram which provided a large amount of 
CaO with some P2O5 in a Na2O-SiO2 matrix. The first bioactive glass which 
was able to form a mechanically strong bond to bone in vivo, called 45S5 
bioglass, was also developed by Hench and had the composition 46.1 mol% 
SiO2, 24.4 mol% Na2O, 26.9 mol% CaO and 2.6 mol% P2O5. The name 
45S5 refers to both the SiO2 content (45 wt%) and the Ca/P molar ratio. The 
adhesion strengths observed were equivalent to, or even greater, than the 
cohesive force of the implanted material or the tissue bonded to the implant 
(Hench and Wilson, 1984). There are three features that distinguish bioactive 
glasses from other glass compositions: <60 mol% SiO2, high Na2O and CaO 
content and high Ca/P ratios (Hench, 1998). 
Figure 2.12 shows a ternary diagram representing the compositional 
dependence, in wt%, of Na2O-CaO-P2O5-SiO2 glasses to bond to bone and 
soft tissues. All the glass compositions represented have a constant 6 wt% of 
P2O5, while the proportion of the other three components will vary depending 
on the distance to each of the three vertices. The lines inside the triangle 
represent lines of iso-bioactivity. 
 
Figure 2.12. Ternary diagram showing the compositional dependence (in wt%) of bone and soft 
tissue bonding for Na2O-CaO-P2O5-SiO2 glasses. All compositions contain a constant 6 wt% of 
P2O5. Ib=Index of bioactivity. Adapted from Hench (1998). 
Literature review 
51 
 
Many of the glass compositions developed by Hench were characterised in 
terms of the index of bioactivity (Ib), which is a measure of the level of 
bioactivity of bioactive materials. Ib is defined as the inverse of the time 
required for more than 50% of the interface of the glass to bond to bone 
(Equation 2.1) 
   
   
    ⁄
 (days-1) Equation 2.1 
Glasses with compositions inside region A (Ib=5) are able to form a strong 
bond with bone. Those compositions in the region enclosed by the dashed 
line (Ib=8) are also able to bind to soft tissues. Compositions in region B are 
inert and will stimulate the formation of a fibrous tissue capsule surrounding 
the implant. Those in region C are resorbed within a period of 10 to 30 days, 
and those in region D cannot be produced (Hench, 1998; De Aza et al., 
2007). 
Bioactive glasses may be made using two routes: the melt-quenching route 
and the sol-gel route. The melt-quench route consists in melting together a 
series of oxides at high temperatures in platinum crucibles and then 
quenching the melt in graphite moulds, to produce rods or blocks; or 
quenching in water, to produce a frit. In the sol-gel route a solution containing 
the precursors of the bioactive glass undergoes a series of chemical 
reactions to form a gel, which is an inorganic network of covalently bonded 
silica. This can then be dried and heated to form a glass (Jones, 2013). 
Glasses produced through the sol-gel route tend to be more porous than 
those produced through the melt-quench route (Sepulveda et al, 2001), 
potentially increasing their solubility and bioactivity. 
The fabrication of porous scaffolds made of bioactive glass has been 
investigated employing three main approaches: using melt-derived bioactive 
glass, using sol-gel derived bioactive glass and using additive manufacturing 
techniques (Jones, 2013). Porous scaffolds using melt-derived bioactive 
glasses are usually made with techniques involving the sintering of glass 
particles around a template. Alternatively, the sintering may be performed 
after a foaming process or after the advanced manufacturing of a desired 
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structure. The main issue of this approach is that bioactive glasses based on 
the composition of 45S5 bioglass tend to crystallise when heated at 
temperatures above their glass transition temperature, potentially affecting 
several properties including their bioactivity (Jones, 2013). Introducing 
different oxides in the glass composition, such as SrO or ZnO, may help by 
increasing the window of temperature at which the sintering may be 
performed (O’Donnell et al., 2010; Oudadesse et al., 2011). Scaffolds made 
with sol-gel derived bioactive glasses do not present this problem as they do 
not need to be heated at such high temperatures. Porous structures have 
been developed by adding a foaming step to the sol-gel process (Sepulveda 
et al., 2002), creating hierarchical pore structures with interconnected 
macropores (Jones and Hench, 2004). Finally, the pore morphology can be 
controlled more efficiently using additive manufacturing techniques, by 
building the structure layer by layer (Jones, 2013). For example, porous 
structures have been fabricated using lithography-based additive 
manufacturing technologies (Tesavibul et al., 2012). 
2.5.2 Atomic structure of bioactive glasses 
The properties of bioactive glasses with respect to its dissolution rate and the 
rate of formation of the HCA layer are directly related with its atomic 
structure.  
Zachariasen (1932) developed a theory to explain the atomic arrangement in 
glass which derived from the observation that, over large ranges of 
temperature, the mechanical properties of glasses and crystals are 
comparable and, thus, the forces that link the atoms in both materials must 
essentially be the same. Therefore the atoms in glass must form extended 
three-dimensional networks, similar to those in crystals. However, these 
networks are neither periodic nor symmetrical and no two atoms are 
structurally equivalent. Figure 2.13 shows a two-dimensional schematic 
representation of the atomic network in crystalline oxides and vitreous 
oxides. 
In oxide glasses the oxygen atoms form polyhedra around a central atom, 
creating the geometric unit of the glass network. The connection between 
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every geometric unit is achieved by the sharing of corners between different 
polyhedra. Those cations which can form a glass structure such as this are 
called network formers and usually exhibit small ionic radii and large 
valences. In the specific case of vitreous silica (i.e. pure SiO2) the glass 
structure consists of a three-dimensional network of SiO4 tetrahedra. Each 
tetrahedron is formed by four oxygen atoms surrounding a central silicon 
atom and is linked to four other tetrahedra through an oxygen atom common 
to both units. 
 
Figure 2.13. Two-dimensional schematic representation of the atomic network in: a) a 
crystalline oxide and b) a vitrous oxide. The large blue circles represent oxygen atoms and the 
smaller green circles represent network-forming cations. Adapted from Zachariasen (1932). 
Ray (1974) proposed that silicate glasses may also be considered as 
polymers of oxygen with a cross-linked network structure that can have 
different packing densities and varying degrees of cross-linking. The network 
may be formed by alternating oxygen atoms with intermediate atoms such as 
boron, silicon and phosphorus. It may also contain other cations which can 
terminate the chains and reduce the connectivity of the network, altering the 
density of packing of the oxygen atoms. These factors may have an 
important effect on the properties of the glass. 
When the silicate glass contains other ionic components than silica, as in 
bioactive glasses, the network structure is modified. These cations, usually 
known as network modifiers, have large ionic radii and low valences, and will 
occupy the empty spaces in the network. When this happens some of the 
oxygen atoms will no longer be bonded to two silicon atoms and are said to 
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be non-bridging oxygens (NBOs), created to compensate the charge brought 
by the addition of the modifier cations. The distribution of NBOs over the 
tetrahedron unit is characterised in terms of a quantity known as Qn, where n 
refers to the number of bridging oxygens on the tetrahedron: Q3 units are 
tetrahedra with one NBO, Q2 units have 2 NBOs, and so on. This can also be 
characterised in terms of the network connectivity (NC), which measures the 
average number of bridging oxygens on each tetrahedron. For example, 
vitreous silica has a NC value of four, while a structure comprised of strings 
of tetrahedra would have a NC value of two. NC has been found to be useful 
to predict different properties of bioactive glasses, particularly their bioactivity 
(Hill, 1996; Hill and Brauer, 2011). 
Melt-derived bioactive glasses contain considerable amounts of network 
modifiers. In the particular case of 45S5 bioglass silicon is the network 
former, generating Si-O-Si bonds, and sodium and calcium are the network 
modifiers, disrupting the glass network and forming NBOs. Phosphorus, 
according to nuclear magnetic resonance analysis (Elgayar et al., 2005; 
Pedone et al., 2010), is present in an orthophosphate environment (i.e. Q0 
unit) with charges balanced by sodium and/or calcium and not forming P-O-
Si bonds. This means that phosphorus is isolated from the silica network and 
prevents sodium and calcium from working as network modifiers. P-O-Si 
bonds can actually be observed in glasses with more than 50 mol% of 
phosphorus (Li et al., 2011), becoming phosphate glasses. 
The connectivity of the silica network in bioactive glass depends on the 
composition. For example, a high content of silica will generate a highly 
connected network with a large proportion of bridging oxygen (BO) bonds 
(i.e. high NC values), resulting in low dissolution and low bioactivity. The NC 
of the glass can then be lowered by adding network modifiers, such as 
calcium or strontium. However, it can be increased by adding a larger 
proportion of phosphorus, resulting in the repolymerisation of the silicate 
network due to the extraction of network modifiers in order to counter-
balance the charges introduced by phosphorus (Mercier et al., 2011). In 
melt-derived glasses the composition in mol% can be used to calculate the 
NC value. Assuming that phosphorus is in the form of orthophosphate and 
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not part of the silica network (i.e. no formation of P-O-Si bonds) the NC value 
for 45S5 bioglass has been reported to be 2.12 (Jones, 2013). Edén (2011) 
suggested a range of NC values between 2.0 and 2.7 for optimal glass 
bioactivity, with greater values indicating that the glass will likely be not 
bioactive due to resistance to dissolution. A previous model of NC (Hill, 
1996), which assumed that phosphorus entered the silica network forming P-
O-Si bonds, reported NC values of 1.90 for 45S5 bioglass. However, as 
phosphorus was shown not to enter the silica network in bioactive glasses 
(Elgayar et al., 2005; Pedone et al., 2010), this earlier model was 
superseded replaced by the later model (Hill and Brauer, 2004). 
In conclusion, the composition of a bioactive glass should be designed in 
such a way that its bioactivity is optimised for any particular application. 
Since bioactivity tends to be enhanced by relatively low silicate network 
polymerisation or by large amounts of orthophosphate groups, these two 
factors should be taken in account when designing bioactive glasses 
(Mathew et al., 2013): first, the network connectivity should present values 
corresponding to open structures mainly built by Q3 and Q2 units (i.e. <2.7), 
which will readily degrade when exposed to an aqueous environment; and 
second, the negative charges of the phosphorus content, present as 
orthophosphate anions dispersed across the glass matrix, should be 
balanced by the positive charges of the network modifier cations in order to 
increase solubility and bioactivity. The composition 45S5 bioglass is often 
considered as the one that presents the best biological properties of all 
bioactive glasses. Therefore, it is not surprising that it has been thoroughly 
investigated and frequently used as the basis for the development of other 
compositions (Jones, 2013) 
2.5.3 Mechanism of activity of bioactive glasses 
The mechanism of bonding to bone has been attributed to the formation of a 
layer of hydroxy-carbonate apatite (HCA) on the glass surface, which is able 
to interact with collagen fibrils in bone tissue to form a strong bond (Hench, 
1998). This HCA layer is formed through a time-dependent modification of 
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the glass surface, which occurs in five stages in physiological fluids or in 
simulated body fluids (SBF) in vitro: 
1) Rapid exchange of Na+ and/or Ca2+ with H+ from solution, creating 
silanol bonds (Si-OH) on the glass surface. This results in an increase 
of the pH and the creation of a region rich in silica near the surface. 
2) The high pH results in an attack of the silica glass network by OH-, 
breaking Si-O-Si bonds. More Si-OH bonds are formed on the 
surface. 
3) Condensation of the Si-OH groups on the surface, forming a silica-gel 
layer. 
4) Migration of Ca2+ and PO4
3- groups to the surface from the solution, 
forming a film rich in CaO-P2O5 on the silica-gel layer. 
5) Incorporation of hydroxyls and carbonate from solution and 
crystallisation of the CaO-P2O5 film into HCA. 
Glass composition has a great effect on the rate of HCA formation and bone 
bonding. For example, a lower content in silica will result in a less connected 
glass network and higher dissolution rates, accelerating the stages listed 
above. As bioactivity has been related to the connectivity of the glass 
network, it will depend on silica content and the presence of other cations in 
the glass composition. 
According to Hench and Best (2013), the interfacial reactions that lead to the 
formation of a strong bond of bioactive glass with bone tissue are: 
1) Adsorption of biological components on the HCA layer. 
2) Action of macrophages. 
3) Bonding of osteoprogenitor stem cells. 
4) Differentiation of osteoprogenitor stem cells. 
5) Production of extracellular matrix. 
6) Mineralisation of the extracellular matrix. 
However, the stages after the HCA layer is formed are not well defined and 
are still under extensive investigation. It is known that the adsorption of 
proteins from serum attracts macrophages, mesenchymal stromal cells and 
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osteoprogenitor cells. For example, fibronectin, a major glycoprotein in 
serum, is known to increase the attachment of osteoblasts to the calcium 
phosphate layer (El-Ghannam et al., 1999). Additionally, the adsorption of 
proteins may affect the surface reactions forming the HCA layer, interfering 
in the maturation of the amorphous calcium-phosphate layer to crystalline 
hydroxyapatite (Ducheyne and Qiu, 1999). The attachment of 
osteoprogenitor stem cells, and their proliferation and differentiation towards 
the osteoblastic phenotype, is suggested to occur within 24 to 48 hours, 
beginning the production of various growth factors which further stimulate 
cell proliferation and the production of extracellular matrix. The mineralisation 
process will begin shortly after, with mature osteocytes being the final result 
by 6 to 12 days both in vitro and in vivo (Hench and Best, 2013). 
Additionally, bioactive glasses are able to induce the formation of bone on 
the glass apart from the implant-bone interface (Jones, 2013). Xynos et al. 
(2000a, 2001) showed that the release of critical concentrations of calcium 
and silicon ions from the composition 45S5 bioglass had an important effect 
in the control of human osteoblast cell cycle. Seven families of genes 
involved in processes associated with osteoblast metabolism and bone 
homeostasis were activated. Xynos et al. (2000b) also reported a significant 
increase in the production by human osteoblasts of insulin-like growth factor 
II (IGF-II), a potent growth factor that induces cellular proliferation, 
suggesting that the stimulatory effect of bioactive glass dissolution products 
may have been mediated by IGF-II. Various studies have been performed 
investigating this topic, as reviewed by Hench (2009), in cells from various 
sources. 
Regarding the study of the osteogenic effect on MSCs, Radin et al. (2005) 
reported that the presence of 45S5 bioglass resulted in increased levels of 
alkaline phosphatase activity cultured both in contact with the samples and 
apart from them, suggesting that the glasses had a stimulatory effect on the 
osteoblastic differentiation of the cells. Yao et al. (2005) reported an 
increased expression of alkaline phosphatase, osteocalcin and bone 
sialoprotein in RNA extracted from rat MSCs exposed to the dissolution 
products released from PLGA microspheres containing 45S5 bioglass 
Literature review 
58 
 
particles. Bosetti and Cannas (2005) also showed that the dissolution of 
calcium ions and silica from the glass stimulated cell proliferation and the 
production of growth factors and extracellular matrix on rat bone marrow 
cells. However, Reilly et al. (2007) reported that human MSCs generally 
produced significantly lower levels of alkaline phosphatase activity than rat 
MSCs when exposed to bioactive glasses. No significant differences were 
observed in human MSCs cultured in 45S5 bioglass and cell culture plastic 
and no consistent effects were observed in response to bioactive glass 
dissolution, suggesting that the beneficial effects of bioactive glass on bone 
regeneration may not be mediated by an accelerated differentiation of MSCs. 
Karpov et al. (2008) observed the differentiation of human MSCs into 
osteoblasts and osteoclasts when the cells were cultured on bioactive glass 
produced through the sol–gel route with low silica content. However, when 
the glass used had high silica content the cells differentiated only into 
osteoblasts. 
2.5.4 Strontium substitution in bioactive glasses 
Strontium is a chemical element which is mainly present in bones, although it 
can also be found in muscles and physiological fluids. It also has a role in the 
endocrine system, acting in a similar way to calcium. Most of the 
administered strontium is deposited on bone tissue, substituting calcium in 
hydroxyapatite, and is preferentially incorporated into new bones and in 
trabecular bone. In overall, the total content of strontium in bone is 
significantly lower than the amount of calcium (Nielsen, 2004). 
Currently, strontium is used as a treatment for osteoporosis, a disease 
characterised by low bone mass and susceptibility to fracture, in the form of 
strontium ranelate (Marie, 2005). This drug has proved to be an effective 
treatment, acting through a mechanism combining the inhibition of bone 
resorption and the stimulation of new bone tissue formation (Marie et al, 
2001). A study by Sila-Asna et al. (2007) showed that strontium was able to 
stimulate the differentiation of human mesenchymal stromal cells into 
osteoblasts, enhancing the expression of certain osteogenic genetic 
markers, as well as increasing the levels of alkaline phosphatase activity. 
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Pharmacological analyses from preclinical studies have shown that strontium 
is able to modulate bone cell recruitment and activity through modulation of 
the calcium sensing receptor (CaSR), extracellular-signal-regulated kinase 
1/2-mitogen-activated protein kinase (ERK1/2-MAPK), nuclear factors of 
activated T-cells (NFATc) and Wnt signalling pathways. This results in 
decreased bone resorption and increased, or at least maintained, bone 
formation in models with lower bone mineral density (Saidak and Marie, 
2012). 
The inclusion of strontium in bioactive glasses has received the attention of 
different researchers. This can be done by substituting calcium in their 
composition and it may be an effective way of delivering a source of 
strontium ions into defect sites. Several studies have been dedicated to 
understanding the effect of the strontium substitution on glass formation, its 
properties and its mechanism of bioactivity using experimental (Fredholm et 
al., 2010, 2011; O’Donnell et al., 2010) and molecular dynamic simulation 
approaches (Xiang and Du, 2011; Du and Xiang, 2012). The potentially 
enhanced osteogenic effect of these glasses on osteoprogenitor cells has 
also been investigated (Gentleman et al., 2010; Isaac et al., 2011; Li et al., 
2012b). In general, it has been reported that increasing the proportion of 
strontium substitution results in an increase of glass density (Fredholm et al., 
2010) and a decrease of glass transition temperature (Fredholm et al., 2010; 
O’Donnell et al., 2010). Molecular dynamic simulations (Xiang and Du., 2011; 
Du and Xiang, 2012) and solid-state NMR data (Fredholm et al., 2010, 2011) 
have agreed that network connectivity does not change with the substitution. 
In vitro studies on osteoblasts and osteoclasts (Gentleman et al., 2010) 
showed that strontium-substituted bioactive glasses were able to increase 
osteoblast metabolic activity, proliferation and alkaline phosphatase activity, 
while osteoclast differentiation and bone resorption was inhibited. Isaac et al. 
(2011) studied a strontium-substituted bioactive glass manufactured through 
the sol-gel process on foetal mouse calvarial cells, observing greater alkaline 
phosphatase activity and the up-regulation of several genetic markers, 
including alkaline phosphatase, type I collagen and osteocalcin. In vivo 
studies have also been performed (Gorustovich et al., 2010) to study the 
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osteoconductivity of these glasses. Although a good bone-bonding ability 
was observed, it is important to note that the substitution of calcium by 
strontium was made on a weight basis rather than on a molar basis. As 
strontium is heavier than calcium, replacing an equivalent weight of strontium 
will result in a smaller amount of strontium atoms in the glass than there 
were calcium atoms. It was suggested by O’Donnell and Hill (2010) that this 
will result in an increase of the network connectivity and a potential reduction 
of glass bioactivity, making it difficult to compare between different glass 
compositions. 
2.6 Summary 
The regenerative capacity of bone tissue means that it can repair itself in 
response to injury. However, surgical intervention may be necessary when 
the defects are large and the conditions required for the tissue regeneration 
process to occur are missing, especially in older patients. 
The clinical procedure that presents the best clinical outcomes is the 
transplantation of autogenous bone grafts. However, there are significant 
issues that can complicate the treatment, such as the limited amount of bone 
which can be obtained from the patient. Allografts and xenografts may also 
be used for this purpose, but the risk of disease transmission and immune 
rejection make other alternatives be preferred over these. 
The pressing clinical needs created by these issues have led to the use of 
materials of diverse composition as bone substitutes and to the development 
of novel approaches to tissue regeneration, such as tissue engineering. 
Bone tissue engineering will require the creation of scaffolds with appropriate 
characteristics to support the formation of new bone tissue: the scaffolds 
should be made of biocompatible and bioresorbable materials; they should 
be sterilised without compromising its characteristics; and the composition 
and architecture of the scaffolds should facilitate cell attachment, 
proliferation, differentiation and the formation of new blood vessels that will 
guarantee its viability. 
Literature review 
61 
 
Electrospinning is a versatile method which may be used to generate fine 
fibres through the application of electrostatic forces to polymeric solutions or 
melts. This technique has received significant attention for the fabrication of 
scaffolds for tissue engineering because the membranes produced are highly 
porous and exhibit large-specific surface areas. Bioresorbable polymers, 
such as poly(α-hydroxy esters), are generally favoured to fabricate 
electrospun scaffolds as they degrade through time without generating toxic 
by-products and may be resorbed by the body after implantation without 
inducing serious side-effects. Their bioresorption also means that a second 
surgery to remove the implant is eliminated, being eventually replaced by the 
new bone tissue as the regeneration process occurs. 
Composite materials with potentially improved biological characteristics may 
also be fabricated using electrospinning by combining bioresorbable 
polymers and particles of different bioceramics or bioactive glasses, resulting 
in structures which may display the chemical and mechanical properties of 
both materials simultaneously. Bioactive glasses are of particular interest for 
this purpose, as their dissolution in an aqueous environment and subsequent 
surface changes may encourage the formation of new bone tissue. 
Additionally, their composition may be modified to include the presence of 
additional chemical elements which may enhance the osteogenic effect of 
the material, such as strontium. 
The strontium cation has been reported to encourage the formation of new 
bone tissue by stimulating osteoblasts and inhibiting osteoclasts when used 
as part of the osteoporotic drug strontium ranelate. The substitution of 
calcium by strontium in bioactive glasses and its effect on different material 
and biological properties has been investigated by several researchers, 
reporting that it may indeed present a similar osteogenic effect and may 
potentially encourage the formation of new bone tissue as well. 
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3 Aim and objectives 
Electrospun membranes have significant potential to be used as scaffolds for 
bone tissue engineering as they exhibit high porosity and large specific 
surface areas. Additionally, electrospun composite materials may be 
produced by incorporating ceramic or glass particles within the fibres, 
potentially enhancing its biological properties. 
Recently, strontium-substituted bioactive glasses have received the attention 
of several researchers as a potential material to be used in bone 
regeneration applications (Lao et al., 2009; Gentleman et al., 2010; 
Gorustovich et al., 2010; O’Donnell et al., 2010; Isaac et al., 2011). It has 
been reported that these glasses have the ability to encourage the formation 
of new bone tissue through the release of the strontium cation in dissolution 
and its subsequent action on bone cells. Hence, these glasses may form the 
basis of promising new materials for bone tissue regeneration. However, 
relatively little work has been directed towards the use of strontium-
substituted bioactive glasses in systems aimed to be used as scaffolds for 
bone tissue engineering. 
Thus, the aim of this project was to design and fabricate an electrospun 
composite material made of PCL, a bioresorbable polymer, and particles of 
strontium-substituted bioactive glass, and to evaluate its potential use as a 
scaffold for bone tissue engineering. 
To achieve this, the following objectives were identified: 
1) To fabricate a series of strontium-substituted bioactive glasses in 
which calcium is substituted by strontium in an increasing proportion 
based on the composition 45S5 bioglass. 
2) To assess and discuss the effect of the strontium substitution on the 
physical properties of the glasses using a range of characterisation 
techniques; and on the mechanism of bioactive glass bioactivity based 
on the data obtained from the different experiments. 
3) To optimise the electrospinning process to produce regular fibres in 
the experimental conditions available in the laboratory. 
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4) To fabricate and characterise a series of electrospun materials using 
PCL and particles of the strontium-substituted bioactive glasses. 
5) To develop suitable methods to place additional bioactive glass 
particles on the surface of the electrospun fibres. 
6) To study the in vitro biocompatibility of all the electrospun materials 
produced by assessing their cytotoxicity on cultures of a particular cell 
line. 
7) To investigate the effect of the dissolution products of strontium-
substituted bioactive glass on the viability of osteoprogenitor cells by 
assessing its cytotoxicity. 
8) To study the potential osteogenic effect of the dissolution products of 
strontium-substituted bioactive glass on osteoprogenitor cells by 
measuring the expression of genes involved in the process of 
osteoblastic differentiation. 
PCL was selected for this study because it is a biocompatible and 
bioresorbable polymer that may be processed using various techniques, 
including electrospinning. Additionally, PCL is a highly permeable polymer, 
making it suitable for the potential release of bioactive glass dissolution 
products from within the polymeric fibres. Finally, PCL was selected as it was 
not expected that the electrospun material would suffer structural shrinkage 
during incubation as it occurs with other bioresorbable polymers, such as 
PLGA (Li et al., 2006). 
Electrospinning was selected because it is a versatile technique capable of 
generating fibres with diameters ranging from a few micrometers down to 
tens of nanometers, fabricating materials potentially capable of physically 
mimicking the extracellular matrix of bone tissue in terms of scale and 
structure. Additionally, it was considered a suitable technique to fabricate 
composite fibres combining PCL and particles of strontium-substituted 
bioactive glass. The resulting materials were considered to be a promising 
system to be used as a scaffold for bone tissue engineering. Alternative 
applications may be working as a filler of bone voids in non-load bearing 
sites of the skeleton or as a bioresorbable component in barrier membranes 
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for guided bone regeneration applications, where it may encourage bone 
growth in structures affected by periodontal disease. 
On completion of this work, a novel electrospun composite biomaterial will be 
produced. A good understanding of the manufacturing process and of 
several physical and biological properties of the material will be gained, 
providing clear indications of its potential to be used as a scaffold in bone 
tissue engineering applications. Finally, a better understanding of the 
mechanism of bioactivity of these glasses may also be gained. 
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4 Materials and methods 
4.1 Bioactive glass production and characterisation 
4.1.1 Bioactive glass batch preparation and melting 
Three bioactive glasses were produced (i.e. Sr0, Sr50 and Sr100) based on 
compositions published by O’Donnell et al. (2010), where Sr0 was based on 
the composition of the original 45S5 bioactive glass, initially reported by 
Hench (1998). Sr50 and Sr100 were compositions where CaO was 
substituted by SrO in proportions of 50 mol% and 100 mol% respectively. 
The substitutions were performed on a molar basis to maintain atomic 
proportionality in the glass structure. Table 4.1 presents the mol% and wt% 
compositions of each bioactive glass, as well as the raw materials used and 
the amounts required to produce 300 g of glass. 
Analytical grade silicon dioxide, calcium carbonate, sodium carbonate, 
sodium phosphate (Fisher Scientific, UK) and strontium carbonate (Sigma 
Aldrich, UK) were thoroughly mixed and slowly loaded into a platinum 
crucible. Each batch was then melted in an electric furnace preheated to 
1350 °C. After an initial hour of melting, the mixture was homogenised by 
continuous stirring using a rotating platinum paddle at a speed of 60 rpm for 
2 hours.  
Table 4.1. Molar percentage (Mol%), weight percentage (Wt%), raw materials and amounts 
required to obtain 300 g of Sr0, Sr50 and Sr100 bioactive glasses. 
Bioactive glass Oxide Mol% Wt% Raw material For 300 g glass 
Sr0 
SiO2 46.13 45.00 SiO2 135.0 g 
Na2O 24.35 24.50 Na2CO3 85.4 g 
CaO 26.91 24.50 CaCO3 131.2 g 
P2O5 2.60 6.00 Na3PO4 41.6 g 
Sr50 
SiO2 46.13 40.77 SiO2 122.3 g 
Na2O 24.35 22.19 Na2CO3 77.3 g 
CaO 13.46 11.10 CaCO3 59.4 g 
SrO 13.46 20.51 SrCO3 87.7 g 
P2O5 2.60 5.44 Na3PO4 37.7 g 
Sr100 
SiO2 46.13 37.26 SiO2 111.8 g 
Na2O 24.35 20.29 Na2CO3 71.0 g 
SrO 26.91 37.49 SrCO3 160.2 g 
P2O5 2.60 4.97 Na3PO4 34.4 g 
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4.1.2 Processing of bioactive glass melts 
A volume of each melt was poured into graphite moulds to produce blocks of 
bioactive glass of dimensions 60 x 20 x 15 mm. The blocks were annealed in 
an electric furnace for 1 hour at 518 °C for Sr0, 486 °C for Sr50 and 456 °C 
for Sr100. The annealing temperatures were based on the glass transition 
temperatures reported by O’Donnell et al. (2010) for each glass composition. 
Finally, all the glasses were cooled down to room temperature at a rate of 1 
°C/minute. 
The remaining melt from each composition was quenched in distilled water to 
form a frit and then left to dry overnight at room temperature. The frit was 
processed to reduce the particle size using a pellet crusher and then it was 
ball milled for a minimum time of 15 hours using cylindrical zirconia milling 
media (10 mm diameter). The resulting materials were sieved on stainless 
steel laboratory test sieves with aperture sizes of 150 μm and 45 μm (Fisher 
Scientific, UK) to obtain powders with particle size <45 μm. 
4.1.3 XRD analysis of bioactive glasses 
X-ray diffraction (XRD) analyses were performed on the bioactive glasses to 
confirm their amorphous nature. Samples of Sr0, Sr50 and Sr100 bioactive 
glasses and of PerioGlas® (Novabone Products LLC, USA), a commercial 
product made of 45S5 bioglass and used in periodontal bone regeneration, 
were grounded to a fine powder using a mortar and pestle and then sieved to 
obtain particles with sizes <45 μm. Each sample was loaded on sample trays 
and analysed in a Philips PW1825/00 diffractometer using Cu radiation, with 
angles ranging from 10° 2θ to 70° 2θ, step sizes of 0.02° 2θ, and a scanning 
speed of 2° per minute. XRD spectra were then processed using WinXPow 
software and Traces software. 
4.1.4 DTA of bioactive glasses 
The glass transition temperature (Tg), the onset of crystallisation temperature 
(Tc) and the peak crystallisation temperature (Tp) of Sr0, Sr50 and Sr100 
bioactive glasses and of PerioGlas® were determined using differential 
thermal analysis (DTA). Samples from all the materials were grounded to a 
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fine powder using a mortar and pestle and then sieved to obtain particles 
with sizes <45 μm. The powders were then loaded into platinum crucibles 
and heated to a temperature of 1200 °C at a rate of 10 °C/minute in a Perkin-
Elmer Diamond DTA/TG. The DTA patterns obtained were processed using 
the Pyris software (Perkin Elmer, UK) and mjograph 4.4.1 software (Ochiai 
Lab, Yokohama National University, Japan). Tg and Tc were determined from 
the point of intersection of curve tangents, and Tp was determined from the 
exothermic plot, as shown in Figure 4.1. 
 
Figure 4.1. Determination of glass transition temperature (Tg), onset of crystallisation 
temperature (Tc) and peak crystallisation temperature (Tp) on a schematic representation of a 
differential thermal analysis pattern. Adapted from Clupper and Hench (2003). 
4.1.5 Experimental measurement of the density of bioactive glasses 
The density of Sr0, Sr50 and Sr100 bioactive glasses was determined using 
the Archimedean principle, which states that when a solid body is completely 
immersed in a fluid, then the volume of the body is equal to the volume of the 
displaced fluid. This makes it possible to derive a relationship (Equation 4.1) 
between the density and the mass of the fluid and the solid: 
       
  
   
 Equation 4.1 
where ρs is the density of the body, ρfl is the density of the fluid, ms is the 
mass of the body, and mfl is the mass of the displaced fluid. 
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In this method, also known as the Archimedes method, the mass of the 
displaced fluid was measured by placing a beaker containing distilled water 
on a balance while the solid body was suspended from a thread and 
immersed in the beaker. Because the weight of the body (Ws=ms·g) was 
carried by the thread and the balance was not loaded, the balance readout 
indicated the mass of the displaced liquid, mfl, assuming that the weight of 
the beaker was zeroed beforehand. 
Three samples of each bioactive glass were produced from the glass blocks 
and were weighed on a precision weighing balance (0.1 mg in resolution). A 
beaker filled with distilled water was placed on the balance dish and the 
balance was zeroed. Meanwhile, the temperature of the distilled water was 
measured to determine its density. Each sample was then hung from a 
thread above the beaker, in such a way that the sample was completely 
immersed in the liquid without touching either the walls or the bottom of the 
beaker. 
4.1.6 Theoretical glass density according to Doweidar’s model 
Doweidar’s model of glass density (1996, 1999) may be used to estimate the 
density of a particular glass from the volume, mass and the molar 
composition of its Qn structural units. 
Each Qn unit is structured as follows (Fredholm et al., 2010): 
1) One Si4+ 
2) n/2 bridging oxygen (BO) 
3) (4-n) non-bridging oxygen (NBO) 
4) (4-n) alkali metal ions or (4n-2)/2 alkaline earth cations, to equilibrate 
the electronic charge if NBOs are present. 
The addition of a modifier oxide R2O/RO to the glass, where R is an alkali or 
an alkaline earth metal, creates NBOs in the SiO2 network, modifying the 
number of NBOs in a way that depends on the concentration of the modifier 
oxide. For example, a Q2 unit would contain one Si4+ atom, 1 BO, 2 NBOs, 
and 2 alkali metal ions or 3 alkaline earth cations. 
Materials and methods 
69 
 
According to Doweidar (1996, 1999), all Q4 units are transformed into Q3 
before Q2 units are formed, and all Q3 units are transformed into Q2 before 
Q1 units are formed. Table 4.2 shows the compositional regions and type of 
unit conversion which occurs within each compositional range of modifier 
oxide R2O/RO. 
Table 4.2. Q
n
 units within the different compositional regions in alkali silicate glasses. Adapted 
from Doweidar (1996) and Fredholm et al. (2010). 
Compositional region Qn unit formation 
Up to 33.3 mol% R2O/RO Q
4 conversion to Q3 
33.3 mol% < R2O/RO < 50 mol% Q
3 conversion to Q2 
50 mol% < R2O/RO < 60 mol% Q
2 conversion to Q1 
60 mol% < R2O/RO < 66.7 mol% Q
1 conversion to Q0 
In this case the Sr0, Sr50 and Sr100 bioactive glass compositions were 
normalised to exclude the phosphate content. As a result, the total R2O/RO 
concentration fell within the 33.3 mol% < R2O/RO < 50 mol% region, and 
consequently the Qn unit formation model was Q3 to Q2. The density was 
then calculated using the following equation: 
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Equation 4.2 
 
where   ,    and    are the molar fractions;               ;   
 ,   
  and 
  
  are the masses; and   
 ,   
  and   
  are the volumes of Na2O, SrO and 
CaO Qn units respectively. Table 4.3 presents the unit volumes of Q3 and Q2 
units containing sodium, calcium and strontium. 
Table 4.3. Volume of the Q3 and Q2 units containing sodium, calcium and strontium. Adapted 
from Doweidar (1999). 
Ions V3 (10-23 cm3) V2 (10-23 cm3) 
Na+ 6.05 7.90 
Ca2+ 5.45 6.64 
Sr2+ 5.69 7.48 
4.1.7 Oxygen density of bioactive glasses 
The oxygen density of a glass may be used to estimate the compactness of 
the glass network. It is calculated by dividing the mass of oxygen atoms 
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present in one mole of glass by the molar volume of the glass. The molar 
volume of a glass is the mass of one mole of glass divided by the 
experimental density (Fredholm et al., 2010) 
In the case of Sr0, Sr50 and Sr100 bioactive glasses, the oxygen density 
was calculated using the following equation: 
   
   (                             )
                                                         
 Equation 4.3 
where      ,      ,      ,      and      are the molar fractions of SiO2, P2O5, 
Na2O, CaO and SrO respectively;   is the atomic mass of oxygen;      , 
     ,      ,      and      are the masses of SiO2, P2O5, Na2O, CaO and 
SrO respectively; and      is the experimentally measured density of the 
glass. 
4.1.8 Solubility study of bioactive glasses 
Solubility studies of Sr0, Sr50 and Sr100 bioactive glasses were performed 
using a method based on the International Standard ISO6872 ‘Dentistry – 
Ceramic Materials’ (2008). Ten discs of 12 ± 0.2 mm in diameter and 1.6 ± 
0.1 mm in thickness were produced from each block of bioactive glass using 
a core driller and a Buehler precision diamond saw. The discs were washed 
in distilled water and dried in an electric furnace at 150°C for 4 hours. After 
weighing and determining the total surface area of each individual disc, the 
samples were placed in 100 ml of a 4% v/v acetic acid solution maintained at 
a temperature of 80°C for a total time of 16 hours. Finally, the samples were 
washed in distilled water, dried in an electric furnace at 150°C and weighed 
again to determine the total mass loss. 
4.1.9 Network connectivity of bioactive glasses 
The theoretical network connectivity of a bioactive glass is a measure of the 
degree of cross-linking and connectivity of SiO2 in the glass network, and 
may be used to predict the bioactivity of the material (Hill, 1996). 
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The network connectivity may be calculated using the following general 
equation (O’Donnell and Hill, 2010): 
     
      
 
 Equation 4.4 
where BO is the total number of bridging oxygens per network-forming ion, 
NBO the number of non-bridging oxygens per network-modifying ion and G 
is the total number of glass forming units. 
The equations used to calculate the network connectivity for Sr0, Sr50 and 
Sr100 bioactive glasses, assuming that phosphorus enters the glass network 
forming of P-O-Si bonds, are shown in Table 4.4. 
Table 4.4. Network connectivity equations for Sr0, Sr50 and Sr100 bioactive glasses. 
Glass Equation 
Sr0        
 (      )  (      )   (      )  (     ) 
      (      ) 
 
 
Equation 4.5 
Sr50        
 (      )  (      )   (      )  (     )  (     ) 
      (      ) 
 
 
Equation 4.6 
Sr100        
 (      )  (      )   (      )  (     ) 
      (      ) 
 
 
Equation 4.7 
However, in melt-derived bioactive glass systems, phosphate typically forms 
orthophosphate units (PO4
3-) rather than becoming part of the silicate 
network, requiring modifier ions to balance the charge (O’Donnell and Hill, 
2010). The modified equations considering this issue are shown in Table 4.5. 
Table 4.5. Modified equations for network connectivity of Sr0, Sr50 and Sr100 bioactive glasses. 
Glass Equation 
Sr0       
(      )   (      )  (     )  (      ) 
    
 Equation 4.8 
Sr50       
(      )   (      )  (     )  (     )  (      ) 
    
 Equation 4.9 
Sr100       
(      )   (      )  (     )  (      ) 
    
 Equation 4.10 
4.1.10 SEM analysis of bioactive glasses 
The surface of Sr0, Sr50 and Sr100 bioactive glass discs was examined 
using scanning electron microscopy (SEM) before and after the solubility 
tests were performed. All the samples were placed on cylindrical aluminium 
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stubs using double-sided adhesive conductive carbon discs and then were 
gold coated by sputtering (3 minutes total sputtering time). SEM micrographs 
were taken on a Jeol JSM6400 scanning electron microscope at various 
magnifications using an emission current of 20 kV. 
4.1.11 EDS analysis of bioactive glasses 
Qualitative energy dispersive X-ray spectroscopy (EDS) was used to study 
the elemental chemical composition of Sr0, Sr50 and Sr100 bioactive 
glasses, before and after the solubility tests. All the samples were placed on 
cylindrical aluminium stubs using double-sided adhesive conductive carbon 
discs and then were carbon coated by sputtering (10 to 15 seconds total 
sputtering time). The EDS analyses were performed on a Jeol JSM6400 
scanning electron microscope equipped with an Oxford Instruments INCAx-
sight energy dispersive X-ray spectrometer at various magnifications, using 
an emission current of 20 kV. EDS patterns were then processed using the 
IncaEnergy software (Oxford Instruments, UK). 
The peaks corresponding to the different chemical elements were identified 
using those characteristic X-ray lines with energy values lower than 5 KeV 
highlighted in Table 4.6 in bold type. In the particular case of strontium, the 
X-ray lines with energy values higher than 5 KeV were not used because the 
peaks observed were generally too small for accurate identification. 
Table 4.6. Characteristic X-ray line energies (KeV) of the chemical elements present in Sr0, Sr50 
and Sr100 bioactive glasses. The values used to identify the peaks are highlighted in bold type. 
Atomic 
number 
and 
element 
Characteristic X-ray line energies (KeV) 
Kβ2 Kβ1 Kβ3 Kα1 Kα2 Lβ3 Lβ4 Lβ1 Lα1 Lα2 
6 C   0.28      
8 O   0.53      
11 Na  1.07 1.04      
14 Si  1.08 1.74 1.74      
15 P  1.84 2.01 2.01      
20 Ca  4.01 3.69 3.69      
38 Sr 16.09 15.84 15.83 14.17 14.10 1.95 1.94 1.87 1.81 1.80 
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4.1.12 Particle size analysis of milled bioactive glasses 
Particle size analysis of Sr0, Sr50 and Sr100 bioactive glass powders was 
performed using the static light scattering technique on a Beckman LS-130 
Coulter device. A laser with a wavelength of 750 nm was used as a light 
source. This method is able to obtain information about the size of particles 
by measuring the intensity characteristics of light scattered by a suspension 
at various angles. When the laser beam interacts with particles, diffraction, 
refraction, reflection and absorption events result in the formation of 
scattering patterns characteristic for the particle size. If the particle is bigger 
than the wavelength of the light, patterns preferentially caused by diffraction 
will be generated and the size information will be derived from the forward 
direction for small diffraction angles. If the particle is similar in size or smaller 
than the wavelength then the light is gradually more scattered with large 
angles to the side and backwards. The smaller the particles are, the greater 
the contribution of refraction and absorption to the light scattering pattern will 
be. Therefore, the scattering patterns should be detected over the entire 
range of angles to perform appropriate measurements of particle size 
distribution. Each sample was slowly loaded into a volume of 1.7 L of water 
with no added deflocculant. The ultrasonic mode was activated to facilitate 
the dispersion of the particles in the suspension fluid. The suspension was 
then pumped through the system until a PIDS (Polarisation intensity 
differential scattering) obscuration value between 45% and 55% was 
reported by the computer. Individual measurements were taken over a period 
of 90 seconds in triplicate. All the samples were analysed using the 
‘Fraunhofer’ optical model of light scattering. 
4.1.13 SEM analysis of bioactive glass powders 
Sr0, Sr50 and Sr100 bioactive glass powders were examined using scanning 
electron microscopy (SEM). Small samples of each glass were placed on 
cylindrical aluminium stubs using double-sided adhesive conductive carbon 
discs and then were gold coated by sputtering (3 minutes total sputtering 
time). SEM micrographs were taken on a Jeol JSM6400 scanning electron 
microscope at various magnifications using an emission current of 20 kV. 
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4.2 Design, fabrication and characterisation of electrospun 
composite materials 
4.2.1 Electrospinning system 
The fabrication of the composite electrospun material was performed using a 
custom made electrospinning system arranged in a vertical configuration. 
The system was composed of a KdScientific pump, used to force a polymer 
solution from inside a 1 ml plastic syringe (Becton Dickinson, UK) into the 
capillary of a 20-gauge blunt metallic needle. The needle was connected to 
an external Alpha IV Brandenburg power source, supplying an electric 
current with voltages between 10 and 30 kV. The electrospun fibres 
deposited on a metallic collecting plate, forming a non-woven mat of 
randomly distributed fibres. The distance between the tip of the needle and 
the collector could be changed if necessary. All the components were 
enclosed inside a chemical fume hood and a switch was attached to the sash 
to prevent the system from being used while the fume hood was open, as 
shown in Figure 4.2. 
 
Figure 4.2. Picture of the electrospinning system used in the project, within a chemical hood at 
the School of Clinical Dentistry of The University of Sheffield. 
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4.2.2 Optimisation study of electrospinning parameters 
An optimisation study of various electrospinning parameters was performed 
to define the conditions that will result in the fabrication of membranes 
exhibiting a small amount of surface defects and consistent fibre diameters. 
Effect of polymer concentration and solvent composition 
In the first part of the study the effect of polymer concentration and solvent 
composition on the electrospinning process was investigated. A series of 
electrospinning solutions were prepared by dissolving poly(caprolactone) 
(PCL) (Average Mw, 80000 Da; Sigma Aldrich, UK) in a blend of 
dichloromethane (DCM) (Fisher Scientific, UK) and dimethylformamide 
(DMF) (Fisher Scientific, UK) at various ratios. This molecular weight was 
necessary to guarantee an appropriate viscosity in order to form the 
electrospun jet. Table 4.7 presents the physical properties of DCM and DMF. 
Table 4.7. Physical properties of dichloromethane (DCM) and dimethylformamide (DMF). 
Physical properties 
Solvent 
DCM DMF 
Formula CH2Cl2 (CH3)2NC(O)H 
Molecular weight 84.93 73.10 
Boiling point 39.75°C 153.0°C 
Density 
1.326 g/mL at 20°C 0.9487 g/mL at 20°C 
1.317 g/mL at 25°C 0.9439 g/mL at 25°C 
Dielectric constant 8.93 at 25°C 36.71 at 25°C 
Polarity index (P') 3.1 6.4 
Viscosity 0.44 cP at 20°C 0.92 cP at 20°C 
Surface tension 28.12 dyn/cm at 20°C 36.76 dyn/cm at 20°C 
Solubility in water 1.60% at 20°C Miscible in all proportions 
The solutions were thoroughly mixed with a magnetic stirrer for a minimum 
time of 2 hours and then were electrospun. The solutions and electrospinning 
conditions used are shown in Table 4.8. 
Table 4.8. Solutions and conditions used in the study of the effect of polymer concentration 
and solvent composition on the electrospinning process. 
Concentration 
(wt%) 
DCM:DMF 
(vol:vol) 
Voltage 
(kV) 
Feed rate 
(ml/h) 
Distance 
(cm) 
8 – 14 100:0 17 2.5 21 
8 – 14 95:5 17 2.5 21 
8 – 14 90:10 17 2.5 21 
8 – 14 85:15 17 2.5 21 
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All the materials were visually examined for physical defects and the 
compositions which produced materials with the lowest amount of defects 
due to sputtering were selected for the following part of the optimisation 
study. The materials were dried at room temperature overnight and stored in 
a desiccator for later use. 
Effect of bioactive glass particle content 
In the second part of the study the effect of the amount of bioactive glass 
particles added to the polymer solution on the electrospinning process was 
studied. A series of electrospinning solutions were prepared by dissolving 
PCL (Average Mw, 80000 Da; Sigma Aldrich, UK) in a blend of DCM (Sigma 
Aldrich, UK) and DMF (Sigma Aldrich, UK). Sr0, Sr50 and Sr100 bioactive 
glass powders were then added to the solution following PCL:glass weight 
ratios between 10:1 and 10:4. The solutions were thoroughly mixed with a 
magnetic stirrer for a minimum time of 2 hours and then were electrospun. 
Table 4.9 presents the solutions and electrospinning conditions used in the 
study. 
Table 4.9. Solutions and conditions used in the study of the effect of bioactive glass particulate 
content on the electrospinning process. 
Concentration 
(wt%) 
DCM:DMF 
(vol:vol) 
PCL:Glass 
weight ratio 
Voltage 
(kV) 
Feed rate 
(ml/h) 
Distance 
(cm) 
10 90:10 10:1 – 10:4 17 2.5 21 
10 85:15 10:1 – 10:4 17 2.5 21 
All the materials were visually examined for physical defects and the 
composition which produced materials with the lowest amount of defects was 
selected to fabricate the electrospun materials that were used in the following 
experiments of the project. The materials were dried at room temperature 
overnight and stored in a desiccator for later use. 
4.2.3 SEM analysis of electrospun materials 
The surface of the electrospun materials was characterised using scanning 
electron microscopy (SEM). Samples (13 mm diameter) were cut from each 
mat using a cork borer and were set on cylindrical aluminium stubs using 
double-sided adhesive conductive carbon discs. The samples were then gold 
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coated by sputtering (3 minutes total sputtering time). SEM micrographs 
were taken on a Jeol JSM6400 scanning electron microscope at various 
magnifications, using emission currents between 9 and 20 kV. Average fibre 
diameters were calculated using the ImageJ software (US NIH, USA) by 
measuring the thickness of the most superficial fibres. A total of 60 
measurements were performed for each material. 
4.2.4 EDS analysis of electrospun materials 
Energy dispersive X-Ray spectroscopy (EDS) was used to determine the 
presence of bioactive glass particles within the fibres of the electrospun 
composite materials. 
Samples (13 mm diameter) were cut from each mat using a cork borer and 
were set on cylindrical aluminium stubs using double-sided adhesive 
conductive carbon discs. The samples were then carbon coated by 
sputtering (10 to 15 seconds total sputtering time) and analysed on a Jeol 
JSM6400 scanning electron microscope equipped with an Oxford 
Instruments INCAx-sight energy dispersive X-ray spectrometer at various 
magnifications, using an emission current of 20 kV. EDS patterns were then 
processed using the IncaEnergy software (Oxford Instruments, UK). The 
peaks corresponding to the different chemical elements were identified as 
previously described in section 4.1.11. 
4.2.5 Solubility study of electrospun materials 
The dissolution of bioactive glass particles from within the electrospun fibres 
was studied by immersion of the materials in deionised water and by the 
measurement of the variation of environmental pH through time. 
Samples (10 mm diameter) were produced from each electrospun mat using 
a cork borer. A total mass of 10 mg of electrospun samples was placed in 20 
ml of deionised water in sterile plastic vials in triplicate and then maintained 
at a constant temperature of 37°C in a water bath for 14 days. Additionally, 
vials with 1 mg from Sr0, Sr50 and Sr100 bioactive glass powders (particle 
size <45 μm) were placed in similar conditions in order to compare the 
results. The pH readings were performed with a Hanna Instruments pH 211 
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Microprocessor pH meter at 0, 12, 24, 48, 72, 120, 168, 192, 264 and 336 
hours. 
4.2.6 Addition of particles to the surface of electrospun fibres 
The addition of extra bioactive glass particles to the surface of the 
electrospun fibres was investigated in order to create new configurations of 
the materials and to study if this had a significant effect on their cytotoxicity 
and potential to work as a scaffold. For this, two methods were developed: 
the ‘loading method’ and the ‘filtering method’. 
Loading method 
The ‘loading method’, based on work published by Dinarvand et al. (2011), 
consisted in placing a sample of the electrospun material in a suspension of 
bioactive glass particles in tissue culture media and then allowing enough 
time for the particles to deposit on its surface due to the gravity force. 
Samples (13 mm diameter) were produced from each electrospun mat using 
a cork borer and then were placed on 24-well plates, where they were 
sterilised by immersion in 200 μl of isopropyl alcohol (Fisher Scientific, UK) 
for a minimum time of 20 minutes. This step increased the hydrophilicity of 
PCL as well, facilitating the handling of the electrospun samples and the 
absorption of the medium. After the isopropyl alcohol was removed, the 
samples were washed twice in 200 μl of sterile phosphate buffered saline 
(PBS; Sigma Aldrich, UK) and were transferred to a new 24-well plate. 
Suspensions of Sr0, Sr50 and Sr100 bioactive glass powders were prepared 
in Dulbecco’s modified Eagle’s medium (DMEM; Sigma Aldrich, UK) or in 
minimum essential medium Eagle’s medium - alpha modification (αMEM; 
Sigma Aldrich, UK) and were placed in an ultrasonic bath for 20 minutes to 
facilitate the dispersion of the particles. A total volume of 1 ml from the 
suspension was added to each sample and the plates were then placed 
overnight in a cell culture incubator at a temperature of 37°C in a 5% CO2 
atmosphere. The following day the suspensions were removed and the 
samples were transferred to a new 24-well plate, where they were washed 
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twice in 200 μl of deionised water. Finally, the samples were left to dry 
overnight at room temperature. 
Filtering method 
The ‘filtering method’ consisted in using the electrospun material as a filter 
through which a suspension of bioactive glass particles was forced, causing 
the particles to be trapped within the fibrous mesh of the sample. 
Samples were produced and sterilised as previously described. After being 
washed twice in 200 μl of sterile PBS (Sigma Aldrich, UK), the samples were 
placed inside a sterile syringe filter holder (13 mm diameter) (Whatman, UK). 
Suspensions of Sr0, Sr50 and Sr100 bioactive glass powders were prepared 
as previously described and a sterile plastic syringe (Becton Dickinson, UK) 
was used to force a total volume of 1 ml of each suspension through the filter 
holder. After this, the samples were placed in a new 24-well plate and 1 ml of 
DMEM or α-MEM was added to each well. All the plates were then placed 
overnight in a cell culture incubator at a temperature of 37°C in a 5% CO2 
atmosphere. The following day the media were removed and the samples 
were washed twice in 200 μl of deionised water. Finally, the samples were 
left to dry overnight at room temperature. 
Comparison of ‘loading’ and ‘filtering’ methods – Different compositions 
The ‘loading’ and ‘filtering’ methods were compared using suspensions of 
Sr0, Sr50 and Sr100 bioactive glass powders at a concentration of 1% w/v in 
DMEM cell culture medium as previously described. The electrospun 
samples were initially weighed using a precision balance (0.1 mg resolution) 
and then processed as previously described to add the particles. After the 
samples were dried overnight, they were reweighed to measure mass 
variation using the following formula: 
                                      Equation 4.11 
The different combinations of materials tested, as well as the names given to 
each one, are presented in Table 4.10. A total of 6 replicates were used in 
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the study. Statistical analysis was performed in Microsoft Excel 2010 
software using two-tailed Student’s t-test to determine the significance levels. 
Table 4.10. Combinations of materials and methods tested to add bioactive glass particles to 
the surface of electrospun fibres. 
Type of electrospun 
samples 
No 
glass 
Bioactive glass compositions 
Sr0 Sr50 Sr100 
Filled samples PCL PCL/Sr0 PCL/Sr50 PCL/Sr100 
Loaded samples PCL PCL + Sr0L PCL + Sr50L PCL + Sr100L 
Filtered samples PCL PCL + Sr0F PCL + Sr50F PCL + Sr100F 
Filled + loaded 
samples 
PCL 
PCL/Sr0 + 
Sr0L 
PCL/Sr50 + 
Sr50L 
PCL/Sr100 + 
Sr100L 
Filled + filtered 
samples 
PCL 
PCL/Sr0 + 
Sr0F 
PCL/Sr50 + 
Sr50F 
PCL/Sr100 + 
Sr100F 
‘Filled samples’ are those with bioactive glass particles within the polymeric 
fibres, as a result of the electrospinning process, ‘loaded samples’ are those 
with bioactive glass particles added using the ‘loading method’ and ‘filtered 
samples’ are those with bioactive glass particles added using the ‘filtering 
method’. 
Comparison of ‘loading’ and ‘filtering’ methods – Series of suspension 
The ‘loading’ and ‘filtering’ methods were also compared using a series of 
suspensions of bioactive glass particles of increasing concentration. 
Suspensions of Sr0 bioactive glass powder with concentrations 0.05, 0.1, 
0.25, 0.5 and 1 % w/v were prepared in αMEM cell culture medium as 
previously described. The electrospun samples were then weighed using a 
precision balance (0.1 mg resolution) and processed as previously described 
to add the particles. After the samples were dried overnight, they were 
reweighed to measure mass variation using Equation 4.11. 
A total of 12 replicates were used in each test. Statistical analysis was 
performed in Microsoft Excel 2010 software using two-tailed Student’s t-test 
to determine the significance levels. 
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4.3 Cytotoxicity of electrospun composite materials 
4.3.1 Expansion of a rat osteosarcoma cell line 
A rat osteosarcoma (ROS) cell line was cultured in order to obtain the 
required number of cells to perform the cytotoxicity assessments. 
Vials containing ROS cells, which were stored in liquid nitrogen, were thawed 
at room temperature and then resuspended in 1 ml of fully supplemented cell 
culture medium, which was composed of DMEM (Sigma Aldrich, UK) 
supplemented with 10 units/ml penicillin (Sigma Aldrich, UK), 0.1 mg/ml 
streptomycin (Sigma Aldrich, UK), 20 mM L-alanyl glutamine and 10% v/v 
foetal calf serum (Biosera, UK). 
After resuspension, the cells were transferred to a sterile 20 ml vial 
containing 10 ml of fully supplemented cell culture medium and then 
centrifuged at a speed of 1000 rpm for 5 minutes to form a pellet. The 
supernatant was removed and the pellet was resuspended in 10 ml of fully 
supplemented cell culture medium. Finally, the number of cells per ml of 
resuspension was determined using a haemocytometer. The cells were then 
seeded in T-75 tissue culture flasks (Greiner Bio-One, UK) at a density of 106 
cells/flask and fresh fully supplemented cell culture medium was added to 
complete a total volume of 15 ml. 
For passaging, the medium was removed from the flask and the monolayer 
of ROS cells was washed twice with 5 ml of sterile PBS (Sigma Aldrich, UK) 
before being covered with 5 ml of a solution 0.05% trypsin/0.02% EDTA 
(Sigma Aldrich, UK) and then being incubated at 37°C in a 5% CO2 
atmosphere for a total time of 5 minutes to induce their detachment from the 
plastic surface. The effect of the trypsin/EDTA solution was then stopped by 
adding 0.5 ml of FCS (Biosera, UK) to the flask, creating a suspension of 
cells which was transferred to a sterile plastic vial and was then centrifuged 
at 1000 rpm for 5 minutes to form a pellet. The supernatant was removed 
and the cells were resuspended in fully supplemented cell culture medium. 
Finally, the number of cells per ml of resuspension was determined using a 
haemocytometer. For further expansion, the ROS cells were seeded at a 
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density of 106 cells in new T-75 flasks and were incubated until the following 
passage. 
4.3.2 Cytotoxicity assessment of electrospun composite materials 
The cytotoxicity of the electrospun materials was assessed by culturing ROS 
cells directly on the electrospun samples and then applying a resazurin dye-
based assay. 
This non-destructive assay is able to measure respiratory activity via a redox 
reaction, which can be quantified by monitoring a colorimetric change 
associated with the reduction of the dye. In the presence of respiration 
products, such as NADH, the dye is reduced to resorufin, as shown in Figure 
4.3. The concentration of resorufin is therefore dependent on the metabolic 
activity of the cells and it can be measured by detecting the fluorescence 
emission from the cell culture medium using a spectrophotometer. 
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Figure 4.3. Reduction of the resazurin molecule to resorufin by NADH. 
Samples (13 mm diameter) were produced from each electrospun material 
using a cork borer and were placed in 24-well plates to be sterilised by 
immersion in 200 μl of isopropyl alcohol (Fisher Scientific, UK), for a 
minimum time of 20 minutes. Afterwards, the samples were washed twice in 
200 μl of sterile PBS (Sigma Aldrich, UK) and then were transferred to a new 
24-well plate, where they were re-washed in 200 μl of sterile PBS. The 
potential cytotoxic effect of the addition of bioactive glass particles to the 
surface of the electrospun fibres using the ‘filtering method’ was also studied. 
Suspensions of 0.05, 0.25 and 1 % w/v of Sr0, Sr50 and Sr100 bioactive 
glass particles in DMEM (Sigma Aldrich, UK) were prepared and the samples 
were processed as previously described. 
All the samples were seeded by adding a volume of the cell suspension 
containing 2.5 x 104 ROS cells and fresh fully supplemented cell culture 
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medium was added to each well to complete a total volume of 1 ml. The 
same amount of cells was directly seeded on wells without any electrospun 
material, to act as untreated controls. Cell-free controls from each material 
were also prepared in order to discard interferences arising from interactions 
between the resazurin dye and the material. The plates were then incubated 
at a temperature of 37°C in a 5% CO2 atmosphere for 72 hours. After this 
time, the cell culture medium was removed and the plates were examined 
with an optical microscope to observe cell attachment and proliferation in the 
bottom of the wells. The electrospun samples were then transferred to a 
sterile 24-well plate, generating two sets of plates: a) plates containing ROS 
cells on the plastic, and b) plates containing the electrospun samples. 
A solution of 10% v/v resazurin in fully supplemented cell culture medium 
was prepared and 2 ml were added to each well on all plates. The plates 
were then incubated at a temperature of 37°C in a 5% CO2 atmosphere and 
the medium surrounding the materials was sampled at 20, 40 and 60 
minutes by transferring two aliquots of 200 μl each per sample to a 96-well 
plate for spectrophotometric analysis. Distilled water and cell culture medium 
were used as internal standards. A volume of 200 μl of the 10% v/v solution 
of resazurin was also included to provide a baseline reading. 
The metabolic activity was finally assessed by measuring the fluorescence 
emission intensity at a wavelength of 590 nm following excitation at a 
wavelength of 560 nm. Equation 4.12 was used to calculate the final 
fluorescence value. 
             (         ) Equation 4.12 
where    is the value of the fluorescence emission obtained from the cells 
attached and proliferating on the bottom of the well,    is the value of the 
fluorescence emission obtained from the wells containing the electrospun 
samples and     is the value of the fluorescence emission obtained from the 
wells containing cell-free controls. 
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A total of 4 replicates were prepared for each test. Statistical analyses were 
performed in Microsoft Excel 2010 software using one-way ANOVA and two-
tailed Student’s t-test to determine the significance levels. 
4.4 Isolation, expansion and characterisation of 
mesenchymal stromal cells 
4.4.1 Isolation of mesenchymal stromal cells 
Mesenchymal stromal cells (MSCs) were obtained from the bone marrow of 
4-5 weeks old male Wistar rats following the method described by 
Maniatopoulos et al. (1988). A total number of 4 animals were used. 
The femora were dissected from the animals in aseptic conditions using 
sterile instrumentation, cleaned of soft tissues, and were immediately 
immersed in 10 ml of DMEM (Sigma Aldrich, UK) supplemented with 100 
units/ml of penicillin (Sigma Aldrich, UK) and 1 mg/ml of streptomycin (Sigma 
Aldrich, UK). The ends of the femora were then removed and the bone 
marrow was flushed into a sterile plastic vial with 5 ml of fully supplemented 
cell culture medium ejected from a sterile syringe with a 20 gauge needle. 
The fully supplemented culture medium was composed of DMEM (Sigma 
Aldrich, UK) supplemented with 10 units/ml penicillin (Sigma Aldrich, UK), 
0.1 mg/ml streptomycin (Sigma Aldrich, UK), 20 mM L-alanyl glutamine 
(Sigma Aldrich, UK), and 10% v/v MSCs qualified foetal calf serum (qFCS; 
Biosera, UK). The media containing each bone marrow were then transferred 
to sterile T-75 flasks and 10 ml of fresh fully supplemented cell culture 
medium were added, making up a total volume of 15 ml. 
All the flasks were incubated at a temperature of 37°C in a 5% CO2 
atmosphere for 24 hours, after which the MSCs attached to the bottom of the 
flask. Non-adherent cells and tissue debris in suspension was then removed 
from each flask by replacing the medium with fresh fully supplemented cell 
culture medium. The cells were daily inspected and the medium was 
changed every 48 to 72 hours until near confluence was achieved. At that 
point the cells were passaged to a new flask or stored for later use. 
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4.4.2 Expansion and storage of mesenchymal stromal cells 
For passaging, the medium was removed from the flask and the monolayer 
of MSCs was washed twice with 5 ml of sterile PBS (Sigma Aldrich, UK) 
before being covered with 5 ml of a solution 0.05% trypsin/0.02% EDTA 
(Sigma Aldrich, UK) and then being incubated at 37°C in a 5% CO2 
atmosphere for a total time between 3 and 5 minutes, to induce their 
detachment from the plastic surface. The effect of the trypsin/EDTA solution 
was then stopped by adding 0.5 ml of FCS (Biosera, UK) to the flask, 
creating a suspension of cells which was transferred to a sterile plastic vial 
and was then centrifuged at 1000 rpm for 5 minutes to form a pellet. The 
supernatant was removed and the cells were resuspended in fully 
supplemented cell culture medium. For further expansion, the MSCs were 
seeded at a density of 1 x 106 cells in T-75 flasks or in petri dishes (Greiner 
Bio-One, UK) and were incubated until the following passage. The storage of 
MSCs was done by transferring a volume of resuspended cells containing a 
total of 2 x 106 cells to a sterile vial. Fully supplemented cell culture medium 
was then added to make up a total volume of 10 ml. The vial was centrifuged 
at 1000 rpm for 5 minutes to form a pellet and the supernatant was removed. 
The cells were then resuspended in 1 ml of a 10% v/v solution of 
dimethylsulfoxide (DMSO; Sigma Aldrich, UK) in FCS and then transferred to 
a 2 ml vial which was stored overnight at -80°C. The following day the vials 
were transferred to a liquid nitrogen dewar for indefinite storage. 
4.4.3 Characterisation of cell population 
Fluorescence-activated cell sorting (FACS) analysis was performed in order 
to characterise the population of MSCs by detecting the presence of specific 
surface molecular markers on the cells. All the antibodies, their isotypes and 
the conjugated fluorochromes (Biolegend, UK) are shown in Table 4.11. 
Table 4.11. Surface marker antibodies, isotypes and conjugated fluorochromes used in the  
characterisation of the population of MSCs by FACS analysis. 
Surface marker antibody Isotype Fluorochrome 
Anti-rat CD44 Anti-mouse IgG2a, κ Isotype  Alexa Fluor 647 (AF) 
Anti-rat CD90 Anti-mouse IgG1, κ Isotype Pacific Blue (PB) 
Anti-rat CD45 Anti-mouse IgG1, κ Isotype Phycoerythrin (PE) 
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Solutions of the antibodies and their isotypes (20 μg/ml concentration; 50 μl 
per test) were prepared in FACS buffer (5% v/v foetal calf serum and 0.1% 
v/v sodium azide in PBS) with the compositions shown in Table 4.12. 
Table 4.12. Composition of the different tubes for FACS analysis of rat MSCs. 
Tube Description 
CD45 
Ab 
CD44 
Ab 
CD90 
Ab 
CD45 
Iso 
CD44 
Iso 
CD90 
Iso 
FACS 
buffer 
1 
Unstained 
cells 
- - - - - - 50 μl 
2 
Only 
isotypes 
- - - 5 μl 10 μl 2 μl 33 μl 
3 
CD45 Ab 
+ Isotypes 
5 μl - - - 10 μl  2 μl 33 μl 
4 
CD44 Ab 
+ Isotypes 
- 2 μl - 5 μl - 2 μl 41 μl 
5 
CD90 Ab 
+ Isotypes 
- - 2 μl 5 μl 10 μl - 33 μl 
6 
Only 
antibodies 
5 μl 2 μl 2 μl - - - 41 μl 
Passage 3 MSCs were removed from the T-75 flasks as previously explained 
and then were resuspended in fully supplemented cell culture medium 
composed of DMEM (Sigma Aldrich, UK) supplemented with 10 units/ml 
penicillin (Sigma Aldrich, UK), 0.1 mg/ml streptomycin (Sigma Aldrich, UK), 
20 mM L-alanyl glutamine (Sigma Aldrich, UK), and 10% v/v qFCS (Biosera, 
UK). 
Volumes containing 5 x 105 cells were aliquoted in sterile Eppendorf tubes, 
were centrifuged at 5000 rpm for 2 minutes and then all the pellets were 
resuspended in 500 μl of FACS buffer. This step was performed twice to 
wash the cells from any remains of cell culture medium. Afterwards, the 
MSCs were resuspended in 50 μl of the antibody solutions as required and 
were incubated for 30 minutes in ice (4°C) in dark conditions. Afterwards, the 
cells were centrifuged at 5000 rpm for 2 minutes and washed twice with 500 
μl of FACS buffer. Finally, the cells were fixed in 300 μl of 4% 
paraformaldehyde in PBS at room temperature for a total time of 15 minutes 
in dark conditions before the FACS analysis was performed. 
All the analyses were performed on a Beckton Dickinson LSRII flow 
cytometer and the data generated was processed using FACS Diva software 
v. 6.1.2, provided by the manufacturer. 
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4.5 Osteogenic effect of strontium-substituted bioactive 
glasses 
The expression of six genes associated with the process of osteoblastic 
differentiation of MSCs was investigated to study the potential osteogenic 
effect of Sr0, Sr50 and Sr100 bioactive glasses. The cells were cultured in 
monolayer as previously described and then were exposed to the dissolution 
products of bioactive glass powders. The minimum amount of bioactive glass 
powders which induced a significant reduction in cell viability was initially 
determined by assessing their cytotoxicity. Finally, the cells were exposed to 
that amount of glass powders and total RNA extraction and reverse 
transcription quantitative polymerase chain reaction (RT-qPCR) analyses of 
those genes were performed. 
4.5.1 Effect of bioactive glass dissolution on cell viability 
The effect of the dissolution products of Sr0, Sr50 and Sr100 bioactive glass 
powders on the viability of MSCs was studied by assessing the cytotoxicity of 
the glasses using a resazurin dye-based assay, in a similar way to what was 
previously described in the study of the cytotoxicity of the electrospun 
materials in section 4.3.2 of this report. 
Passage 3 MSCs were cultured in monolayer in sterile 6-well plates. A total 
of 1.5 x 105 cells were seeded per well and 2 ml of fully supplemented cell 
culture medium was added, which was composed of DMEM (Sigma Aldrich, 
UK) supplemented with 10 units/ml penicillin (Sigma Aldrich, UK), 0.1 mg/ml 
streptomycin (Sigma Aldrich, UK), 20 mM L-alanyl glutamine (Sigma Aldrich, 
UK) and 10% v/v FCS (Biosera, UK). The plates were then incubated for 24 
hours at a temperature of 37°C in a 5% CO2 atmosphere to ensure cell 
attachment. 
Sr0, Sr50 and Sr100 bioactive glass powders were heat sterilised in a dry 
oven for 2 hours at 160°C, and samples containing 5, 10, 20, 40, 80, 160 and 
320 mg from each glass were then prepared by weighing them in sterile 
Eppendorf tubes on a precision weighing balance (0.1 mg resolution). All the 
samples were placed in sterile cell culture inserts of 0.4 μm pore size 
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(Greiner Bio-one, UK) in such a way that MSCs would be exposed to the 
dissolution products but would not be in direct contact with the bioactive 
glass particles. Additionally, wells containing MSCs not exposed to any 
bioactive glass were used as untreated controls. Cell-free controls for each 
glass sample were also prepared in order to discard interferences arising 
from interactions between the resazurin dye and the glass dissolution 
products. 
After 24 hours of incubation the cell culture medium was removed from the 6-
well plates and the inserts were placed in. Fresh fully supplemented cell 
culture medium (3 ml) was added to each sample (2 ml in each well and 1 ml 
in each insert) and all the plates were incubated for 72 hours at a 
temperature of 37°C in a 5% CO2 atmosphere. A solution of 10% v/v 
resazurin in fully supplemented cell culture medium was prepared and 2 ml 
of this solution were added to each well. The plates were then incubated and 
the medium was sampled at 15, 45, 100 and 130 minutes. Two aliquots of 
200 μl each were taken per sample and transferred to a 96-well plate for 
spectrophotometric analysis. Distilled water and fully supplemented cell 
culture medium were used as internal standards and the solution of 10% v/v 
resazurin was also included to provide a baseline reading.  
A total of 3 replicates were used in each test. Statistical analysis was 
performed in Microsoft Excel 2010 software using one-way ANOVA and two-
tailed Student’s t-test to calculate the significance levels. 
4.5.2 Total RNA isolation from rat MSCs 
Passage 3 MSCs were cultured in monolayer in sterile 6-well plates. A total 
of 1.5 x 105 cells were seeded per well and 2 ml of fully supplemented cell 
culture medium was added, which was composed of α-MEM (Sigma Aldrich, 
UK) supplemented with 10 units/ml penicillin (Sigma Aldrich, UK), 0.1 mg/ml 
streptomycin (Sigma Aldrich, UK), 10 mM L-alanyl glutamine and 10% v/v 
FCS (Biosera, UK). The plates were then incubated for 24 hours at a 
temperature of 37°C in a 5% CO2 atmosphere to ensure cell attachment. 
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Sr0, Sr50 and Sr100 bioactive glasses powders were heat sterilised in a dry 
oven for 2 hours at 160°C, and samples containing 20 mg from each glass 
were then prepared by weighing them in sterile Eppendorf tubes on a 
precision weighing balance (0.1 mg resolution). All the samples were placed 
in sterile cell culture inserts of 0.4 μm pore size (Greiner Bio-one, UK) in 
such a way that MSCs would be exposed to the dissolution products but 
would not be in direct contact with the bioactive glass particles. 
After 24 hours of incubation the cell culture medium was removed from the 6-
well plates, the cell culture inserts were placed in and a volume (3 ml; 2 ml in 
each well and 1 ml in each insert) of standard and osteogenic cell culture 
media were added to the wells. The compositions of both cell culture media 
are shown in Table 4.13. All the plates were then incubated at a temperature 
of 37°C in a 5% CO2 atmosphere for 14 days, with the cell culture media 
changed every 72 hours. 
Table 4.13. Standard and Osteogenic cell culture media compositions. 
Component Standard medium Osteogenic medium 
Cell culture medium 
α-MEM 
(Sigma Aldrich, UK) 
α-MEM 
(Sigma Aldrich, UK) 
Penicillin 
(P) 
10 units/ml 
(Sigma Aldrich, UK) 
10 units/ml 
(Sigma Aldrich, UK) 
Streptomycin 
(S) 
0.1 mg/ml 
(Sigma Aldrich, UK) 
0.1 mg/ml 
(Sigma Aldrich, UK) 
L-Alanyl Glutamine 
(L-Glu) 
10 mM 
(Sigma Aldrich, UK) 
10 mM 
(Sigma Aldrich, UK) 
Foetal calf serum 
(FCS) 
10% v/v 
(Biosera, UK) 
10% v/v 
(Biosera, UK) 
Ascorbic Acid 
(AA) 
- 
50 μg/ml 
(Sigma Aldrich, UK) 
β-Glycerophosphate 
(β-GP) 
- 
10 mM 
(Fluka Biochemika, UK) 
Dexamethasone 
(Dex) 
- 
10-8 M 
(Sigma Aldrich, UK) 
On days 1, 3, 6 and 14 of the experiment, certain plates were terminated 
and, following the manufacturer’s instructions, total RNA extraction from the 
cells was performed using the RNeasy® Mini Kit (Qiagen, UK). For this 
purpose, the cell culture medium was removed from each well and the cells 
were washed three times in 300 μl of sterile PBS (Sigma Aldrich, UK). Then 
350 μl of buffer RLT with 10% v/v β-mercaptoethanol (Sigma Aldrich, UK) 
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were added to the wells and the lysate was collected using a sterile cell 
scraper and pipetted into a QIAshredder® spin column (Qiagen, UK). The 
columns were centrifuged for 2 minutes at full speed and then 350 μl of 70% 
solution of ethanol in nuclease-free water were added to the homogenised 
lysate. Up to 700 μl of each lysate was then transferred to an RNeasy spin 
column and were centrifuged for 15 seconds at ≥8000 g. The flow-through 
was discarded and 700 μl of buffer RW1 were added to the column and were 
centrifuged for 15 seconds at ≥8000 g. After discarding the flow-through, the 
columns were washed by adding 500 μl of buffer RPE and were centrifuging 
for 15 seconds at ≥8000 g. Another 500 μl of buffer RPE were later added, 
followed by centrifugation again for 2 minutes at ≥8000 g. Finally, the spin 
columns were placed in new 1.5 ml tubes and 30 to 50 μl of RNase-free 
water were added and were centrifuged for 1 minute at ≥8000 g to elute the 
RNA. 
The final concentration of isolated RNA in ng/μl was then determined using 
the Nanodrop 1000 spectrophotometer (Thermo Scientific, UK). Light 
absorbance measurements were performed at wavelengths of 260 nm and 
180 nm to assess the purity of the RNA by calculating the ratio between both 
absorbance values. The RNA samples were then stored at -80°C until used. 
All the work was performed using nuclease-free Fisherbrand SureOne® pipet 
tips (Fisher Scientific, UK). 
4.5.3 Reverse transcription of total isolated RNA to cDNA 
Reverse transcription of total RNA to single-stranded cDNA was performed 
on all the RNA samples using the High Capacity cDNA RT Kit (Applied 
Biosystems, UK), following the manufacturer’s instructions.  
Initially, a 2X reverse transcription master mix was prepared with the 
composition shown in Table 4.14. A volume of 10 μl of total RNA was 
pipetted and mixed with an equal volume of master mix in a 0.5 ml 
Eppendorf tube to create a 1X solution with a total volume per reverse 
transcription reaction of 20 μl. The tubes were vortexed to thoroughly mix the 
solution and then briefly centrifuged (30 seconds at 3000 g). Reverse 
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transcription was finally performed on a thermal cycler using the conditions 
shown in Table 4.15. 
Table 4.14. Amounts required to produce a volume of 10 μl of Master Mix per reaction using the 
High-Capacity cDNA RT Kit. 
High-Capacity cDNA RT Kit components Volumen (μl) 
10X RT Buffer 2.0 
25X dNTP Mix (100 mM) 0.8 
10X RT Random Primers 2.0 
MultiScribeTM Reverse Transcriptase 1.0 
Nuclease-free water 3.2 
Total volume per reaction 10 
Table 4.15. Thermal cycle conditions recommended by the manufacturer of the High Capacity 
cDNA RT kit. 
 Step 1 Step 2 Step 3 Step 4 
Temperature (°C) 25 37 85 4 
Time (min) 10 120 5 ∞ 
A number of additional reactions were included in the preparation of the 
reverse transcription Master Mix to provide excess volume for the loss that 
may occur during pipetting. All the samples were prepared using nuclease-
free Fisherbrand SureOne® pipet tips (Fisher Scientific, UK) and were kept 
in ice (4°C) while they were not in use. Finally, all the cDNA samples were 
stored at -80°C. 
4.5.4 RT-qPCR analyses of cDNA 
Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was 
performed on a 7900HT Fast Real-Time PCR System (Applied Biosystems, 
UK) using TaqMan® Gene Expression Assays (Applied Biosystems, UK), 
following the manufacturers’ instructions. The genetic markers of osteogenic 
differentiation to be investigated and the endogenous control used, as well 
as their function, the probe dye and the TaqMan assay ID, are shown in 
Table 4.16. 
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Table 4.16. Name, symbol, function and TaqMan assay ID of the genes selected for the 
experiment. 
Gene 
Gene 
symbol 
Function 
Probe 
dye 
TaqMan  
Assay ID 
Runt-related 
transcription factor 2 
Runx2 
Encodes nuclear protein 
essential for osteoblastic 
differentiation and skeletal 
morphogenesis. 
FAM Rn01512298_m1 
Alkaline 
phosphatase, 
liver/bone/kidney 
Alpl 
Encodes a membrane 
bound enzyme that may 
play a role in bone 
mineralisation. 
FAM Rn01516028_m1 
Collagen type I, 
Alpha I 
Col1a1 
Encodes the pro-alpha1 
chains of type I collagen, 
abundant in bone and other 
connective tissues. 
FAM Rn01463848_m1 
Bone gamma-
carboxyglutamate 
(gla) protein 
Bglap 
Encodes a protein 
composing 1-2% of the total 
bone protein and which 
binds strongly to apatite and 
calcium. 
FAM Rn00566386_g1 
Bone morphogenetic 
protein 2 
Bmp2 
Encodes a protein which 
induces bone and cartilage 
formation. 
FAM Rn00567818_m1 
Secreted 
phosphoprotein 1 
Spp1 
Encodes a protein which 
forms an integral part of the 
mineralised matrix. May play 
an important role in cell 
attachment. 
FAM Rn01449972_m1 
Glyceraldehyde-3-
phosphate 
dehydrogenase 
Gapdh 
Encodes a protein involved 
in glycolysis and nuclear 
functions. Used as 
endogenous control. 
VIC Rn01775763_g1 
All the TaqMan assays and cDNA samples were thawed in ice and briefly 
centrifuged to bring the liquid to the bottom of the tubes. A PCR reaction mix 
was prepared with the composition per RT-qPCR reaction shown in Table 
4.17. The total volume of PCR reaction mix required was calculated by 
determining the number of RT-qPCR reactions to be performed. Extra 
reactions were included to compensate for the potential loss of volume that 
may occur when pipetting. 
A volume of 9.5 μl of PCR reaction mix was then transferred into the wells of 
Fast 96-well reaction plates (Applied Biosystems, UK). A volume of 0.5 μl of 
cDNA was then added to each well and was thoroughly mixed by pipetting. 
Controls were also included to determine the presence of contaminating 
DNA in the plate, by replacing the cDNA with the original RNA and with 
water. The plates were then loaded into the system and the process was 
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configured following the manufacturer’s instructions. Each reaction was run 
in triplicate. 
Table 4.17. Composition of PCR reaction mix per single 10 μl RT-qPCR reaction 
Component 
Volume 
(For 10 μl reaction) 
2X TaqMan Gene Expression Master Mix 5 μl 
20X TaqMan Gene Expression Assay Primer and Probe 0.5 μl 
20X TaqMan Gapdh Endogenous Control 0.5 μl 
RNase-free water 3.5 μl 
Total volume 9.5 μl 
4.5.5 Analysis of RT-qPCR data 
The data obtained from all the RT-qPCR analyses was collected by a 
computer running the Sequence Detection Systems (SDS) software v. 2.4 
(Applied Biosystems, UK) and was then analysed using the comparative Ct 
method (i.e. ΔΔCt method). All the calculations were performed in Microsoft 
Excel 2010. 
First, the mean Ct values and the standard deviation for all the RT-qPCR 
reactions were calculated using the data provided by the SDS software. 
Then the ΔCt value was calculated with Equation 4.13. 
       (    )      (     ) Equation 4.13 
The standard deviation (sd) of the ΔCt value was calculated from the 
standard deviations of the gene and the Gapdh value, as shown in Equation 
4.14. 
   (      
         
 )
 
 ⁄  Equation 4.14 
Then the ΔΔCt was calculated by subtracting the ΔCt value of the untreated 
control from the sample being studied. 
         (      )       (                 ) Equation 4.15 
The standard deviation of ΔΔCt was the same as the standard deviation of 
the ΔCt value. 
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The fold difference in gene expression was calculated by 2-ΔΔCt. This 
difference may also be expressed as a range by incorporating the standard 
deviation of the ΔΔCt value into the fold difference calculation by replacing 
ΔΔCt with (ΔΔCt + sd) and (ΔΔCt – sd), where sd was the standard deviation 
of the ΔΔCt value. 
Statistical analysis was performed on the ΔCt values in Microsoft Excel 2010 
software using the Wilcoxon two group test, as recommended by Yuan et al. 
(2006). 
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5 Results 
5.1 Bioactive glass characterisation 
5.1.1 XRD analyses of bioactive glasses 
X-ray diffraction (XRD) spectra of Sr0, Sr50 and Sr100 bioactive glasses are 
presented in Figure 5.1. The presence of one broad peak in every spectrum 
confirmed the absence of any significant crystalline phase and, therefore, 
showed that all the materials were amorphous. It was observed that the 
peaks progressively moved toward smaller values of angle 2θ with the 
increase of calcium substitution by strontium in the glass compositions. 
Finally, the spectra were comparable to the spectrum produced by 
PerioGlas®, a commercial bone graft material made of 45S5 bioglass. 
5.1.2 DTA of bioactive glasses 
Differential thermal analysis (DTA) patterns of Sr0, Sr50 and Sr100 bioactive 
glasses and of PerioGlas® are presented in Figure 5.2. The estimated 
values for glass transition temperature (Tg), onset of crystallisation 
temperature (Tc) and peak crystallisation temperature (Tp) are presented in 
Table 5.1. It was observed that the Tg of the glasses decreased as the 
substitution of calcium by strontium in the composition increased. Both Tc 
and Tp presented a minimum value in Sr50 bioactive glass. The working 
range, which is calculated by subtracting Tg from Tc, generally increased with 
the strontium substitution in the in-house bioactive glasses. 
Table 5.1. Estimated glass transition temperature (Tg), onset of crystallisation temperature (Tc), 
peak crystallisation temperature (Tp) and working range for Sr0, Sr50 and Sr100 bioactive 
glasses and PerioGlas®. 
 
Bioactive glasses 
PerioGlas® Sr0 Sr50 Sr100 
Glass transition temperature (Tg) 523 525 492 479 
Onset of crystallisation temperature (Tc) 630 613 583 610 
Peak crystallisation temperature (Tp) 690 682 671 691 
Working range (Tc - Tg) 107 88 91 131 
  
Results 
96 
 
 
Figure 5.1. X-ray diffraction spectra of Sr0, Sr50 and Sr100 bioactive glasses, and of 
PerioGlas®. 
 
Figure 5.2. Differential thermal analysis patterns of Sr0, Sr50 and Sr100 bioactive glasses, and 
of PerioGlas®. The regions where the glass transition temperature, the onset of crystallisation 
temperature and the peak crystallisation temperature were estimated are identified with Tg, Tc 
and Tp, respectively. 
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5.1.3 Experimental and theoretical density of bioactive glasses 
The experimentally measured densities of Sr0, Sr50 and Sr100 bioactive 
glasses and the theoretical densities, calculated using Doweidar’s model of 
glass density, are shown in Table 5.5 and are graphically represented in 
Figure 5.3. It was observed that glass density increased linearly in proportion 
to the substitution of calcium by strontium in the glass composition. The 
theoretical densities of the three glass compositions showed a similar linear 
increase with increasing strontium substitution. 
Table 5.2. Values of experimentally measured and theoretically calculated densities of Sr0, Sr50 
and Sr100 bioactive glasses. 
 
Bioactive glasses 
Sr0 Sr50 Sr100 
Experimental density (g·cm-3) 2.73 ± 0.02 2.95 ± 0.02 3.14 ± 0.01 
Theoretical density (g·cm-3) 2.73 2.93 3.11 
5.1.4 Oxygen density of bioactive glasses 
The estimated oxygen densities of Sr0, Sr50 and Sr100 bioactive glasses 
are shown in Table 5.3 and are graphically presented in Figure 5.4. It was 
observed that the oxygen density of the bioactive glasses decreased linearly 
as the proportion of calcium substitution by strontium in the glass 
composition increased. 
Table 5.3. Estimated oxygen density for Sr0, Sr50 and Sr100 bioactive glasses. 
 
Bioactive glass 
Sr0 Sr50 Sr100 
Oxygen density (g·cm-3) 1.11 1.09 1.06 
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Figure 5.3. Graphical representation of the experimentally measured densities and the 
theoretically calculated densities (Doweidar’s density) of Sr0, Sr50 and Sr100 bioactive glasses. 
 
Figure 5.4. Estimated oxygen densities of Sr0, Sr50 and Sr100 bioactive glasses. 
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5.1.5 Solubility study of bioactive glasses 
The values of the solubility of Sr0, Sr50 and Sr100 bioactive glasses, 
measured using a method based on the International Standard ISO 6872 
‘Dentistry –Ceramic Materials’ (2008), are graphically represented in Figure 
5.5. It was observed that the solubility of the glasses increased linearly in 
proportion to the substitution of calcium by strontium in the glass 
composition, from 2.78 x 104 µg·cm-2 for Sr0 to 3.88 µg·cm-2 for Sr100. 
Each bioactive glass composition was also observed to react differently to 
the treatment of immersion in acetic acid. The surface of the discs was 
modified after the solubility tests were performed, changing in colour and 
became more brittle. The most external layer of material could then be 
removed from the discs by mechanical action, exposing an unmodified 
surface of bioactive glass. However, it was more difficult to remove the 
modified surface layer as the proportion of substitution of calcium by 
strontium in the glass composition increased. 
5.1.6 Network connectivity of bioactive glasses 
The calculated values of network connectivity for Sr0, Sr50 and Sr100 
bioactive glasses are presented in Table 5.4. The results of the calculations 
assuming that phosphorus entered the glass network forming P-O-Si bonds 
(NC’’) were consistently lower than the values calculated assuming that 
phosphorus formed orthophosphate units instead of becoming part of the 
silicate network (NC’). The NC values were the same for the three 
compositions in both cases.  
Table 5.4. Network connectivity values of Sr0, Sr50 and Sr100 bioactive glasses. 
 
Bioactive glass 
Sr0 Sr50 Sr100 
NC' 2.12 2.12 2.12 
NC’’ 1.90 1.90 1.90 
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Figure 5.5. Solubility of Sr0, Sr50 and Sr100 bioactive glasses, determined using a method 
based on the International Standard ISO6872 ‘Dentistry –Ceramic Materials’ (2008). 
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5.1.7 SEM analysis of bioactive glasses 
Scanning electron microscopy (SEM) micrographs of Sr0, Sr50 and Sr100 
bioactive glass discs are presented in Figure 5.6, Figure 5.7 and Figure 5.8 
respectively. The micrographs showed materials exhibiting a generally 
coarse surface which changed after the solubility tests were performed, 
adopting a smoother texture. It was observed that the surface of samples 
made of bioactive glasses containing a larger proportion of strontium in their 
composition (i.e. Sr50 and Sr100) usually exhibited a coarser surface than 
those samples made of Sr0 bioactive glass after the solubility tests were 
performed and the modified surface layer was removed, mainly because a 
fraction of the modified surface remained attached to those samples. 
5.1.8 EDS analysis of bioactive glasses 
Plots of the energy dispersive X-ray spectroscopy (EDS) analysis of Sr0, 
Sr50 and Sr100 bioactive glasses are shown in Figure 5.6, Figure 5.7 and 
Figure 5.8 respectively. EDS confirmed the presence of all the chemical 
elements which form each bioactive glass compositions (i.e. oxygen, sodium, 
silicon, phosphorus, calcium and strontium), demonstrating that the 
technique was appropriate to differentiate between the three glasses. The 
data also confirmed that a compositional change occurred on the surface of 
the bioactive glass discs during the solubility test. The main chemical 
elements detected in the detached surface material were silicon and oxygen, 
suggesting that the material may be mainly composed by an oxidised form of 
silicon which remained after the dissolution of the other chemical elements 
present in the glass composition. 
  
Results 
102 
 
 
Sr0 bioactive glass 
Bioactive glass disc surface before solubility test 
SEM EDS 
  
Bioactive glass disc surface after solubility test 
and removal of surface material 
SEM EDS 
  
Fragment of detached surface material after solubility test 
SEM EDS 
  
 
Figure 5.6. Scanning electron microscopy (SEM) micrographs and energy dispersive X-ray 
spectroscopy (EDS) spectra of Sr0 bioactive glass discs before and after the solubility tests, 
and of the surface material which became detached after the solubility tests. 
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Sr50 bioactive glass 
Bioactive glass disc surface before solubility test 
SEM EDS 
  
Bioactive glass disc surface after solubility test 
and removal of surface material 
SEM EDS 
  
Fragment of detached surface material after solubility test 
SEM EDS 
  
 
Figure 5.7. Scanning electron microscopy (SEM) micrographs and energy dispersive X-ray 
spectroscopy (EDS) spectra of Sr50 bioactive glass discs before and after the solubility tests, 
and of the surface material which became detached after the solubility tests. 
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Sr100 bioactive glass 
Bioactive glass disc surface before solubility test 
SEM EDS 
  
Bioactive glass disc surface after solubility test 
and removal of surface material 
SEM EDS 
  
Fragment of detached surface material after solubility test 
SEM EDS 
  
 
Figure 5.8. Scanning electron microscopy (SEM) micrographs and energy dispersive X-ray 
spectroscopy (EDS) spectra of Sr100 bioactive glass discs before and after the solubility tests, 
and of the surface material which became detached after the solubility tests. 
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5.1.9 Particle size analysis of milled bioactive glasses 
Particle size analyses of the bioactive glass powders were performed using 
static light scattering particle size analysis. The distributions of the differential 
volume and the differential number of particles of Sr0, Sr50 and Sr100 
bioactive glass powders produced through milling and sieving are shown in 
Figure 5.9 and Figure 5.10, respectively. Table 5.5 also presents the largest 
detected particle size, the mean particle size and the median particle size of 
each sample, as well as the standard deviation values. 
The differential volume plots (Figure 5.9) show the volume occupied by each 
particle size, revealing that the greatest proportion of the volume in the three 
samples was occupied by particles with sizes around 10 μm and that a 
significant volume was occupied by particles with sizes below 1 μm. The 
differential number plots (Figure 5.10) show the number of particles detected 
for each particle size, revealing that particles with sizes below 1 μm were the 
most abundant in the three samples. 
It was also observed that the particle size appeared to increase as the 
substitution of calcium by strontium in the glass composition increased 
(Table 5.5). SEM micrographs of the bioactive glass powders (Figure 5.11) 
showed that the samples exhibited a large variety of particle sizes and 
morphologies. The micrographs also confirmed the presence of a significant 
amount of particles smaller than 10 μm, which tended to agglomerate 
together or on the surface of larger particles. 
Table 5.5. Largest detected particle size, mean particle size, median particle size and standard 
deviations of the distributions of Sr0, Sr50 and Sr100 bioactive glass powders. 
Bioactive 
glass 
Largest detected 
particle size 
(μm) 
Mean 
particle size 
(μm) 
Median 
particle size 
(μm) 
Standard 
deviation 
(μm) 
Sr0 44.6 9.9 7.9 8.2 
Sr50 48.9 11.2 8.6 9.5 
Sr100 58.6 12.2 9.7 10.0 
 
  
Results 
106 
 
 
Figure 5.9. Graphical representation of the differential volume distribution of Sr0, Sr50 and 
Sr100 bioactive glass powders. This showed that particles with sizes around 10 µm occupied 
the greatest proportion of the volume in the three samples and that a significant volume was 
occupied with particles with sizes below 1 µm. 
 
Figure 5.10. Graphical representation of the differential number distribution of Sr0, Sr50 and 
Sr100 bioactive glass powders. This showed that particles with sizes <1 µm were the most 
abundant in the samples of the three bioactive glasses.  
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a) b) 
  
c) d) 
  
e) f) 
  
Figure 5.11. Scanning electron microscopy micrographs of Sr0 (a and b), Sr50 (c and d) and 
Sr100 (e and f) bioactive glass powders at various magnifications. 
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5.2 Electrospinning of composite materials 
5.2.1 Optimisation study of electrospinning parameters 
Effect of polymer concentration and solvent composition 
The first part of this study investigated the effect of poly(caprolactone) (PCL) 
concentration and solvent composition on the electrospinning process. 
Visual examination of the electrospun materials showed that the surface of 
the membranes displayed the lowest levels of defects caused by sputtering 
when concentrations between 10 and 12 wt% of PCL dissolved in blends of 
DCM and DMF with ratios 90:10 v/v and 85:15 v/v were used. Other 
concentrations of PCL and ratios of DCM:DMF generally produced rougher 
surfaces. In addition, solutions using only DCM generated materials which 
were too fragile and broke easily, in particular those made with a 
concentration of 8 wt% PCL. 
Scanning electron microscopy (SEM) micrographs of the materials, 
presented in Figure 5.12 and Figure 5.13, showed that the samples 
produced with the solvent blend DCM:DMF 100:0 v/v exhibited an irregular 
distribution of fibre diameters. Increasing the proportion of DMF in the 
solvent blend resulted in the production of fibres with less variability in fibre 
diameter and, potentially, a more homogeneous distribution of fibre sizes. 
Regarding the effect of polymer concentration, the samples produced with 
solutions of 8 wt% PCL exhibited fibres with beads. Increasing the 
concentration of PCL appeared to generate a more regular distribution of 
fibre sizes and to reduce the amount of beads. At 10 wt% a small amount of 
beading could still be observed in the samples fabricated using DCM:DMF 
95:5 v/v, but this effect was eliminated in those samples fabricated using 
DCM:DMF 90:10 v/v and 85:15 v/v. However, the higher concentrations also 
resulted in an apparent increase in fibre diameter. SEM micrographs of the 
materials generated with solutions of 10 wt% PCL, presented in Figure 5.12 
and Figure 5.13, appeared to exhibit an apparently more homogeneous 
distribution of fibre sizes and smaller diameters.  
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In conclusion, the solution compositions of 10 wt% PCL in DCM:DMF 90:10 
v/v and in DCM:DMF 85:15 v/v were selected to be used in the following part 
of the optimisation study as these appeared to produce the most regular fibre 
diameters and morphologies of electrospun fibres. 
Effect of bioactive glass particle content 
The second part of the study investigated the effect of bioactive glass particle 
content in the electrospinning process. 
Visual examination of the materials showed that the surface of the 
membranes exhibited a larger amount of defects caused by sputtering as the 
amount of glass particles added to the PCL solution increased. The smallest 
amount of surface defects were observed in those materials fabricated using 
solutions of PCL with bioactive glass particles added following a 10:1 
PCL:glass weight ratio. In addition, it was observed that the solvent blend 
DCM:DMF 90:10 v/v generally produced smoother surfaces than DCM:DMF 
85:15 v/v. Finally, the increase in glass particle content also resulted in the 
generation of more fragile materials. 
SEM micrographs of the composite materials, shown in Figure 5.14, also 
exhibited an apparent increase in fibre diameter after the bioactive glass 
particles were added to the solutions. 
In conclusion, the solution composition of 10 wt% PCL in DCM:DMF 90:10 
v/v was selected to fabricate the electrospun composite materials to be used 
in the rest of the project. This composition was considered appropriate due to 
generally producing electrospun materials which could be handled without 
breaking; they presented the smallest observed amounts of surface and fibre 
defects; and generated relatively regular distributions of fibre sizes compared 
with other compositions. 
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Figure 5.12. Scanning electron microscopy micrographs of non-composite electrospun 
materials produced for the first part of the optimisation study. The composition of the polymer 
solutions used were 8 wt%, 10 wt%, 12 wt% and 14 wt% of poly(caprolactone) (PCL) in blends 
of dichloromethane (DCM) and dimethylformamide (DMF) with ratios of 100:0 v/v and 95:5 v/v. 
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Figure 5.13. Scanning electron microscopy micrographs of non-composite electrospun 
materials produced for the first part of the optimisation study. The composition of the polymer 
solutions used were 8 wt%, 10 wt%, 12 wt% and 14 wt% of poly(caprolactone) (PCL) in blends 
of dichloromethane (DCM) and dimethylformamide (DMF) with ratios of 90:10 v/v and  85:15 v/v. 
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Figure 5.14. Scanning electron microscopy micrographs of the composite electrospun 
materials fabricated for the second part of the optimisation study. Sr0, Sr50 and Sr100 bioactive 
glass particles were added to the poly(caprolactone) (PCL) solution following PCL:glass weight 
ratios 10:1, 10:2, 10:3 and 10:4. 
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5.2.2 SEM analysis of electrospun materials 
SEM micrographs of the electrospun materials fabricated using the 
composition selected in the optimisation study showed that the non-
composite materials made of only PCL (Figure 5.15, a and b) were 
composed of fibres with relatively regular diameters and no apparent defects 
on their surface. Larger magnification micrographs of the materials (Figure 
5.15, c and d) showed that the surface of the fibres was generally porous. 
In the case of the composite electrospun materials made of PCL and 
particles of Sr0 (Figure 5.16), Sr50 (Figure 5.17) and Sr100 (Figure 5.18) 
bioactive glasses, it was observed that many of the fibres presented regions 
with increased diameters and irregular morphologies where the glass 
particles may be contained. The distribution of such regions in the material 
appeared to be random and no areas were identified on the mats where 
those regions may have been preferentially formed. 
The micrographs also showed an apparent increase in the variability of fibre 
diameter compared to the non-composite materials, as previously mentioned 
in the optimisation study. No significant differences were observed between 
samples containing particles of different bioactive glass compositions. The 
surface of the fibres in the composite materials was also observed to be 
porous, with the irregular regions potentially showing a higher degree of 
porosity (Figure 5.16, d; and Figure 5.18, d). 
The non-composite fibres, showing no apparent variations in their 
morphology, were labelled ‘unfilled fibres’. The irregular regions, observed in 
the composite fibres, were labelled ‘filled regions’. The average diameters of 
both ‘unfilled fibres’ and ‘filled regions’ were calculated using SEM 
micrographs of the electrospun materials and the results are shown in Table 
5.6. 
Table 5.6. Average diameters and standard deviation for the 'unfilled’ fibres and the 'filled’ 
regions on the composite electrospun materials. 
 Unfilled fibres Filled regions 
Diameter ± SD (μm) 1.99 ± 0.36 14.02 ± 7.67 
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a) b) 
  
c) d) 
  
Figure 5.15. Scanning electron microscopy micrographs of non-composite electrospun PCL at 
various magnifications. 
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a) b) 
  
c) d) 
  
Figure 5.16. Scanning electron microscopy micrographs of composite electrospun materials 
made of PCL and Sr0 bioactive glass particles at various magnifications. The red arrows 
indicate regions in the fibres with increased diameters and irregular morphologies where the 
particles may be contained. 
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a) b) 
  
c) d) 
  
Figure 5.17. Scanning electron microscopy micrographs of composite electrospun materials 
made of PCL and Sr50 bioactive glass particles at various magnifications. The red arrows 
indicate regions in the fibres with increased diameters and irregular morphologies where the 
particles may be contained. 
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a) b) 
  
c) d) 
  
Figure 5.18. Scanning electron microscopy micrographs of composite electrospun materials 
made of PCL and Sr100 bioactive glass particles at various magnifications. The red arrows 
indicate regions in the fibres with increased diameters and irregular morphologies where the 
particles may be contained. 
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5.2.3 EDS analysis of electrospun materials 
Energy dispersive X-ray spectroscopy (EDS) plots of the electrospun 
materials are presented in Figure 5.19. In the case of the ‘unfilled fibres’ in 
the non-composite material EDS detected the presence of only carbon and 
oxygen. However, in the case of the ‘filled regions’ in the composite 
materials, made of PCL and particles of Sr0, Sr50 and Sr100 bioactive glass, 
the analyses also detected the presence of the chemical elements which 
constitute each bioactive glass composition (i.e. oxygen, sodium, silicon, 
phosphorus, calcium and strontium), being able to differentiate between the 
three glasses. 
5.2.4 Solubility study of electrospun materials 
The pH variation plots of the solubility study of the electrospun materials are 
presented in Figure 5.20. In the case of the bioactive glass powders (Figure 
5.20, a), it was observed that there was an initial rapid increase of the pH 
towards alkaline values. It peaked at values around 10 by the end of the first 
24 hours and then slowly decreased to values around 8 by the end of the 
experiment. The pH of the control samples, composed of deionised water 
only, remained approximately constant throughout the whole study. In the 
case of the composite electrospun materials (Figure 5.20, b), a similar initial 
increase of the pH was observed, with peak values around 10 after 24 hours 
as well. However, the subsequent reduction of pH occurred significantly 
faster, reaching values between 8 and 9 after 168 hours and then stabilising 
at values around 7 by the end of the study. The pH of the control samples 
also remained approximately constant throughout the whole experiment. 
Statistically significant differences (Two-tailed Student’s t-test) between the 
pH values of the electrospun materials PCL/Sr0 and PCL/Sr100 were 
observed in the period of time between 48 hours and 192 hours; and were 
also observed between the pH values of the electrospun materials PCL/Sr50 
and PCL/Sr100 in the period comprised between 72 hours and 168 hours. 
PCL/Sr0 and PCL/Sr50 presented statistically significant differences only at 
24 hours. The relevant statistical information is shown in Table 5.7.  
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Figure 5.19. Energy dispersive X-ray spectroscopy plots of non-composite ‘unfilled fibres’ 
made of electrospun poly(caprolactone) (PCL) and of composite ‘filled regions’ made of PCL 
containing Sr0 (PCL/Sr0), Sr50 (PCL/Sr50) and Sr100 (PCL/Sr100) bioactive glass particles. The 
peaks belonging to the detected chemical elements are identified using their corresponding 
symbols (i.e. Si, Na, Ca, Sr, O, C). 
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a) 
 
b) 
 
Figure 5.20. pH variation plots of the solubility study of electrospun materials: a) 1 mg of Sr0, 
Sr50 and Sr100 bioactive glass powders in 20 ml of deionised water; b) 10 mg of non-composite 
electrospun poly(caprolactone) in 20 ml of deionised water (PCL) and 10 mg of composite 
electrospun PCL containing particles of Sr0 (PCL/Sr0), Sr50 (PCL/Sr50) and Sr100 (PCL/Sr100) 
bioactive glass. The control samples were vials containing only 20 ml of deionised water. 
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Table 5.7. Statistical information from two-tail Student’s t-test analyses of the pH values in the 
time period between 24 hours and 264 hours for: a) PCL/Sr0 vs. PCL/Sr50; b) PCL/Sr0 vs. 
PCL/Sr100; and c) PCL/Sr50 vs. PCL/Sr100 (n = 3; α = 0.05). 
  
a) PCL/Sr0 vs PCL/Sr50 
Time  Sample Mean SD t - value p - value 
24 h 
PCL/Sr0 9.82 0.07 
-5.20 0.035 
PCL/Sr50 9.91 0.05 
48 h 
PCL/Sr0 9.83 0.02 
-0.58 0.622 
PCL/Sr50 9.84 0.03 
72 h 
PCL/Sr0 9.78 0.03 
-0.33 0.774 
PCL/Sr50 9.79 0.04 
120 h 
PCL/Sr0 9.52 0.02 
<-0.01 1.000 
PCL/Sr50 9.52 0.05 
168 h 
PCL/Sr0 9.04 0.10 
0.41 0.720 
PCL/Sr50 8.93 0.45 
192 h 
PCL/Sr0 7.84 0.11 
<-0.01 0.995 
PCL/Sr50 7.84 0.81 
264 h 
PCL/Sr0 7.30 0.05 
0.03 0.977 
PCL/Sr50 7.29 0.22 
 
  
b) PCL/Sr0 vs PCL/Sr100 
Time  Sample Mean SD t - value p - value 
24 h 
PCL/Sr0 9.82 0.07 
0.16 0.888 
PCL/Sr100 9.81 0.01 
48 h 
PCL/Sr0 9.83 0.02 
4.61 0.044 
PCL/Sr100 9.68 0.06 
72 h 
PCL/Sr0 9.78 0.03 
42.50 <0.001 
PCL/Sr100 9.50 0.03 
120 h 
PCL/Sr0 9.52 0.02 
24.00 0.002 
PCL/Sr100 9.04 0.05 
168 h 
PCL/Sr0 9.04 0.10 
6.69 0.022 
PCL/Sr100 7.94 0.26 
192 h 
PCL/Sr0 7.84 0.11 
16.09 0.004 
PCL/Sr100 7.26 0.09 
264 h 
PCL/Sr0 7.30 0.05 
4.13 0.054 
PCL/Sr100 7.07 0.05 
 
  
c) PCL/Sr50 vs PCL/Sr100 
Time  Sample Mean SD t - value p - value 
24 h 
PCL/Sr50 9.91 0.05 
3.33 0.080 
PCL/Sr100 9.81 0.01 
48 h 
PCL/Sr50 9.84 0.03 
3.33 0.080 
PCL/Sr100 9.68 0.06 
72 h 
PCL/Sr50 9.79 0.04 
7.32 0.018 
PCL/Sr100 9.50 0.03 
120 h 
PCL/Sr50 9.52 0.12 
5.20 0.035 
PCL/Sr100 9.04 0.05 
168 h 
PCL/Sr50 8.93 0.45 
8.32 0.014 
PCL/Sr100 7.94 0.26 
192 h 
PCL/Sr50 7.84 0.81 
1.25 0.340 
PCL/Sr100 7.26 0.09 
264 h 
PCL/Sr50 7.29 0.22 
1.45 0.285 
PCL/Sr100 7.07 0.05 
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5.2.5 Addition of particles to the surface of electrospun fibres 
The ‘loading method’ and the ‘filtering method’ were developed to add 
bioactive glass particles on the surface of the electrospun fibres. 
Figure 5.21a presents the average mass variation in electrospun samples 
processed using both methods and suspensions of bioactive glass powders 
in DMEM cell culture medium at a concentration of 1% w/v. The control 
samples, processed using DMEM without any glass content (i.e. PCL, 
PCL/Sr0, PCL/Sr50 and PCL/Sr100), showed small negative mass 
variations. However, all the samples processed using the bioactive glass 
powder suspensions exhibited some degree of mass increase, which was 
significantly greater in the case of the ‘filtering method’. Figure 5.21b 
presents the average mass variation of electrospun samples processed 
using both methods and a series of suspensions of Sr0 bioactive glass 
powder in αMEM cell culture medium at various concentrations (i.e. 0% w/v, 
0.05% w/v, 0.10% w/v, 0.25% w/v, 0.50% w/v and 1.00% w/v). The ‘filtering 
method’ showed significant increases of mass starting at a concentration of 
0.05% w/v, while the ‘loading method’ showed it starting at a concentration of 
0.50% w/v. In general, the ‘filtering method’ consistently presented greater 
mass variations. Statistical analyses (Two-tailed Student’s t-test, Table 5.8 
and Table 5.9) reported significant differences in the mass variation between 
both methods in both tests. 
Figure 5.22 and Figure 5.23 show SEM micrographs of electrospun samples 
processed using the ‘loading method’ and the ‘filtering method’ respectively. 
The micrographs showed particles of varying size and shape on the surface 
of the material. It was observed that the amount of particles was significantly 
greater in samples processed using the ‘filtering method’, forming larger 
masses of particles with more homogeneous distributions. In any case, the 
distribution of particles appeared to be random in both methods. Large 
amounts of deposited particles also appeared to block the pores of the 
electrospun mesh. 
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a) 
 
b) 
 
Figure 5.21. Average mass variation of non-composite electrospun PCL samples processed 
using the 'loading' and 'filtering' methods to add further bioactive glass particles on the surface 
of the materials: a) Samples processed using a 1% w/v suspension of Sr0, Sr50 and Sr100 
bioactive glass powders in DMEM cell culture medium. b) Samples processed using a series of 
suspensions of increasing concentration of Sr0 bioactive glass powder in αMEM cell culture 
medium. 
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a) b) 
  
c) d) 
  
Figure 5.22. Scanning electron microscopy micrographs of electrospun materials processed 
using the 'loading method' and a 1% w/v suspension of bioactive glass powders.  
a) PCL + Sr0
L
; b) PCL/Sr0 + Sr0
L
; c) PCL/Sr50 + Sr50
L
; d) PCL/Sr100 + Sr100
L
. 
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a) b) 
  
c) d) 
  
Figure 5.23. Scanning electron microscopy micrographs of electrospun materials processed 
using the ‘filtering method' and two suspensions of bioactive glass powders of different 
concentration. a) and b) PCL + Sr0
F
 with 0.05% w/v suspension; c) and d) PCL + Sr0
F
 with 0.25% 
w/v suspension. 
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Table 5.8. Statistical information from two-tailed Student’s t-tests of the mass variation of 
electrospun samples processed using the ‘loading’ and ‘filtering’ methods to add further 
bioactive glass particles to the surface of the materials (n = 12; α = 0.05). 
Analysis Material 
Mean mass 
variation (mg) 
SD t-value p-value 
1 
PCLF 0.07 0.12 
1.78 0.102 
PCLL -0.03 0.10 
2 
PCL/Sr0F -0.13 0.08 
-1.47 0.171 
PCL/Sr0L -0.08 0.09 
3 
PCL/Sr50F -0.12 0.04 
-0.36 0.723 
PCL/Sr50L -0.11 0.08 
4 
PCL/Sr100F -0.3 0.06 
-5.48 <0.001 
PCL/Sr100L -0.08 0.11 
5 
PCL + Sr0F 9.12 1.76 
8.38 <0.001 
PCL + Sr0L 1.71 2.21 
6 
PCL + Sr50F 9.73 1.03 
17.28 <0.001 
PCL + Sr50L 0.76 1.17 
7 
PCL + Sr100F 8.15 2.05 
9.17 <0.001 
PCL + Sr100L 1.17 1.79 
8 
PCL/Sr0 + Sr0F 9.12 1.76 
12.87 <0.001 
PCL/Sr0 + Sr0L 0.81 0.84 
9 
PCL/Sr50 + Sr50F 7.17 1.54 
10.02 <0.001 
PCL/Sr50 + Sr50L 1.17 1.10 
10 
PCL/Sr100 + Sr100F 8.48 1.28 
16.44 <0.001 
PCL/Sr100 + Sr100L 1.35 0.85 
 
Table 5.9. Statistical information from two-tailed Student’s t-tests of the mass variation of 
electrospun samples processed using the ‘loading’ and ‘filtering’ methods to add further 
bioactive glass particles on the surface of the materials (n = 6; α = 0.05). 
Analysis Material  
Mean weight 
variation (mg) 
SD t-value p-value 
1 
PCL + Sr0F 0% w/v -0.10 0.06 
-1 0.363 
PCL + Sr0L 0% w/v -0.07 0.05 
2 
PCL + Sr0F 0.05% w/v 0.17 0.05 
4 0.010 
PCL + Sr0L 0.05% w/v 0.03 0.10 
3 
PCL + Sr0F 0.10% w/v 0.55 0.11 
9.22 <0.001 
PCL + Sr0L 0.10% w/v -0.02 0.13 
4 
PCL + Sr0F 0.25% w/v 2.12 0.56 
9.84 <0.001 
PCL + Sr0L 0.25% w/v -0.05 0.06 
5 
PCL + Sr0F 0.50% w/v 3.57 1.11 
6.10 0.002 
PCL + Sr0L 0.50% w/v 0.32 0.26 
6 
PCL + Sr0F 1.00% w/v 8.85 1.03 
10.61 <0.001 
PCL + Sr0L 1.00% w/v 1.60 1.04 
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5.2.6 Cytotoxicity assessment of electrospun materials 
The cytotoxicity of the electrospun materials was assessed by culturing a rat 
osteosarcoma (ROS) cell line directly on the samples. Cellular respiratory 
activity was then measured using a resazurin dye-based assay and by 
determining fluorescence emission from the cell culture medium. 
Figure 5.24a presents the fluorescence emission levels from the cell culture 
media used with electrospun materials PCL, PCL/Sr0, PCL/Sr50 and 
PCL/Sr100. Figure 5.24b and Figure 5.25 present the fluorescence emission 
levels from the cell culture media used with electrospun materials with added 
bioactive glass particles on their surface PCL/Sr0 + Sr0F, PCL/Sr50 + Sr50F 
and PCL/Sr100 + Sr100F. No statistically significant differences were 
reported between the means in the case of the electrospun materials PCL, 
PCL/Sr0, PCL/Sr50 and PCL/Sr100, and in the case of the samples 
processed with the 0.05% w/w suspension as determined by one-way 
ANOVA (Table 5.10). However, statistically significant differences between 
the means were reported in the case of the materials processed using the 
0.25% w/v and 1.00 w/v suspensions as determined by one-way ANOVA 
(Table 5.10) and two-tailed Student’s t-test (Table 5.11). 
Figure 5.26 presents a comparison of the fluorescence emission levels in the 
cell culture media used on every electrospun material tested, represented as 
a percentage of the fluorescence emission values in the control samples. It 
was observed that the levels of fluorescence of the electrospun materials 
with no particles added on their surface and those processed using the 
0.05% w/v suspensions presented comparable levels of fluorescence, but 
then the emission generally decreased as the amount of glass particles 
added to the materials increased. 
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a) 
 
b) 
 
Figure 5.24. Fluorescence emission levels from cell culture media used in the study of the 
cytotoxic effect of the electrospun materials on a rat osteosarcoma (ROS) cell line. A) PCL, 
PCL/Sr0, PCL/Sr50 and PCL/Sr100; b) PCL/Sr0 + Sr0
F
, PCL/Sr50 + Sr50
F
 and PCL/Sr100 + Sr100
F
 
processed using the ‘filtering’ method and suspensions of bioactive glass powder of 
concentration 0.05% w/v. The control samples were ROS cells cultured directly on plastic. 
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a)  
 
b) 
 
Figure 5.25. Fluorescence emission levels from cell culture media used in the study of the 
cytotoxic effect of the electrospun materials on a rat osteosarcoma (ROS) cell line. A) PCL/Sr0 
+ Sr0
F
, PCL/Sr50 + Sr50
F
 and PCL/Sr100 + Sr100
F
 processed using suspensions of bioactive 
glass powder of concentration 0.25% w/v.; b) PCL/Sr0 + Sr0
F
, PCL/Sr50 + Sr50
F
 and PCL/Sr100 
+ Sr100
F
 processed using the ‘filtering’ method and suspensions of bioactive glass powder of 
concentration 1.00% w/v. The control samples were ROS cells cultured directly on plastic. The 
lines indicate significant differences between the mean fluorescence of the control and the 
materials (* = p < 0.05). 
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Figure 5.26. Comparison of the fluorescence emission levels from cell culture media used in 
the studies of the cytotoxic effect of the electrospun materials on a rat osteosarcoma cell line, 
presented as a percentage of the fluorescence emission levels in the control samples 
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Table 5.10. Statistical information from one-way ANOVA performed with the fluorescence 
emission levels of cell culture media used in the study of the cytotoxic effect of the electrospun 
materials (n = 4; α = 0.05). 
Glass 
content 
Material 
Mean 
fluorescence 
SD 
DF 
Between 
groups 
DF 
Within 
groups 
F-
value 
p-
value 
0% 
w/v 
Control 29007.38 1335.87 
4 15 2.96 0.055 
PCL 32974.63 4366.77 
PCL/Sr0 27889.88 850.60 
PCL/Sr50 26125.63 4011.56 
PCL/Sr100 28163.25 2448.78 
0.05% 
w/v 
Control 16633.50 1723.55 
3 12 1.60 0.240 
PCL/Sr0 + 
Sr0
F
 
19591.50 4272.99 
PCL/Sr50 + 
Sr50
F
 
18331.63 2607.39 
PCL/Sr100 
+ Sr100
F
 
21731.50 4242.64 
0.25% 
w/v 
Control 25696.50 4119.31 
3 12 10.45 0.001 
PCL/Sr0 + 
Sr0
F
 
11823.25 2760.72 
PCL/Sr50 + 
Sr50
F
 
14198.38 4291.68 
PCL/Sr100 
+ Sr100
F
 
16846.00 3639.23 
1.00% 
w/v 
Control 29644.75 3046.40 
3 12 80.95 <0.001 
PCL/Sr0 + 
Sr0
F
 
11283.50 864.98 
PCL/Sr50 + 
Sr50
F
 
14315.88 1044.10 
PCL/Sr100 
+ Sr100
F
 
15131.50 1476.59 
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Table 5.11. Statistical information from two-tailed Student’s t-test analysis performed with the 
fluorescence emission levels from cell culture media used in the study of the cytotoxic effect of 
the electrospun materials (n = 4; α = 0.05). 
Glass 
content 
Material  
Mean 
fluorescence 
SD DF 
t – 
value 
p – 
value 
0.25% w/v 
Control 25696.50 4119.31 3 
5.08 0.015 PCL/Sr0 +  
Sr0F 
11823.25 2760.72 3 
Control 25696.50 4119.31 3 
6.09 0.009 PCL/Sr50 +  
Sr50F 
14198.38 4291.68 3 
Control 25696.50 4119.31 3 
3.92 0.030 PCL/Sr100 + 
Sr100F 
16846.00 3639.23 3 
1.00% w/v 
Control 29644.75 3046.40 3 
13.09 0.001 PCL/Sr0 +  
Sr0F 
11283.50 864.98 3 
Control 29644.75 3046.40 3 
11.64 0.001 PCL/Sr50 +  
Sr50F 
14315.88 1044.10 3 
Control 29644.75 3046.40 3 
17.58 <0.001 PCL/Sr100 + 
Sr100F 
15131.50 1476.59 3 
  
Results 
133 
 
5.3 Osteogenic effect of strontium-substituted bioactive 
glasses 
5.3.1 Characterisation of cell population 
Figure 5.27 presents the dot plots generated by FACS analysis for the 6 
tubes of MSCs used: forward scatter channel vs. side scatter channel (FSC 
vs. SSC), CD45 Blue 575 channel vs. side scatter channel (CD45 vs. SSC), 
and CD90 Violet 450 channel vs. CD44 Red 660 channel (CD90 vs. CD44). 
The FSC vs. SSC plot identified a cellular subpopulation of 10000 elements 
which was then used in the analysis, differentiating between cellular and 
non-cellular elements (e.g. debris). The CD45 vs. SSC and the CD44 vs. 
CD90 plots were used to identify those cellular elements in the subpopulation 
which were positive for the presence of the antibodies, depending on the 
region of the plot where they appeared. Table 5.12 presents the numerical 
data for each dot plot and Table 5.13 presents the median fluorescence 
emission intensities detected in every tube by the CD45 Blue 575, CD90 
Violet 450 and CD44 Red 660 channels. 
In the case of Tube 1 (Unstained), all the cells appeared to be negative for 
CD45, CD44 and CD90 antibodies and no fluorescence emission from the 
cells was detected. Tube 2 (All isotypes) presented no positive results for 
CD44 and CD90 emissions, although a small group of CD45-isotype positive 
cells (0.4% of the parent population) was identified. A small subpopulation of 
CD45-antibody positive cells (1.3% of the parent population) was also 
detected in Tube 3 (CD45 Ab and other isotypes). Both Tube 4 (CD44 Ab 
and other isotypes) and Tube 5 (CD90 Ab and other isotypes) presented 
significant positive subpopulations for those antibodies. A sizable 
subpopulation of CD44-antibody positive cells (26% of parent population) 
was detected in Tube 4. The majority of cells in Tube 5 (99.9% of parent 
population) were CD90-antibody positive. Finally, Tube 6 (All antibodies) 
showed that 29.2% of the parent population was positive for both CD44 and 
CD90 antibodies, while 70.8% of the parent population was positive for only 
CD90 antibody.  
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Figure 5.27. FSC vs. SSC, CD45 vs. SSC plots and CD90 vs. CD44 dot plots for the 6 tubes used in 
the characterisation of the population of rat mesenchymal stromal cells by FACS analysis. 
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Table 5.12. Numerical data of the dot plots for the 6 tubes used in the characterisation of the 
population of rat mesenchymal stromal cells by FACS analysis. 
 Tube 1 - Unstained Tube 2 - All isotypes 
 Events % Parent % Total Events % Parent % Total 
All events 12686 - 100.0 11921 - 100.0 
FSC SSC 10000 78.8 78.8 10000 83.9 83.9 
CD45+ 8 0.1 0.1 44 0.4 0.4 
CD44+ 0 0.0 0.0 3 0.0 0.0 
CD90+ 1 0.0 0.0 3 0.0 0.0 
CD44+ CD90+ 0 0.0 0.0 5 0.0 0.0 
Negative 9999 100.0 78.8 9989 99.9 83.8 
 
Tube 3 - CD45 Ab 
and other isotypes 
Tube 4 – CD44 Ab 
and other isotypes 
 Events % Parent % Total Events % Parent % Total 
All events 12387 - 100.0 12025 - 100.0 
FSC SSC 10000 80.7 80.7 10000 83.2 83.2 
CD45+ 134 1.3 1.1 45 0.4 0.4 
CD44+ 1 0.0 0.0 2603 26.0 21.6 
CD90+ 4 0.0 0.0 1 0.0 0.0 
CD44+ CD90+ 4 0.0 0.0 4 0.0 0.0 
Negative 9991 99.9 80.7 7392 73.9 61.5 
 
Tube 5 – CD90 Ab 
and other isotypes 
Tube 6 – All antibodies 
 Events % Parent % Total Events % Parent % Total 
All events 14307 - 100.0 15475 - 100.0 
FSC SSC 10000 69.9 69.9 10000 64.6 64.6 
CD45+ 42 0.4 0.3 166 1.7 1.1 
CD44+ 0 0.0 0.0 1 0.0 0.0 
CD90+ 9990 99.9 69.8 7078 70.8 45.7 
CD44+ CD90+ 5 0.0 0.0 2921 29.2 18.9 
Negative 5 0.0 0.0 0 0.0 0.0 
 
Table 5.13. Median fluorescence emission intensities detected by the CD45 Blue 575, CD90 
Violet 450 and CD44 Red 660 channels in the 6 tubes used in the characterisation of the 
population of rat mesenchymal stromal cells by FACS analysis. 
Tube Description 
CD45 
Blue 575 
CD90 
Violet 450 
CD44 
Red 660 
1 Unstained 142 87 12 
2 All isotypes 155 92 12 
3 CD45 Ab and other isotypes 166 92 14 
4 CD44 Ab and other isotypes 161 87 329 
5 CD90 Ab and other isotypes 153 19480 13 
6 All antibodies 158 19460 342 
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5.3.2 Effect of bioactive glass dissolution on cell viability 
The effect of Sr0, Sr50 and Sr100 bioactive glass dissolution on the viability 
of MSCs was assessed by exposing a monolayer culture of the cells to a 
series of increasing amounts of bioactive glass powders. Cellular viability 
was assessed by measuring respiratory activity after exposition to the 
dissolution products using a resazurin dye-based assay and by determining 
fluorescence emission from cell culture medium. 
Figure 5.28 presents the fluorescence emission levels of the samples 
exposed to 0, 5, 10, 20, 40, 80, 160 and 320 mg of bioactive glass powders. 
Figure 5.29 presents a comparison of the same results represented as a 
percentage of the fluorescence emission in the control samples. It was 
observed that the fluorescence emission generally decreased as the amount 
of bioactive glass powder used increased, indicating a reduction of cellular 
viability. The samples also exhibited different patterns of emission depending 
on the glass composition they were exposed to. In the case of samples 
treated with Sr0 and Sr100 bioactive glasses, fluorescence emission 
decreased from the beginning of the study. In contrast, samples treated with 
Sr50 bioactive glass exhibited an initial increase of emission at 5 mg and 
higher levels of emission than Sr0 and Sr100 up to 80 mg. The fastest rate of 
decrease of all samples was observed in those treated with Sr100, which 
generally presented lower levels of emission than both Sr0 and Sr50. 
These results were compared with the fluorescence emission from the 
control samples, which were MSCs not exposed to bioactive glass powders, 
and if statistically significant reductions of fluorescence emission were 
reported then those materials would be considered as toxic. One-way 
ANOVA (Table 5.14) reported statistically significant differences between the 
means of the emission levels of samples treated with the three bioactive 
glass compositions. Two-tailed Student’s t-tests (Table 5.15) reported 
statistically significant differences between the control samples and the 
samples treated with amounts of bioactive glass powders greater than 20 mg 
for Sr0 and Sr50; and greater than 10 mg for Sr100.  
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a) 
 
  
b) 
 
Figure 5.28. Fluorescence emission levels obtained from cell culture media used in the study of 
the effect of a series of increasing amounts of Sr0, Sr50 and Sr100 bioactive glass powders on 
the viability of rat mesenchymal stromal cells. The amounts tested were: a) 0, 5, 10, 20 and 40 
mg of bioactive glass powders; b) 0, 80, 160 and 320 mg of bioactive glass powders. The lines 
indicate significant differences between the mean fluorescence emission levels of the control 
and the samples (n=3, * = p < 0.05). 
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Figure 5.29. Comparison of the fluorescence emission levels obtained from cell culture 
media used in the study of the effect of a series of increasing amounts of Sr0, Sr50 and 
Sr100 bioactive glass powders on the viability of rat mesenchymal stromal cells, 
represented as percentage of the fluorescence emission levels in the control sample (n = 3). 
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Table 5.14. Statistical information from one-way ANOVA performed with the fluorescence 
emission levels obtained from the cell culture media used in the study of the effect of a series 
of increasing amounts of Sr0, Sr50 and Sr100 bioactive glass powders on the viability of rat 
mesenchymal stromal cells. (n = 3; α = 0.05). 
Bioactive 
glass 
Amount Mean SD 
DF 
Between 
groups 
DF 
Within 
groups 
F- 
value 
p-
value 
Sr0 
0 mg 32502.23 4787.78 
4 10 25.26 <0.001 
5 mg 29369.57 696.58 
10 mg 28159.4 1243.73 
20 mg 24695.73 932.45 
40 mg 15036.40 962.81 
Sr0 
0 mg 38863.83 789.79 
3 8 6097.20 <0.001 
80 mg 1502.83 197.49 
160 mg 1336.00 116.23 
320 mg 1329.50 121.28 
Sr50 
0 mg 32502.23 4787.78 
4 10 17.89 <0.001 
5 mg 35120.73 2137.47 
10 mg 34396.40 2758.86 
20 mg 32707.73 1964.86 
40 mg 18140.90 1605.63 
Sr50 
0 mg 38863.83 789.79 
3 8 6866.40 <0.001 
80 mg 1516.17 78.24 
160 mg 271.50 33.62 
320 mg 300.33 77.86 
Sr100 
0 mg 32502.23 4787.78 
4 10 62.49 <0.001 
5 mg 21313.73 485.36 
10 mg 19539.40 1530.08 
20 mg 13136.07 1046.70 
40 mg 2982.07 1333.21 
Sr100 
0 mg 38863.83 789.79 
3 8 7063.10 <0.001 
80 mg 311.33 75.55 
160 mg 227.00 46.49 
320 mg 296.33 27.43 
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Table 5.15. Statistical information from two-tailed Student’s t-test performed with the 
fluorescence emission levels obtained from the cell culture media used in the study of the 
effect of a series of increasing amounts of Sr0, Sr50 and Sr100 bioactive glass powders on the 
viability of rat mesenchymal stromal cells. (n = 3; α = 0.05). 
Bioactive 
glass 
Amount 
Mean 
fluorescence 
SD 
t-
value 
p-
value 
Sr0 
0 mg 32502.23 4787.78 
1.33 0.316 
5 mg 29369.57 696.58 
0 mg 32502.23 4787.78 
1.45 0.285 
10 mg 28159.40 1243.73 
0 mg 32502.23 4787.78 
3.06 0.093 
20 mg 24695.73 932.45 
0 mg 32502.23 4787.78 
7.67 0.017 
40 mg 15036.40 962.81 
0 mg 38863.83 789.79 
104.77 <0.001 
80 mg 1502.83 197.49 
0 mg 38863.83 789.79 
94.66 <0.001 
160 mg 1336.00 116.23 
0 mg 38863.83 789.79 
95.01 <0.001 
320 mg 1329.50 121.28 
Sr50 
0 mg 32502.23 4787.78 
-1.07 0.398 
5 mg 35120.73 2137.47 
0 mg 32502.23 4787.78 
-0.98 0.430 
10 mg 34396.40 2758.86 
0 mg 32502.23 4787.78 
-0.06 0.960 
20 mg 32707.73 1964.86 
0 mg 32502.23 4787.78 
4.57 0.045 
40 mg 18140.90 1605.63 
0 mg 38863.83 789.79 
90.44 <0.001 
80 mg 1516.17 78.24 
0 mg 38863.83 789.79 
87.37 <0.001 
160 mg 271.50 33.62 
0 mg 38863.83 789.79 
93.57 <0.001 
320 mg 300.33 77.86 
Sr100 
0 mg 32502.23 4787.78 
3.85 0.061 
5 mg 21313.73 485.36 
0 mg 32502.23 4787.78 
3.55 0.071 
10 mg 19539.40 1530.08 
0 mg 32502.23 4787.78 
6.07 0.026 
20 mg 13136.07 1046.70 
0 mg 32502.23 4787.78 
12.61 0.006 
40 mg 2982.10 1333.21 
0 mg 38863.83 789.79 
91.96 <0.001 
80 mg 311.33 75.55 
0 mg 38863.83 789.79 
89.88 <0.001 
160 mg 227.00 46.49 
0 mg 38863.83 789.79 
87.33 <0.001 
320 mg 296.33 27.43 
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5.3.3 Total RNA isolation 
Total RNA was isolated from MSCs cultured in monolayer and exposed to 20 
mg of Sr0, Sr50 and Sr100 bioactive glass powders placed on tissue culture 
inserts. The concentration of the elution of isolated RNA and the A260/A280 
and A260/A230 ratios, determined by spectrophotometry, for days 1, 3, 6 
and 14 are shown in Table 5.16 and Table 5.17. The mean amount of 
isolated RNA for each experimental condition is presented in Figure 5.30. 
It was observed that the total amount of isolated RNA generally increased 
with the passage of time. However, it was also observed that the isolated 
amounts were smaller in the case of the samples treated with bioactive glass 
powders compared to the untreated controls. A similar reduction was also 
observed in the case of the samples cultured in osteogenic cell culture 
medium compared to the samples cultured in standard cell culture medium. 
The samples cultured in osteogenic cell culture medium at day 14 had 
decreased significantly in cell number and the amount of total RNA isolated 
from them was too small to perform quantitative real-time PCR analyses. 
Therefore, those samples were excluded from the study. 
The A260/A280 and A260/A230 ratios measured by spectrophotometry 
provided an estimate of the purity of the isolated RNA. A sample of RNA 
would usually be considered as ‘pure’ if the A260/A280 ratio is around 2.0 or 
higher, and if the A260/A230 ratio is around 2.0 or higher. Lower ratios may 
indicate contamination with elements which absorb at those wavelengths, 
such as proteins at 280 nm and phenol at 230 nm. All the samples of total 
RNA presented A260/A280 ratios higher than 2.0, except those isolated from 
MSCs cultured with osteogenic cell culture medium at day 14. A larger 
variability was observed in the values of the A260/A230 ratio, with several 
samples presenting values lower than 2.0. 
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Table 5.16. Concentration, A260/A280 ratio and A260/A230 ratio of the total RNA isolated from 
rat mesenchymal stromal cells at days 1 and 3 for the study of the osteogenic effect of Sr0, 
Sr50 and Sr100 bioactive glass powders. 
Day Sample 
Standard cell 
culture medium 
Osteogenic cell 
culture medium 
RNA 
(ng/μl) 
A260/A280 
ratio 
A260/A230 
ratio 
RNA 
(ng/μl) 
A260/A280 
ratio 
A260/A230 
ratio 
1 
Control – 1 162.57 2.08 2.03 237.33 2.09 2.15 
Control – 2 166.47 2.09 1.77 255.80 2.07 2.15 
Control – 3 144.66 2.10 1.09 224.40 2.07 2.03 
Sr0 – 1 168.38 2.09 2.05 118.26 2.08 2.13 
Sr0 – 2 171.63 2.08 2.08 143.10 2.08 2.01 
Sr0 – 3 171.92 2.10 0.78 119.79 2.09 2.03 
Sr50 - 1 163.70 2.10 1.92 112.28 2.07 2.00 
Sr50 – 2 176.97 2.08 2.07 119.83 2.09 2.07 
Sr50 – 3 160.37 2.13 0.42 117.16 2.08 2.04 
Sr100 – 1 153.95 2.09 2.00 85.06 2.09 0.75 
Sr100 – 2 149.42 2.09 1.36 130.75 2.07 2.07 
Sr100 – 3 161.98 2.10 1.51 131.70 2.10 1.27 
3 
Control – 1 246.34 2.08 2.32 276.72 2.08 2.07 
Control – 2 323.51 2.07 2.17 287.86 2.08 2.11 
Control – 3 297.43 2.09 2.13 358.81 2.06 1.96 
Sr0 – 1 243.95 2.07 2.05 180.90 2.09 2.03 
Sr0 – 2 286.01 2.10 1.25 223.22 2.09 2.11 
Sr0 – 3 210.61 2.04 2.04 184.50 2.09 1.82 
Sr50 - 1 226.76 2.09 2.13 130.20 2.09 1.85 
Sr50 – 2 241.74 2.08 2.09 148.63 2.09 2.13 
Sr50 – 3 230.10 2.10 1.67 163.60 2.09 1.98 
Sr100 – 1 200.57 2.09 2.15 132.08 2.07 1.92 
Sr100 – 2 182.52 2.10 0.88 146.63 2.10 2.08 
Sr100 – 3 201.76 2.11 1.25 123.84 2.10 0.86 
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Table 5.17. Concentration, A260/A280 ratio and A260/A230 ratio of the total RNA isolated from 
rat mesenchymal stromal cells at days 6 and 14 for the study of the osteogenic effect of Sr0, 
Sr50 and Sr100 bioactive glass powders. 
Day Sample 
Standard cell 
culture medium 
Osteogenic cell 
culture medium 
RNA 
(ng/μl) 
A260/A280 
ratio 
A260/A230 
ratio 
RNA 
(ng/μl) 
A260/A280 
ratio 
A260/A230 
ratio 
6 
Control – 1 330.08 2.07 2.11 333.38 2.07 1.85 
Control – 2 286.22 2.08 1.64 413.34 2.06 2.15 
Control – 3 379.74 2.07 2.14 426.64 2.05 1.85 
Sr0 – 1 241.76 2.1 2.16 241.24 2.09 1.9 
Sr0 – 2 244.38 2.1 2.16 227.61 2.13 0.57 
Sr0 – 3 234.42 2.09 2.17 216.79 2.1 2.08 
Sr50 - 1 235.74 2.1 2.17 230.18 2.1 1.34 
Sr50 – 2 214.09 2.11 1.81 206.11 2.07 1.89 
Sr50 – 3 256.55 2.08 2.16 166.71 2.1 1.26 
Sr100 – 1 230.2 2.09 2.11 152.83 2.09 2.06 
Sr100 – 2 208.55 2.1 1.81 183.8 2.06 2.16 
Sr100 – 3 226.45 2.13 0.51 193.68 2.1 2.15 
14 
Control – 1 446.52 2.05 1.98 278.35 2.09 1.76 
Control – 2 428.45 2.05 2.12 292.46 2.08 2.09 
Control – 3 556.63 2.12 2.15 208.61 2.07 1.89 
Sr0 – 1 274.6 2.08 1.89 1.22 1.25 0.07 
Sr0 – 2 278.22 2.09 2.1 1.12 1.86 0.17 
Sr0 – 3 347.16 2.07 2.11 0.89 1.87 0.12 
Sr50 - 1 310.62 2.08 2.15 264.01 2.09 2.08 
Sr50 – 2 323.88 2.07 1.76 251.24 2.08 2.13 
Sr50 – 3 361.41 2.05 2.19 179.75 2.1 0.96 
Sr100 – 1 331.55 2.06 2.16 170.27 2.1 1.99 
Sr100 – 2 345.88 2.05 2.16 170.01 2.09 2.02 
Sr100 – 3 443.88 2.05 2.1 126.5 2.11 2.05 
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a) 
 
b) 
 
Figure 5.30. Mean amount of RNA isolated from rat mesenchymal stromal cells for the study of 
the osteogenic effect of Sr0, Sr50 and Sr100 bioactive glass powders. Cells were cultured in 
two different experimental conditions, using a) standard cell culture medium, and b) osteogenic 
cell culture medium (n = 3). 
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5.3.4 Analysis of RT-qPCR data 
The levels of expression of the genes Runx2, Alpl, Col1a1, Bglap, Bmp2 and 
Spp1 in MSCs exposed to 20 mg of Sr0, Sr50 and Sr100 bioactive glass 
powders and cultured in both standard and osteogenic media are presented 
in a series of figures from Figure 5.31 to Figure 5.36. The fold changes in 
expression were calculated employing the ΔΔCt method, using the levels of 
expression of the same genes in MSCs not exposed to bioactive glasses as 
a standard. Statistically significant differences (Wilcoxon two-group test, 
Table 5.18 and Table 5.19) were reported between the samples treated with 
bioactive glass powder and the untreated controls, and also between 
samples treated with different bioactive glasses. 
Runx2 presented significant differences between the control and the three 
bioactive glass compositions at days 3 and 6, in both standard and 
osteogenic media. An initial increase in the levels of expression in samples 
exposed to the glass was observed between days 1 and 6, with a peak at 
day 6 and a final decrease at day 14. 
Alpl presented significant differences between the control and the three glass 
compositions at days 3, 6 and 14 in standard cell culture medium, exhibiting 
an initial increase that peaked at day 6 and a final decrease at day 14. The 
pattern of expression obtained when analysing cells exposed to osteogenic 
cell culture medium looked similar, although the increase occurred earlier in 
time. The significant differences were then observed at days 1, 3 and 6, 
peaking at day 3 and then decreasing from that point. 
Col1a1 presented a pattern of expression similar to Runx2, with significant 
differences between the control and the three glass compositions at days 3 
and 6 in both standard and osteogenic cell culture media. However, in the 
case of cells cultured standard cell culture medium the peak of expression 
was observed at day 6, while in osteogenic cell culture medium it occurred at 
day 3. 
Bglap presented significant differences between the control and the three 
glass compositions only at day 6 in standard cell culture medium, while the 
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levels of expression at the other days were comparable to the untreated 
control. In osteogenic cell culture medium, however, significant differences 
were observed at days 3 and 6, peaking at day 3 and then exhibiting lower 
levels at day 6. 
In the case of Bmp2 no significant differences between the control and the 
three glass compositions in standard cell culture medium were observed 
simultaneously at any time point. However, there were significant differences 
in osteogenic cell culture medium at day 3. 
Finally, Spp1 presented simultaneous significant differences between the 
control and the three glass compositions at days 1 and 14 in standard cell 
culture medium. There was an initial decrease between days 1 and 6, and 
then a final increase by day 14. In osteogenic cell culture medium there were 
significant differences at days 1, 3 and 6, presenting a pattern of general 
decrease in the levels of expression as time progressed. 
Significant differences between the control and only one or two of the 
bioactive glass compositions were also observed at some time points. In 
standard cell culture medium these were at: Runx2, in Sr0 at day 1 and in 
Sr50 at day 14; Col1a1, in Sr100 at day 1 and in Sr50 at day 14; Bmp2; in 
Sr0 at days 1 and 3, and in Sr50 at all days; and Spp1, in Sr100 at day 3 and 
in Sr50 at day 6. In osteogenic cell culture medium these were at: Runx2, in 
Sr0 and Sr50 at day 1; Bmp2, in Sr0 and Sr50 at day 1 and in Sr100 at day 
14; and Spp1, in Sr50 at day 14. 
The combined effect of the osteogenic cell culture medium and bioactive 
glass dissolution products was also studied by calculating the folding change 
in genetic expression of the six genes in MSCs cultured in osteogenic cell 
culture medium in relation to the levels of expression in the untreated 
controls in standard cell culture medium. Figure 5.37 shows the levels of 
expression for Runx2 and Alpl, Figure 5.38 for Col1a1 and Bglap, and Figure 
5.39 for Bmp2 and Spp1. Statistically significant differences (Wilcoxon two-
group test, Table 5.20) were reported between the control in standard cell 
culture medium and most of the samples cultured in osteogenic cell culture 
medium.  
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 Runx2 
a) 
 
b) 
 
Figure 5.31. Variation in the expression of Runx2 in rat mesenchymal stromal cells exposed to 
20 mg of Sr0, Sr50 and Sr100 bioactive glass powders at various points in time. Studies were 
carried in two experimental conditions: a) cells cultured in standard cell culture medium and b) 
cells cultured in osteogenic medium. The lines indicate significant differences between the 
mean fluorescence of the control and the samples. (n = 9, * = p < 0.05). 
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 Alpl 
a) 
 
b) 
 
Figure 5.32. Variation in expression of Alpl in rat mesenchymal stromal cells exposed to 20 mg 
of Sr0, Sr50 and Sr100 bioactive glass powders at various points in time. Studies were carried 
in two experimental conditions: a) cells cultured in standard cell culture medium and b) cells 
cultured in osteogenic medium. The lines indicate significant differences between the mean 
fluorescence of the control and the samples. (n = 9, * = p < 0.05). 
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 Col1a1 
a) 
 
b) 
 
Figure 5.33. Variation in expression of Col1a1 in rat mesenchymal stromal cells exposed to 20 
mg of Sr0, Sr50 and Sr100 bioactive glass powders at various points in time. Studies were 
carried in two experimental conditions: a) cells cultured in standard cell culture medium and b) 
cells cultured in osteogenic medium. The lines indicate significant differences between the 
mean fluorescence of the control and the samples. (n = 9, * = p < 0.05). 
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 Bglap 
a) 
 
b) 
 
Figure 5.34. Variation in expression of Bglap in rat mesenchymal stromal cells exposed to 20 
mg of Sr0, Sr50 and Sr100 bioactive glass powders at various points in time. Studies were 
carried in two experimental conditions: a) cells cultured in standard cell culture medium and b) 
cells cultured in osteogenic medium. The lines indicate significant differences between the 
mean fluorescence of the control and the samples. (n = 9, * = p < 0.05). 
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 Bmp2 
a) 
 
b) 
 
Figure 5.35. Variation in expression of Bmp2 in rat mesenchymal stromal cells exposed to 20 
mg of Sr0, Sr50 and Sr100 bioactive glass powders at various points in time. Studies were 
carried in two experimental conditions: a) cells cultured in standard cell culture medium and b) 
cells cultured in osteogenic medium. The lines indicate significant differences between the 
mean fluorescence of the control and the samples. (n = 9, * = p < 0.05). 
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 Spp1 
a) 
 
b) 
 
Figure 5.36. Variation in expression of Spp1 in rat mesenchymal stromal cells exposed to 20 mg 
of Sr0, Sr50 and Sr100 bioactive glass powders at various points in time. Studies were carried 
in two experimental conditions: a) cells cultured in standard cell culture medium and B) cells 
cultured in osteogenic medium (Ost medium). The lines indicate significant differences 
between the mean fluorescence of the control and the samples. (n = 9, * = p < 0.05). 
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Table 5.18. P-values generated by Wilcoxon two-group test analysis performed between the ΔCt 
values obtained from RT-qPCR analyses of the genes Runx2, Alpl, Col1a1, Bglap, Bmp2 and 
Spp1 in rat mesenchymal stromal cells exposed to Sr0, Sr50 and Sr100 bioactive glass powders 
in standard cell culture medium. The background colour of each cell indicates if the analysis 
reported significant differences between both groups (i.e. Green) or not (i.e. Red). 
(n = 9; α = 0.05). 
Standard cell culture medium 
Gene Day 
Control 
vs. Sr0 
Control 
vs. Sr50 
Control vs. 
Sr100 
Sr0 vs. 
Sr50 
Sr0 vs. 
Sr100 
Sr50 vs. 
Sr100 
Runx2 
1 0.020 0.301 0.496 0.359 0.039 0.203 
3 0.004 0.004 0.004 0.250 0.910 0.359 
6 0.004 0.004 0.004 0.203 0.359 0.055 
14 0.055 0.020 0.301 0.129 0.203 0.055 
Alpl 
1 0.129 0.164 0.098 0.734 >0.999 >0.999 
3 0.004 0.004 0.004 0.012 0.098 >0.999 
6 0.004 0.004 0.004 0.004 0.004 0.301 
14 0.004 0.004 0.004 0.910 0.983 0.3594 
Col1a1 
1 0.734 0.496 0.020 0.359 0.203 0.250 
3 0.004 0.004 0.004 0.570 0.820 0.359 
6 0.004 0.004 0.004 0.020 0.004 >0.999 
14 0.098 0.039 0.496 0.426 0.004 0.008 
Bglap 
1 0.129 0.250 0.301 0.652 >0.999 0.496 
3 0.164 0.301 0.129 0.652 0.910 0.426 
6 0.039 0.012 0.004 0.301 0.004 0.027 
14 0.652 0.734 0.426 0.910 0.910 0.910 
Bmp2 
1 0.004 0.004 0.203 0.055 0.012 0.055 
3 0.004 0.004 0.055 0.129 0.012 0.359 
6 0.129 0.020 0.570 0.250 0.129 0.039 
14 0.129 0.039 0.496 0.734 0.039 0.074 
Spp1 
1 0.004 0.004 0.004 0.820 0.496 0.910 
3 0.129 0.129 0.020 0.910 0.426 >0.999 
6 0.055 0.008 0.570 0.359 0.008 0.004 
14 0.008 0.012 0.004 0.039 0.910 0.027 
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Table 5.19. P-values generated by Wilcoxon two-group test analysis performed between the ΔCt 
values obtained from the RT-q PCR analyses of the genes Runx2, Alpl, Col1a1, Bglap, Bmp2 
and Spp1 in rat mesenchymal stromal cells exposed to Sr0, Sr50 and Sr100 bioactive glass 
powders in osteogenic cell culture medium. The background colour of each cell indicates if the 
analysis reported significant differences between both groups (i.e. Green) or not (i.e. Red). 
(n = 9; α = 0.05). 
Osteogenic cell culture medium 
Gene Day 
Control 
vs. Sr0 
Control 
vs. Sr50 
Control vs. 
Sr100 
Sr0 vs. 
Sr50 
Sr0 vs. 
Sr100 
Sr50 vs. 
Sr100 
Runx2 
1 0.020 0.020 0.129 0.910 >0.999 0.820 
3 0.004 0.004 0.004 0.570 0.426 0.203 
6 0.004 0.004 0.004 0.164 0.426 0.359 
14 - 0.004 0.004 - - >0.999 
Alpl 
1 0.004 0.008 0.008 0.250 0.020 0.098 
3 0.004 0.004 0.004 0.570 0.004 0.012 
6 0.004 0.004 0.004 0.004 0.004 0.734 
14 - 0.250 0.098 - - 0.004 
Col1a1 
1 0.734 0.496 0.910 0.820 0.301 0.098 
3 0.020 0.004 0.008 0.250 0.359 0.496 
6 0.012 0.004 0.004 0.426 0.359 0.570 
14 - 0.129 0.129 - - >0.999 
Bglap 
1 0.910 0.734 0.129 0.570 0.098 0.496 
3 0.008 0.008 0.004 0.098 0.004 >0.999 
6 0.004 0.004 0.004 0.012 0.652 0.250 
14 - 0.652 0.055 - - 0.734 
Bmp2 
1 0.004 0.012 0.074 0.020 0.039 0.570 
3 0.004 0.004 0.004 0.004 0.910 0.008 
6 0.652 0.055 0.164 0.012 0.004 0.820 
14 - 0.203 0.039 - - 0.027 
Spp1 
1 0.004 0.004 0.004 0.098 0.426 0.570 
3 0.004 0.004 0.004 0.910 0.020 0.820 
6 0.004 0.004 0.004 0.004 0.004 0.098 
14 - 0.008 0.496 - - 0.008 
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a) Runx2 
 
b) Alpl 
 
Figure 5.37. Variation in expression of a) Runx2 and b) Alpl in rat mesenchymal stromal cells 
exposed to Sr0, Sr50 and Sr100 bioactive glass powders and cultured in osteogenic cell culture 
medium, in relation to the levels of expression in the untreated control in standard cell culture 
medium. The lines indicate significant differences between the mean fluorescence of the 
control and the samples. (n = 9, * = p < 0.05). 
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a) Col1a1 
 
b) Bglap 
 
Figure 5.38. Variation in expression of a) Col1a1 and b) Bglap in rat mesenchymal stromal cells 
exposed to Sr0, Sr50 and Sr100 bioactive glass powders cultured in osteogenic cell culture 
medium, in relation to the levels of expression in the untreated control in standard cell culture 
medium. The lines indicate significant differences between the mean fluorescence of the 
control and the samples. (n = 9, * = p < 0.05). 
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a) Bmp2 
 
b) Spp1 
 
Figure 5.39. Variation in expression of a) Bmp2 and b) Spp1 in rat mesenchymal stromal cells 
exposed to Sr0, Sr50 and Sr100 bioactive glass powders cultured in osteogenic cell culture 
medium, in relation to the levels of expression in the untreated control in standard cell culture 
medium. The lines indicate significant differences between the mean fluorescence of the 
control and the samples. (n = 9, * = p < 0.05). 
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Table 5.20. P-values generated by Wilcoxon two-group test analysis performed between the ΔCt 
values obtained from RT-qPCR analyses of the genes Runx2, Alpl, Col1a1, Bglap, Bmp2 and 
Spp1 in rat mesenchymal stromal cells. The samples analysed were the control in standard cell 
culture medium (Std) versus all the samples in osteogenic cell culture medium (Ost). The 
background colour of each cell indicates if the analysis reported significant differences 
between both groups (i.e. Green) or not (i.e. Red). (n = 9; α = 0.05). 
 Osteogenic cell culture medium 
Gene Day 
Control Std vs. 
Control Ost 
Control Std vs 
Sr0 Ost 
Control Std vs 
Sr50 Ost 
Control Std 
Sr100 Ost 
Runx2 
1 0.039 0.301 0.164 0.203 
3 0.004 0.004 0.004 0.004 
6 0.004 0.004 0.004 0.004 
14 0.004 - 0.004 0.004 
Alpl 
1 0.004 0.004 0.004 0.004 
3 0.004 0.910 >0.999 0.055 
6 0.004 0.004 0.004 0.004 
14 0.004 - 0.004 0.004 
Col1a1 
1 0.004 0.004 0.004 0.004 
3 0.004 0.004 0.004 0.250 
6 0.004 0.004 0.004 0.004 
14 0.004 - 0.098 0.039 
Bglap 
1 0.250 >0.999 0.820 0.652 
3 0.734 0.055 0.004 0.008 
6 0.004 0.004 0.004 0.004 
14 0.004 - 0.004 0.004 
Bmp2 
1 0.012 0.129 0.734 0.426 
3 0.359 0.004 0.004 0.004 
6 0.004 0.004 0.004 0.004 
14 0.004 - 0.004 0.004 
Spp1 
1 0.004 0.004 0.004 0.004 
3 0.004 0.004 0.004 0.004 
6 0.004 0.004 0.004 0.004 
14 0.004 - 0.004 0.004 
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6 Discussion 
The aim of this project was to produce a novel electrospun composite 
material combining poly(caprolactone) and particles of strontium-substituted 
bioactive glass, and to study its potential use as a scaffold for bone tissue 
engineering. The research work performed to fulfil this aim may be divided 
into three sections: 
1) The production and characterisation of melt-derived strontium-
substituted bioactive glass. 
2) The fabrication, characterisation and cytotoxicity testing of electrospun 
composite materials made of poly(caprolactone) and particles of 
strontium-substituted bioactive glass. 
3) The study of the osteogenic effect of strontium-substituted bioactive 
glass on osteoprogenitor cells. 
6.1 Production and characterisation of strontium-
substituted bioactive glass 
Three melt-derived bioactive glasses were fabricated (Sr0, Sr50 and Sr100) 
in which calcium was substituted by strontium in molar proportions of 0, 50 
and 100%, respectively. All the melts produced optically clear blocks of glass 
after pouring on moulds and annealing, and also optically clear glass frits 
after pouring on distilled water. These materials were then characterised 
using a range of methods. 
6.1.1 XRD analysis of bioactive glasses 
X-ray diffraction (XRD) analyses confirmed that Sr0, Sr50 and Sr100 
bioactive glasses were amorphous in nature and were free of any significant 
crystalline phases. The diffraction maximum of the amorphous spectra 
(Figure 5.1) progressively moved toward smaller 2θ values with increasing 
strontium substitution, suggesting an expansion of the glass network in order 
to accommodate the larger strontium cation. This is in agreement with a 
previous study by Fredholm et al. (2010), which reported a similar movement 
of the diffraction maximum with increasing strontium substitution. 
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6.1.2 DTA of bioactive glasses 
The decrease in glass transition temperature (Tg) observed with the 
increasing strontium substitution (Table 5.1) may have been caused by an 
expansion of the glass network in order to accommodate the larger strontium 
cation, weakening the silicate network and lowering the thermal energy 
barrier for the transition from glass to liquid state to occur. This is in general 
agreement with a study performed by O’Donnell et al. (2010), which reported 
that the Tg of bioactive glasses changed linearly in proportion to the 
strontium substitution. 
The working range was observed to increase with strontium substitution, 
suggesting that it may be less difficult to process the strontium-substituted 
bioactive glasses than the unmodified parent compositions at temperatures 
higher than Tg. The working range is the difference between Tc and Tg, 
indicating the range of temperature in which the glasses can be shaped and 
sintered by a viscous flow process. The low silica content and high calcium 
content of 45S5 bioglass makes it prone to crystallisation during sintering 
(Huppa and Yli-Urpo, 2012; Jones, 2013), which is a problem if it is desired 
to process the glass in its more fluid form. However, it is known that 
increasing the oxide content in the glass composition may create a wider 
working range by increasing the difference between both characteristic 
temperatures (Huppa and Yli-Urpo, 2012). Although this increase in working 
range is not essential for this project because the glasses were used in a 
particulate form, melt-derived strontium-substituted bioactive glasses may 
also be of interest for applications which may require a larger working range. 
Examples of this are the production of glass coatings for metal implants or 
the generation of glass fibres. 
Differences were observed in the estimated characteristic temperatures of 
PerioGlas® and Sr0 bioactive glass, both materials based on the 
composition of 45S5 bioglass. Although the Tg values are similar in both 
cases (523°C for PerioGlas® and 525°C for Sr0), the Tc and Tp values are 
consistently lower for Sr0 than for Perioglas® (Tc, 630°C vs. 613°C; Tp, 
690°C vs. 682°C), resulting in a greater working range in Perioglas®. This 
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may be attributed to the manufacturing process, with Sr0 being produced in-
house and PerioGlas® being produced under much stricter requirements in 
order to be commercialised as a medical device. This may require a study to 
determine if there were significant compositional variations with respect to 
the base composition of 45S5 bioglass, for example using X-ray 
fluorescence analysis. 
6.1.3 Density and oxygen density of bioactive glasses 
The experimentally measured density of the bioactive glasses increased 
linearly in proportion to strontium substitution (Table 5.2 and Figure 5.3), 
suggesting that the strontium cation increased the overall mass of the 
glasses. Additionally, a good agreement was observed between the 
experimentally measured densities and the theoretical densities calculated 
using Doweidar’s model. Doweidar hypothesised that in alkali-silicate 
glasses the volume of the Qn structural units depends only on the type of 
modifier ions present in the composition but not on their concentration. 
Therefore, the volume of the units can then be calculated as a function of the 
radius and charge of the modifier ion and the number of non-bridging 
oxygens (Doweidar, 1999; Fredholm et al., 2010). The good agreement 
between the experimental and theoretical densities confirmed that the 
volume of the Qn units with strontium was larger than the volume of the 
equivalent Qn units with calcium because of the larger atomic radius of Sr2+, 
as shown in Table 6.1. Although this increase in volume may seem contrary 
to an increase in density, the effect of strontium substitution on glass density 
may be explained by the higher atomic weight of strontium, which is 
proportionally greater than the increase in volume caused by the larger ionic 
radius. 
Table 6.1 Ionic radius and atomic weight for sodium (Na
+
), calcium (Ca
2+
) and strontium (Sr
2+
) 
cations. Adapted from Doweidar (1999). 
Cation Ionic radius (nm) Atomic weight (g·mol-1) 
Na+ 0.095 - 0.102 22.99 
Ca2+ 0.094 - 0.106 40.078 
Sr2+ 0.110 - 0.127 87.62 
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The linear decrease of oxygen density with strontium substitution (Table 5.3 
and Figure 5.4) suggested an expanded and less rigidly bonded glass 
network. This was probably caused by the larger strontium cation and is 
consistent with the larger volumes of the Qn units with strontium 
hypothesised by Doweidar. These results are in agreement with a previous 
study by Fredholm et al. (2010), which reported a linear increase of bioactive 
glass density from 2.71 g cm-3 to 3.10 g cm-3 and a linear decrease of 
oxygen density with strontium substitution. 
6.1.4 Solubility study of bioactive glasses 
The solubility of the bioactive glasses increased linearly in proportion to 
strontium substitution (Figure 5.5), suggesting an expansion of the glass 
network in order to accommodate the larger strontium cation which may 
allow the modifier ions (i.e. Na+, Ca2+ and Sr2+) to be more easily released to 
the local environment than in unmodified glasses. 
This increase in solubility may have a potentially intensifying effect on the 
reactivity of the glasses and, consequently, on their bioactivity. O’Donnell et 
al. (2010) argued that this effect is possible because the substitution of 
calcium by strontium was done on a molar basis and not on a weight basis. If 
the substitution is done on a weight basis, as in the case of work reported by 
Lao et al. (2009) and Gorustovich et al. (2010), the contents of other 
components in the glass (e.g. silicon) will increase. If the silica content in a 
silicate glass is increased, the network becomes more polymerised (i.e. 
larger amount of Q3 structural units at the expense of Q2 units) and it results 
in reduced solubility, degradation rates and bioactivity. However, if the 
substitution is done on a molar basis the network structure is not significantly 
changed and the bioactivity may be retained. O’Donnell et al. also suggested 
that the bioactivity of strontium-substituted bioactive glasses may even be 
higher than in unmodified glasses due to the biological effect of strontium on 
bone-forming cells and, also, due to the increase in solubility caused by the 
expansion of the glass network produced by the larger strontium cation. 
Results from qualitative energy dispersive x-ray spectroscopy (EDS) 
analyses performed before and after the solubility studies (Figure 5.6, Figure 
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5.7 and Figure 5.8) confirmed that the dissolution of the glasses began at the 
surface of the samples, as expected for bioactive glasses. The main 
chemical elements detected on fragments of the detached surface material 
after the solubility tests were performed were silicon and oxygen, suggesting 
that the modifier ions (i.e. Na+, Ca2+ and Sr2+) were released in dissolution 
and that the glass network composed of silicon and oxygen remained. The 
high temperature (80°C) and the acetic acid solution used in the study may 
have accelerated the ionic release due to a corrosive effect of the solution on 
the glass. This was also in general agreement with what is expected to occur 
during the first steps of bioactive glass dissolution, when the rapid exchange 
of the modifier ions with H+ from the solution creates Si-OH bonds on the 
surface of the glass (Hench, 1998). 
6.1.5 Network connectivity of bioactive glasses 
Although the results of the NC calculations may suggest that the substitution 
of calcium by strontium in the bioactive glass composition may not affect the 
bioactivity of the material, even if it results in an expanded glass network, it is 
certainly possible that two glasses with different dissolution rates may 
present identical network connectivity values if calculated with the models 
used in this report. 
NC is a measure of the average number of bridging oxygens on each SiO4 
tetrahedron. It is calculated from the molar composition of the glass 
(Equation 4.4) and may be used to predict a number of properties, including 
its bioactivity. For example, the bioactivity of bioactive glasses generally 
increases as NC decreases (O’Donnell et al., 2010). To calculate NC, the 
number of non-bridging oxygens (NBOs) created by the network modifying 
oxides is subtracted from the number of bridging oxygens (BOs) formed by 
the network former oxide. This value is then divided by the number of glass 
forming units. Since a molecule of both CaO and SrO will form two NBOs 
each, it is expected that the substitution of calcium by strontium on a molar 
basis will not produce any changes in the theoretical values. 
The NC’ value (i.e. assuming that phosphorus is within the glass structure in 
the form of orthophosphate but does not enter the glass network) for Sr0, 
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Sr50 and Sr100 bioactive glass compositions were the same (i.e. 2.12) and 
were within the range suggested by Edén (2011) for optimal glass bioactivity 
(i.e. 2.0 ≤ NC’ ≤ 2.6). This was also the same value calculated for 45S5 
bioglass (Jones, 2013). The NC’’ value (i.e. assuming that phosphorus 
enters the glass network forming P-O-Si bonds) for Sr0, Sr50 and Sr100 
bioactive glass compositions was the same as the value reported for 45S5 
bioglass (i.e. 1.90) (Hill, 1996). The composition of Sr0, Sr50 and Sr100 were 
based on the original composition of 45S5 bioglass, so it was expected to 
obtain the same values of NC. 
NMR analyses of Sr0, Sr50 and Sr100 bioactive glasses should be 
performed to experimentally determine if the NC of the materials was actually 
altered in any significant way in response to the substitution. However, 
previous solid-state NMR studies by Fredholm et al. (2010) showed that the 
NC and the structure of the glass did not change significantly with the 
substitution of calcium by strontium in bioactive glasses. Therefore, these 
analyses of the glasses were not considered as necessary. 
6.1.6 Particle size analysis of milled bioactive glasses 
Particle size analyses of the bioactive glass powders produced by milling and 
sieving showed that the particle size distributions for Sr0, Sr50 and Sr100 
bioactive glasses presented similar profiles (Figure 5.9 and Figure 5.10). 
A general increase in particle size was observed (Table 5.5) as the 
proportion of strontium in the glass composition increased. This may be 
caused by a potential increase of material fragility as a consequence of the 
expansion of the glass network in order to accommodate the larger strontium 
cation. This may result in the production of greater amounts of smaller sized 
particles during milling, potentially forming aggregates which may be 
detected as larger particles during the particle size analysis. SEM 
micrographs of the glass powders (Figure 5.11) suggested that the smaller 
particles tended to aggregate together or to attach to the surface of larger 
particles. Therefore, it is possible that a powder sample containing a larger 
proportion of small sized particles may result in the formation of larger 
groups of particles. 
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6.1.7 Conclusions from the production and characterisation of strontium-
substituted bioactive glass 
Calcium was successfully substituted by strontium in the composition of 
bioactive glass, resulting in measureable changes to several material 
properties. The substitution affected the characteristic temperatures of the 
material, decreasing glass transition temperature due to the expansion of the 
glass network to accommodate the larger strontium cation. Additionally, the 
onset of crystallisation temperature and the peak crystallisation temperature 
presented a minimum value in Sr50 bioactive glass. The working range of 
temperature also increased with strontium substitution, a variation that may 
have potential benefits for the processing of these glasses for various 
applications. 
The substitution also induced a linear increase of glass density, due to the 
presence of the heavier strontium cation; and a linear decrease of oxygen 
density, due to the expansion of the glass network. The solubility of the 
glasses also increased linearly in proportion to strontium substitution. This 
may potentially result in increased bioactivity levels due to higher reactivity. 
However, network connectivity calculations, a measurement used to estimate 
glass bioactivity, did not vary with strontium substitution. This may suggest 
that the substitution does not have an effect on glass bioactivity, but it has 
been hypothesised (O’Donnell and Hill, 2010) that the structural model used 
in these calculations does not take into account the field strength of the 
network modifier ions, so it is possible that two glasses with different 
dissolution rates may present identical network connectivity values 
Finally, it is possible that strontium substitution may affect glass mechanical 
properties, increasing its fragility due to the expanded and less rigidly 
bonded glass network, as revealed by the decreased oxygen density. This 
may result in a larger proportion of smaller particles in powders produced by 
the milling of bioactive glasses with higher strontium content. The more 
abundant smaller particles may then aggregate to form clusters which may 
be identified as larger particles in the analyses of particle size. 
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6.2 Fabrication, characterisation and cytotoxicity testing of 
electrospun composite materials 
6.2.1 Optimisation of electrospinning parameters 
An optimisation study of several electrospinning parameters was performed 
in order to fabricate materials exhibiting a small amount of surface defects 
and consistent fibre diameters. The study was divided in two parts: first, the 
effect of polymer concentration and solvent composition was studied; and 
second, the effect of the addition of bioactive glass particles on the 
production of electrospun fibres was investigated. 
Effect of polymer concentration and solvent composition 
As previously mentioned in section 5.2.1 of this report, in the first stage of the 
optimisation study the solutions of 10 wt% PCL dissolved in blends of 
DCM:DMF 90:10 v/v and of DCM:DMF 85:15 v/v were selected because the 
electrospun mats produced presented the smallest amount of defects and 
the most regular fibres with respect to diameter and morphology. 
The processing parameters governing the electrospinning process can be 
divided into three main categories: ‘system’ parameters, which are those 
related to the system used to produce the electrospun fibres (e.g. applied 
voltage); ‘solution’ parameters, which are those related to the polymer 
solution used to produce the electrospun fibres (e.g. polymer concentration); 
and ‘environmental’ parameters, which are those factors external to the 
electrospinning process (e.g. atmospheric humidity). The main ‘solution’ 
parameters affecting fibre diameter and morphology are the conductivity and 
volatility of the solvent used, and polymer concentration. 
It is known that PCL dissolves well in DCM but poorly in DMF (Woodruff and 
Hutmacher, 2010). From the boiling point and dielectric constant values 
(Table 4.7) it is possible to derive that DCM is significantly more volatile and 
less conductive than DMF. Therefore, the addition of DMF to DCM had the 
overall effect of reducing the volatility and increasing the conductivity of the 
solvent mixture, resulting in the production of more regular electrospun 
fibres. Furthermore, the higher conductivity may have resulted in potentially 
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smaller fibre diameters by an associated increase in the tensile forces that 
the fibre jets are subjected to in the electric field (Supaphol et al., 2012). This 
effect may be observed in the micrographs of the materials produced with 10 
wt% PCL dissolved in DCM:DMF 90:10 v/v and 85:15 v/v (Figure 5.13). This 
is in general agreement with work performed by Lee et al. (2003), in which a 
series of solutions of PCL dissolved in blends of DCM and DMF with ratios 
100:0, 85:15, 75:25 and 40:60 v/v were electrospun and which showed that 
the diameter of the PCL fibres decreased as the content of DMF in the 
solution increased, probably due to increased conductivity and reduced 
surface tension and viscosity of the solution. 
The beading observed in the electrospun samples produced using the 8 wt% 
PCL solution was probably caused by the low polymer concentration. 
Generally, the morphology of the fibres will gradually change from beaded to 
smooth as the polymer concentration increases. Within an optimal range it is 
possible to produce uniform fibres with diameters that increase with the 
concentration, but concentrations higher than optimal will usually result in a 
disruption of the flow due to an increase in solution viscosity (Supaphol et al., 
2012). This effect was also observed in this study, as the samples produced 
using the 12 wt% and 14 wt% solutions presented a higher level of surface 
defects due to sputtering than those produced using the 10 wt% solution. 
Effect of bioactive glass particle content 
In the second stage of the optimisation study, the solution of 10 wt% PCL 
dissolved in DCM:DMF 90:10 v/v with bioactive glass particles added 
following a 10:1 PCL:glass weight ratio was selected to fabricate the 
electrospun materials used in the project. This composition produced 
materials which were generally strong enough to be handled without 
breaking and presented the smallest amount of surface defects due to 
sputtering. Additionally, it was considered that the composition using the 
lowest amount of DMF would be favoured due to the potential toxicity hazard 
posed by this solvent. 
It was noted that increasing the amount of particles added to the polymer 
solution resulted in samples with more apparent defects on the surface of the 
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electrospun membrane due to sputtering. Additionally, the materials 
fabricated using the PCL:glass weight ratio 10:4 were more fragile than 
materials produced using other ratios. Finally, SEM micrographs (Figure 
5.14) also suggested that the addition of glass particles may result in larger 
variations and less homogeneous distributions of fibre diameters compared 
to materials electrospun without glass particles. 
The sputtering may be due to a disruption of the polymer jet caused by the 
addition of the particles to the polymer solution. SEM micrographs (Figure 
5.16, Figure 5.17 and Figure 5.18) showed regions in the fibres with 
increased diameters and irregular morphologies which did not generally 
disrupt the fibre. However, if the glass particles were contained in those 
regions, it cannot be discarded that large particles or clusters of particles 
may result in broken fibres as the polymer jet is stretched on its way towards 
the collector. The variation in diameter due to the presence of glass particles 
may be caused by a non-homogeneous distribution of the polymer solution in 
the fibres containing the particles, potentially resulting in regions with 
increased polymer concentration and variable rates of solvent evaporation. 
6.2.2 SEM and EDS analyses of electrospun materials 
Electrospun materials were then fabricated using the solution composition 
selected in the optimisation study. The thickness of the mats were not 
experimentally determined, although they generally were <1 mm. 
Low magnification SEM micrographs of non-composite electrospun materials 
(i.e. PCL with no added glass particles) showed regular fibres with no 
apparent defects on their surface (Figure 5.15, a, b and c). Higher 
magnification micrographs of the same samples suggested that the surface 
of the fibres was generally porous (Figure 5.15d). SEM micrographs of the 
composite electrospun materials (i.e. electrospun PCL with Sr0, Sr50 and 
Sr100 bioactive glass particles) showed that the fibres presented certain 
regions with increased diameters and irregular morphologies (Figure 5.16, 
Figure 5.17 and Figure 5.18). The presence of bioactive glass particles within 
those regions was confirmed by EDS analysis, through the detection of all 
the chemical elements that formed each glass composition (Figure 5.19). 
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These particular regions were consequently known as ‘filled regions’, while 
PCL fibres that did not contain glass particles were known as ‘unfilled fibres’. 
The micrographs of the ‘filled regions’ also showed that the particles were 
embedded within the fibres and were covered by a layer of PCL. The fibres 
were generally not broken by the presence of the glass particles, despite the 
particles being significantly larger in size than the average ‘unfilled fibres’. In 
some cases the glass particles were not completely covered by the polymer 
and some parts of them remained exposed to the local environment, 
potentially facilitating their dissolution and release of their ionic content. The 
surface of the polymer in the ‘filled regions’ was observed to be porous as 
well (Figure 5.16d and Figure 5.18d), suggesting that the process of pore 
formation may occur throughout the whole electrospun structure. 
Porous electrospun fibres have been produced using diverse polymers, 
solvents, and process parameters (Megelski et al., 2002). Two main 
mechanisms have been found to be responsible for pore formation: breath 
figures process and phase separation. The breath figures process, first 
described by Srinivasarao et al. (2001), is able to generate ordered pore 
patterns on a polymer surface through the condensation of water droplets 
from atmospheric humidity. The rapid evaporation of the solvent reduces the 
temperature on the surface of the electrospinning jet as it travels from the 
Taylor cone to the collector and, depending on the properties of the solvent, 
this cooling may be sufficient to promote the condensation of water droplets. 
These droplets remain as individual entities and arrange themselves on the 
surface, partially sinking into the solution. The solution then surrounds the 
template created by the droplets and, as the droplets evaporate after the jet 
has completely dried, an imprint on the surface of the fibres appears in the 
form of pores. This process requires the presence of certain levels of 
atmospheric humidity and the use of a volatile solvent with low water 
solubility. The characteristics of the pores thus depend on the polymer (i.e. 
chemistry and molecular weight), the solvent (i.e. vapour pressure, surface 
tension) and the solution used (i.e. viscosity, hydrophilicity, thermal 
properties) (Megelski et al., 2002; Migliaresi et al., 2012). 
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Phase separation is a process which leads to the formation of two phases in 
a polymer solution. When a polymer solution is cast on a mould, evaporation 
occurs under convective conditions. As the solvent evaporates, the solution 
becomes thermodynamically unstable and separation occurs into polymer-
rich and the polymer-poor phases. The polymer-rich phase solidifies shortly 
afterwards and forms a matrix, while the polymer-poor phase forms the 
pores. Megelski et al. (2002) suggested that these general aspects could be 
transferred to the formation of porous polymeric fibres. Bognitzki et al. (2001) 
described the formation of pores in electrospun fibres using several polymers 
and proposed that this occurred due to the rapid evaporation of the solvent 
caused by the increase in surface area in the electrospun material and 
subsequent rapid solidification. 
The presence of pores on the surface suggests an increased surface area 
compared to a similar material made of non-porous fibres. As a 
consequence, the materials produced for this work may present a potentially 
larger capability to absorb water and release the ionic dissolution products 
contained in the bioactive glass particles to the local environment. 
Furthermore, fibre porosity has been proposed as of fundamental importance 
in the production of electrospun scaffolds for tissue engineering because cell 
behaviour may be influenced by the topographical features on the surface 
they attach to (Migliaresi et al., 2012). The characteristics of the polymer 
solution used to fabricate the electrospun materials here discussed support 
the breath figures process as a potential mechanism of pore formation. The 
main solvent used, DCM, is highly volatile and does not dissolve well in 
water. Additionally, PCL is highly hydrophobic, facilitating the conditions for 
the formation of water droplets on the fibre surface. However, the phase 
separation process has also been proposed by some researchers as the 
main cause of pore formation on electrospun PCL fibres (Hartman et al., 
2010). 
The average diameter of the ‘unfilled fibres’ was measured to be 1.99 ± 0.36 
μm, while the average diameter of the ‘filled regions’ was 14.02 ± 7.67 μm. 
According to the plots of the particle size distribution (Figure 5.9), the 
greatest volume in the particle distribution was occupied by particles with 
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sizes around 10 μm. This range of sizes, combined with a layer of polymer 
covering the glass particles of potentially around 1 μm in thickness, may 
potentially yield diameters similar to the average diameter of the ‘filled 
regions’. Particles with sizes <2 μm may not have produced apparent 
changes in fibre morphology and diameter because of their small 
dimensions. 
6.2.3 Solubility study of electrospun materials 
A solubility study of the electrospun materials was performed to investigate 
the dissolution of the bioactive glass particles from within the polymeric fibres 
and the subsequent release of the ionic dissolution products to the local 
environment. 
When bioactive glasses are submerged in an aqueous environment a rapid 
exchange of sodium, calcium and/or strontium ions with H+ from the solution 
occurs on the glass surface, resulting in an increase of the pH (Hench, 
1998). It was previously described in this report that the substitution of 
calcium by strontium in the glass composition resulted in a linear increase in 
glass solubility. As a consequence of this increase, the electrospun materials 
containing Sr50 and Sr100 bioactive glass particles were probably able to 
induce higher increases of pH compared with those containing Sr0 bioactive 
glass particles (Figure 5.20). This agrees with a report by Fredholm et al. 
(2012), who observed a correlation between pH increases and the increasing 
content of strontium in bioactive glasses when particles of the material were 
immersed in simulated body fluids. 
The high surface area of the glass powders and of the electrospun fibres 
may also have resulted in an increased dissolution rate due to the small 
particle size and the larger surface area of the electrospun fibres, allowing for 
a greater capacity to absorb water and release the ionic dissolution products 
to the environment. 
The gradual decrease in pH observed after the initial 24 hours may have 
been caused by the dissolution of atmospheric CO2, as the vials were not 
sealed from the atmosphere during the study and were regularly opened to 
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perform the pH measurements. In the case of the electrospun composite 
materials the decrease of pH values occurred at a faster rate than in the 
case of the samples only containing bioactive glass powders. 
These results suggested two ideas: first, the glass particles may indeed 
dissolve from within the polymeric fibres, releasing their ionic content to the 
local environment and consequently increasing the pH. Second, an 
interaction may occur between the polymer and the bioactive glass particles 
in the composite materials, facilitating the faster decrease of pH. A potential 
mechanism for this effect may be as follows. It is known that the first stage of 
PCL degradation involves the random hydrolytic breakage of ester bonds in 
the polymeric chains of the amorphous regions of the polymer, reducing 
chain length (Middleton and Tipton, 2000; Woodruff and Hutmacher, 2010). 
Lam et al. (2008) performed a study of the in vitro degradation of porous, 
three-dimensional PCL scaffolds, including composite samples containing 
particulate tricalcium phosphate (TCP). NaOH was added to the media in 
order to accelerate polymer degradation through alkalinisation. They 
reported that the degradation process was regulated by polymer molecular 
weight, crystallinity, hydrophilicity and the design of the polymeric device, 
and observed that the scaffolds degraded via a surface degradation pathway 
in the alkalinised conditions instead of a bulk degradation pathway. 
Surface degradation occurs when water penetrates the polymer at a slower 
rate than the hydrolytic cleavage of the polymer chains. The degradation by-
products then diffuse rapidly into the media and no water molecules reach 
the centre of the matrix. Therefore, degradation mainly occurs at the surface 
and the device suffers a ‘thinning’ effect in which material is eliminated from 
the surface while the molecular weight of the polymer remains intact. As the 
degradation begins at the amorphous regions and occurs at a very fast rate, 
the remaining crystalline regions are held together by the amorphous 
segments until they are dislocated from the main polymer bulk. The erosion 
of the amorphous polymer regions induces the fragmentation and final 
erosion of the packed crystalline regions at the surface as well, thus 
contributing to a faster initial loss of mass. The process is schematically 
represented in Figure 6.1. 
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Figure 6.1. Schematic diagram of the potential mechanism of fragmentation of crystalline 
regions during the degradation of poly(caprolactone) (PCL). Adapted from Lam et al. (2008). 
It has been suggested (Baji et al., 2010) that the rapid evaporation of the 
solvent from the electrospinning jet may lead to less developed structures in 
the fibres. This rapid evaporation may result in a reduction of the jet 
temperature and, consequently, polymer molecules that are aligned along 
the fibre axis have less time to realign themselves, leading to a less 
favourable packing and lower levels of crystallinity in semi-crystalline 
polymers due to non-optimal formation of crystalline lamellae. Lee et al. 
(2003) reported wide angle X-ray diffractions measurements that suggested 
a reduction in the crystallinity of electrospun PCL fibres compared to the 
crystallinity of PCL films. This reduction of the overall crystallinity in 
electrospun PCL fibres may potentially result in increased degradation rates 
by increasing the proportion of amorphous regions in the fibres, more 
susceptible to degradation than the crystalline regions. 
Lam et al. (2008) also reported that PCL scaffolds containing TCP particles 
(60 μm particle size) degraded entirely after 54 hours in 5 M NaOH at 37˚C, 
while PCL only scaffolds degraded entirely within 6 weeks under the same 
conditions. They suggested that this substantial difference may be due to a 
reduction of the molecular weight of the scaffolds caused by the presence of 
the TCP particles, which affected the arrangement of the polymer chains 
surrounding them and exposed them more readily to hydrolytic cleavage of 
chain-end scissions. It is possible that the presence of the bioactive glass 
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particles in the electrospun materials, which were smaller in size than the 
particles used by Lam et al. (2008), may have resulted in a similar effect. 
It is also possible that the rapid increase of environmental pH due to glass 
dissolution may accelerate the rate of PCL degradation, similar to the effect 
caused by the addition of NaOH in the study performed by Lam et al. (2008). 
Although the change of pH was global and affected the whole medium in 
each sample, the accelerating effect may have been particularly severe in 
the polymeric regions surrounding the glass particles. As the polymer 
degraded, acidic degradation products from PCL may have been released 
from the sample to the medium, decreasing the pH. The statistically 
significant differences observed in the experiments suggested that the 
increased solubility of the strontium-substituted bioactive glasses may result 
in a more pronounced accelerating effect. 
It has been frequently proposed that the increase of pH induced by the 
dissolution of bioactive glasses may be used to neutralise the acidic effect 
caused by the degradation of bioresorbable polymers such as PCL. That 
way, it is argued, it may be possible to avoid potential inflammation 
responses post-implantation (Boccaccini and Maquet, 2003; Suggs et al., 
2007; Jones, 2013). However, the degradation rate of the polymer and the 
dissolution rate of the glass should ideally match to optimise the buffering 
effect. The results here discussed suggested that bioactive glass dissolution 
occurs at a significantly faster rate than polymer degradation, which is 
usually counted in months rather than in days (Middleton and Tipton, 2000; 
Wang et al., 2010). Although some evidence of the buffering effect of 
bioactive glass on polymer degradation has been reported in the literature 
(Stamboulis et al., 2002), it may be argued that the large disparity between 
the two rates would not support the proposed buffered system. However, the 
results of this project suggested that the composite system may be used in 
the opposite way, with the accelerated polymer degradation buffering the 
rapid initial increase of pH induced by the glass dissolution. 
No significant changes of pH were observed in those samples containing 
only electrospun PCL, suggesting that the polymer may not degrade at the 
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same rate without the presence of the bioactive glass particles. Similarly, no 
significant changes were observed in the samples containing only deionised 
water, suggesting that the medium used did not induce the pH changes 
observed in the previous cases. 
6.2.4 Addition of glass particles to electrospun materials 
Two methods used to place additional bioactive glass particles on the 
surface of the electrospun fibres were developed and investigated. The 
purpose of this study was to create new configurations of the materials and 
to study if the further addition of exposed bioactive glass particles had a 
significant effect on their cytotoxicity and potential to work as a scaffold. 
Their efficiency was studied by performing two separate tests. The first test 
used suspensions of Sr0, Sr50 and Sr100 bioactive glass powders in cell 
culture medium at a constant concentration of 1% w/v, while the second test 
used a series of suspensions of increasing concentration of Sr0 bioactive 
glass powder in cell culture medium. Although the results of the tests showed 
that both methods were able to add bioactive glass particles on the 
electrospun samples, it was demonstrated that the ‘filtering method’ was 
consistently more efficient and was capable of adding most of the glass 
content present in the suspensions on the samples (Figure 5.21). The first 
test showed that the ‘loading method’ was able to add an average of 1.16 mg 
of glass particles on the samples, which is approximately 12% of the glass 
content present in 1 ml of the suspensions. The ‘filtering method’ was able to 
add an average of 8.51 mg of glass particles, which is approximately 85% of 
the glass content. The efficiency of the ‘filtering’ method was also shown to 
be higher in the second test, exhibiting values between 70% and 90% using 
suspensions with concentrations of 0.25% w/v and higher. 
These differences in efficiency between both methods may be due to the 
way they work. The ‘loading method’ is based on the deposition of glass 
particles in suspension on the surface of the samples solely depending on 
gravitational force. As the path the particles take cannot be controlled, many 
will be deposited outside the sample. On the other hand, the ‘filtering 
method’ allows for a finer control as the whole suspension is pushed through 
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the electrospun material and, consequently, the majority of the content of 
glass particles present on the suspension will be deposited on the sample. 
SEM micrographs showed that in the case of samples processed using the 
‘filtering method’ (Figure 5.23, a and b) many particles were trapped in the 
mesh of electrospun fibres. However, as the amount of glass particles added 
increased, the new particles appeared to accumulate on top of the previously 
deposited particles, potentially block the pores of the mesh. This may be 
considered an undesirable outcome, especially for tissue engineering 
applications since the presence of open pores is an important requirement 
for scaffolds. However, it may be an interesting approach for other 
applications, such as the development of membranes for guided bone 
regeneration. It is suggested that suspensions of glass particles of low 
concentration (i.e. 0.05% w/v or lower) should be used if it is desired to 
minimise pore blockage. 
It was also apparent from the SEM micrographs (Figure 5.23, c and d) that 
most of the last glass particles added were not in direct contact with the 
mesh. After drying, the glass particles were able to separate from the 
electrospun material with relative ease, suggesting that the glass did not 
firmly attach to the surface of the fibres. It is possible that the particles may 
attach to each other as the bioactive glass dissolves, inducing the formation 
of the HCA layer. According to Hench (1998), this process takes fewer than 
20 hours from the moment in which the reactions begin. In this study the 
samples were incubated in cell culture medium for 24 hours after the 
particles were added, so the process of HCA formation may have already 
started. However, this may only be able to create a mechanic attachment of 
the glass particles to the electrospun fibres if the most external particles 
become attached through HCA formation to the particles trapped within the 
mesh. In general, the loss of particles appeared to increase as the amount of 
glass added to the electrospun samples increased. 
Small reductions of mass were observed in the control composite samples 
(i.e. electrospun materials processed with cell culture medium without 
Discussion 
177 
 
bioactive glass particles), probably due to the dissolution of the glass 
particles and the potentially accelerated degradation of PCL.  
The variability observed in the results of the ‘filtering’ method may be due to 
a series of reasons. The first source of variability may have been 
inaccuracies in the process of suspension preparation, including more or less 
amount of glass powder than required. Second, although the suspensions 
were stirred to homogenise the distribution of particles, it is possible that the 
sample of suspension did not contain the expected amount of glass particles. 
Third, it is also possible that some glass particles may have gone through the 
electrospun sample as the suspension was pushed through. Finally, it is 
possible that some of the glass particles deposited on the surface of the 
samples were lost in the final washing and drying steps or when handling the 
samples for weighing. 
6.2.5 Cytotoxicity of electrospun composite materials 
The cytotoxicity of all the electrospun materials produced was tested by 
culturing a rat osteosarcoma (ROS) cell line on the samples and then 
applying a resazurin-dye based assay, which assessed cellular metabolic 
activity by measuring fluorescence emission levels from the cell culture 
medium used. 
Results from the study suggested that electrospun PCL and the inclusion of 
bioactive glass particles within the fibres did not induce an appreciable 
detrimental effect on cell viability in vitro (Figure 5.24a). Fabbri et al. (2010) 
reported similar results when testing the in vitro cytotoxicity of porous 
scaffolds made of PCL and particles of 45S5 bioglass fabricated using a 
solid-liquid phase separation method, observing no appreciable differences 
in cell proliferation as the content of added glass particles was varied 
between 25% and 50% by weight with respect to PCL. Although the cytotoxic 
effect of increasing the content of glass particles in the electrospun samples 
was not tested in this study, no significant differences were observed 
between the samples as the content of strontium in the glass was increased, 
which may intensify the cytotoxic effect due to higher dissolution rates and 
greater subsequent rises in pH. For example, an increase in cytotoxicity 
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associated with strontium content in the composition of bioactive glasses 
was reported by O’Donnell et al. (2010) after they observed that proliferation 
of human osteosarcoma cells cultured in media enriched with the dissolution 
products of a series of strontium-substituted bioactive glasses was reduced 
as the proportion of strontium substitution increased to 100%. 
In the case of Fabbri et al. (2010), the amount of bioglass 45S5 particles in 
the scaffolds was increased, boosting the potential cytotoxicity of the 
material, while in this work the potential cytotoxicity of the materials was 
enlarged by increasing the amount of strontium present in the glass. In both 
situations no significant differences were observed between the controls (i.e. 
cell cultured on tissue culture plastic) and the samples containing glass 
particles. 
Fabbri et al. (2010) also reported that cell proliferation on the samples was 
about 25% of the proliferation observed on tissue culture plastic and 
suggested that this may have been caused by the hydrophobicity and low 
wettability of PCL. It was also observed in this study that, before the 
sterilisation step by immersion in isopropyl alcohol, the electrospun PCL 
samples were highly hydrophobic. Results from the resazurin-dye based 
assays, which may also be used to measure cell proliferation, showed that 
there were no significant differences between the cells seeded on plastic and 
on the electrospun samples, suggesting that the increase in hydrophilicity 
due to immersion in isopropyl alcohol may have encouraged cell attachment. 
Results from the study of the cytotoxic effect of the electrospun samples 
processed with the ‘filtering’ method suggested that the addition of 0.05 mg 
of glass particles on the surface of the electrospun fibres may not have a 
detrimental effect on cell viability (Figure 5.24b). Statistically significant 
differences were then observed (Figure 5.25) between the control (i.e. cells 
cultured directly on cell culture plastic without electrospun PCL and without 
bioactive glass particles) and the samples processed using suspensions of 
glass particles with concentrations of 0.25% w/v and 1.00% w/v, indicating 
that the addition of amounts over 0.05 mg of glass particles may have a 
detrimental effect on cellular viability. These results suggested that the 
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cytotoxic effect of the addition of bioactive glass particles on the surface of 
the electrospun fibres may be more influenced by the amount of glass added 
than by the content in strontium in the glass composition. 
Isaac et al. (2011) tested the cytotoxic effect of strontium-substituted 
bioactive glass particles in direct contact with mouse osteoblastic cells at a 
concentration of 4 mg/ml, observing no significant differences in viability and 
metabolic activity after 72 hours between the samples and the control (i.e. 
cells cultured directly on cell culture plastic without bioactive glass particles) 
as the amount of strontium increased. The glass particles had been pre-
incubated for 24 hours in cell culture medium prior to the experiments, a step 
similar to what was done to the electrospun materials after the glass particles 
were added to their surface. This may reduce the cytotoxic effect of the 
glasses as the initial dissolution and change in pH occurs during that period 
of time, before exposure to cells. Although this may be an interesting 
approach depending on the application for the material, reducing its potential 
detrimental effect, it is expected that a considerable proportion of the ionic 
content in the glass will be lost before their exposure to the cells and, 
consequently, the potential stimulatory effect may be diminished. 
It is also possible that the potential cytotoxic effect of the bioactive glass 
dissolution may be dampened by the inclusion of the particles within the 
polymeric matrix. As the cells proliferate, they mainly attach to the surface of 
the fibres and, thus, may not be in direct contact with the glass particles. 
However, in the case of the samples with added bioactive glass particles on 
their surface, the cells will be in direct contact with the particles and may be 
more exposed to the effects of glass dissolution. This is expected to 
potentially induce a different cellular behaviour. 
6.2.6 Conclusions from the fabrication, characterisation and cytotoxicity 
testing of electrospun composite material 
The effect of polymer concentration, solvent composition and content of 
bioactive glass particles on the electrospinning process was studied in order 
to optimise the fabrication of electrospun materials with appropriate 
characteristics to fulfil the aim of this project. The solution of PCL which 
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generated electrospun materials presenting the lowest amount of observable 
defects and the most regular fibres was 10 wt% PCL dissolved in a blend of 
DCM and DMF mixed in a proportion 90:10 v/v. Bioactive glass particles with 
sizes <45 μm were then added to this solution following a 10:1 PCL:glass 
weight ratio prior to electrospinning, since this ratio produced materials with 
the smallest amount of observable defects. 
The electrospun materials produced with this composition were composed of 
fibres (1.99 ± 0.36 μm mean diameter) exhibiting porous surfaces and 
regular morphologies. In the case of the composite materials, the bioactive 
glass particles were contained within certain regions of the fibres (i.e. ‘filled 
regions’) which presented an increased diameter (14.02 ± 7.67 μm mean 
diameter) and an irregular morphology. The polymeric surface on the ‘filled 
regions’ was also porous, increasing the surface area of the material and 
potentially facilitating water absorption, glass dissolution and the release of 
the ionic dissolution products to the environment. 
Dissolution of bioactive glass particles from within the polymeric fibres and 
the release of the ionic dissolution products were confirmed by means of a 
study which showed a rapid initial increase of pH towards alkaline values, as 
expected to occur in bioactive glasses. In the case of the composite 
materials this initial increase was later reduced to values close to neutral 
levels faster than samples composed of bioactive glass powders only, 
suggesting a possible interaction between the polymer and the glass 
particles which may facilitate this effect. This reduction of pH may be 
associated to an accelerated degradation of PCL induced by the alkaline 
conditions created by the rapid glass dissolution, releasing acidic 
degradation products to the local environment and, thus, resulting in a 
reduction of pH. This effect may also be encouraged by a lower degree of 
crystallinity of the polymer caused by the electrospinning process and the 
presence of the glass particles within the matrix, potentially increasing its 
degradation rate. This may prove to be a useful approach to neutralise the 
possibly detrimental effect of glass dissolution on cells and tissues post-
implantation. 
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Two methods to place bioactive glass particles on the surface of the 
electrospun fibres were also developed and studied. Although that both 
methods were successful, the ‘filtering’ method was demonstrated to be the 
most efficient, achieving efficiencies between 80% and 90% and allowing a 
finer control in the addition of glass particles than the ‘loading’ method. 
However, it was observed that the glass particles may not be firmly attached 
to the electrospun material and may detach with ease if they are not 
entrapped within the fibre mesh. 
The electrospun materials generally presented good levels of in vitro 
biocompatibility. However, the addition of bioactive glass particles on the 
surface of the fibres generally increased the cytotoxic effect when amounts 
larger than 0.05 mg of glass particles were added. It is possible that the 
cytotoxic effect of these compositions may be more strongly influenced by 
the amount of glass particles used than by the level of strontium substitution. 
6.3 Study of the osteogenic effect of strontium-substituted 
bioactive glass 
6.3.1 Characterisation of rat MSCs by FACS analysis 
Undifferentiated mesenchymal stromal cells (MSCs) were isolated from rat 
bone marrow and then pooled into one general population. The cells were 
cultured until passage 3 and then were characterised by evaluating the 
expression of several surface molecular markers using fluorescence-
activated cell sorting (FACS) analysis. The results suggested that 29.2% of 
the parent population may be actual multipotent MSCs (Figure 5.27 and 
Table 5.12).  
Rat MSCs express various molecular surface markers, including CD9, CD10, 
CD13, CD29, CD44, CD54, CD55, CD90, CD105, CD166, D7-FIB; and are 
negative for CD14, CD34, CD45 and CD133 (Pountos et al., 2007). 
However, only antibodies against three surface markers (i.e. CD90, CD44 
and CD45) were initially selected to characterise the population due to cost 
concerns and because the aim of the study was to perform a general 
identification. CD90 is positively expressed in bone marrow MSCs of several 
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species and is one of the main surface molecular markers used in the 
identification of human MSCs as determined by the International Society of 
Cell Therapy (Boxall and Jones, 2012). 
CD44 is also positively expressed in MSCs, although there is evidence that it 
may display irregular expression patterns depending on rat strain and 
passage (Barzilay et al., 2009). The levels of CD44 expression in rat bone 
marrow MSCs isolated from Wistar rats reported by Barzilay et al. were 
significantly lower (9.76%) than those measured in this study (26%). Kim et 
al. (2010) characterised passage 2 bone marrow MSCs isolated from 
Sprague Dawley rats, observing that CD44 was expressed at higher levels 
(74.24%) than those reported in this study and by Barzilay et al. Yue et al. 
(2008) characterised passage 3 MSCs obtained from Wistar rats and 
reported even higher levels of CD44 expression (98.2%). The high variability 
of CD44 in rat MSCs, as evidenced by all these studies, suggests that this 
may not be the most appropriate surface molecular marker for the 
identification of rat bone marrow MSCs. Boxall et al. (2012) also suggested 
that, as CD44 is expressed in different types of cells simultaneously in 
various tissues, its lack of specificity may limit its usefulness as a marker for 
MSCs. Both CD90 and CD44 surface molecular markers are expressed in 
MSCs and haematopoietic stem cells, but CD44 is also expressed in cells 
from the lymphoid, myeloid, megakaryotic, erythroid and endothelial 
lineages. 
CD45 is a surface molecular marker which is expressed in haematopoietic 
stem cells and is absent on MSCs of multiple species, although it is known 
that in some cases rat bone marrow MSCs may express CD45 at levels 
below 5% (Barzilay et al., 2009; Boxall et al., 2012). The generally low levels 
of positive detection of CD45 observed in this study appear to agree with this 
and suggested that few haematopoietic stem cells were isolated together 
with the MSCs. 
Based on the results of this study and the evidence found in the literature, it 
is concluded that alternative surface molecular markers to CD44 may provide 
more consistent results. For example, it is reported that CD105 is usually 
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expressed in rat MSCs, as well as in the myeloid and endothelial lineages, at 
levels between 50% and 100% (Boxall et al., 2012). 
6.3.2 Effect of bioactive glass dissolution on cell viability 
The observed reduction in MSCs viability (Figure 5.28) suggested that, in 
general, increasing the amount of bioactive glass powder used and the level 
of strontium substitution may result in significant increases of material 
cytotoxicity. This effect was particularly clear when the cells were exposed to 
the dissolution products of amounts of glass powders greater than 20 mg. 
As previously discussed, this effect may be a consequence of the increase in 
glass solubility induced by the strontium substitution and its associated 
increase of environmental pH (O’Donnell et al., 2010). The study of the 
cytotoxicity of the electrospun materials suggested that the increased 
cytotoxic effect may have been mainly caused by the amount of glass 
particles placed on the surface of the fibres rather than by the increased 
solubility induced by the strontium content. However, the amounts of glass 
powders used in that study were considerably smaller than the amounts 
used here (i.e. 0.05 mg vs. 5 mg, smallest amounts used in each study). It is 
expected that larger amounts of glass powders will have a more severe 
effect on environmental pH, which may consequently make the differences 
caused by the various glass composition more evident. Additionally, although 
the bioactive glass compositions used in both studies were the same, it 
cannot be discarded that the presence of the polymer in the electrospun 
materials may have resulted in more favourable conditions for the cells. ROS 
cells were also cultured in direct contact with the particles, while in this case 
the MSCs were only exposed to the glass dissolution products. The process 
to add the particles on the surface of the electrospun fibres also required a 
step in cell culture medium for 24 hours, which resulted in the pre-incubation 
of the particles and a reduction of their potential impact, while in this study 
the glass particles were not pre-incubated. Finally, it is also possible that 
MSCs may react differently to the dissolution products of bioactive glass 
dissolution than ROS cells. 
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The apparently lower cytotoxicity of Sr50 bioactive glass (Figure 5.29) may 
be due to a stimulatory effect of that specific composition on MSCs. Isaac et 
al. (2011) reported a similar result when they assessed the viability of mouse 
osteoblastic cells exposed to strontium-substituted bioactive glasses. They 
observed that cell viability after 24 hours of direct exposition to particles of a 
glass with a 5 wt% strontium substitution was higher than in the control (i.e. 
cells cultured without bioactive glass), and than in cells exposed to other 
glass composition (i.e. 0 wt% and 1 wt% strontium). That amount of 
strontium in the glass was equivalent to 2.9 mol%, which is considerably 
lower than the 13.46 mol% used on Sr50 bioactive glass. However, it should 
be noted that the glasses used by Isaac et al. (2011) were pre-incubated, 
losing part of its content in strontium and diminishing their potential 
enhancing effect. It may be expected that a non-pre-incubated glass may 
take longer time to release their complete ionic content and may have a 
more prolonged effect, which is what was observed in Sr50 as the results 
here discussed were observed after 72 hours of exposition. Similarly, 
O’Donnell et al. (2010) reported higher levels of proliferation of human 
osteosarcoma cells in exposition to the dissolution products from a bioactive 
glass with a similar composition to Sr50, than in exposition to the dissolution 
products of an unmodified glass or a glass with a similar composition to 
Sr100. However, the composition that, according to O’Donnell et al. (2010), 
presented the highest levels of cell proliferation had a substitution of calcium 
by strontium of only 10%, suggesting that there may be a particular ratio in 
calcium and strontium content in the bioactive glass composition which may 
present the most enhancing effects. 
Finally, an amount of 20 mg was selected to perform the study of the 
osteogenic effect of the glasses on MSCs, as this amount did not induce a 
statistically significant detrimental effect on MSCs in the case of Sr0 and 
Sr50 bioactive glasses, and it was the smallest amount that induced a 
significant detrimental effect in the case of Sr100. 
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6.3.3 Total RNA isolation from rat MSCs 
The complete RNA content from MSCs cultured in monolayer and exposed 
to the dissolution products from 20 mg of Sr0, Sr50 and Sr100 bioactive 
glasses was isolated and measured (Figure 5.30).  
The general increase in isolated total RNA observed from day 1 to day 14 
may be associated with an increase in cell numbers due to proliferation. 
Although the generally lower amounts of total RNA isolated from the cells 
exposed to bioactive glass may be associated to the cytotoxic effect of glass 
dissolution, it was observed that the amount of RNA isolated at day 1 from all 
the samples treated with glass powders were similar to the control and then 
were lower than the control from day 3 onwards. As the glasses used in this 
study were not pre-incubated, it may be expected that the main cytotoxic 
effect will occur during the initial 24 hours. However, it is possible that the 
change in pH in the conditions used in this study may have longer term 
effects on the cells, slowing down cell proliferation rather than killing the 
cells. Additionally, the amounts of RNA obtained from the samples treated 
with the glass powders at day 14 increased as the substitution of calcium by 
strontium in the glass increased. This suggested that the presence of the 
strontium-substituted glass may have had a stimulatory effect on the MSCs 
rather than a deleterious effect. 
In the case of the samples cultured in osteogenic medium conditions, the 
increase of total RNA isolated from MSCs from day 1 to day 6 may also be 
associated with cell proliferation. Also, the samples treated with bioactive 
glasses generally produced lower amounts of RNA than the control samples, 
cultured without any glass. In general, the samples appeared to show a 
different pattern to what was observed in the samples cultured in standard 
cell culture medium. The total amount of RNA obtained from the control 
samples at day 14 was generally lower than at day 6, suggesting that a 
particular change occurred to the cells between those two time points, 
slowing down their proliferation and even decreasing their numbers. 
Additionally, these results did not suggest a stimulatory effect of strontium on 
the proliferation of MSCs, as the amount of RNA obtained at day 14 in the 
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samples treated with Sr100 was lower than in the samples treated with Sr50. 
Finally, the samples treated with Sr0 at day 14 had reduced significantly in 
cell number and did not produce enough RNA. 
Huang et al. (2007) suggested that three stages can be observed in the 
growth of osteoprogenitor cells in vitro. Cell proliferation occurs mainly from 
day 1 to day 4 of exposition to osteogenic cell culture medium. Early 
differentiation into osteoblasts then occurs from day 5 to day 14, followed by 
terminal differentiation and maturation of bone matrix from day 15 to day 28. 
They reported an increase of isolated DNA from murine MSCs during the first 
4 days of culture followed by a gradual reduction until day 28. Although it 
may be difficult to determine a direct relationship between isolated RNA and 
cell numbers in a similar manner, the increase of isolated RNA in the control 
samples cultured in osteogenic cell culture medium between day 1 and 6 
may suggest the occurrence of the proliferation stage as defined by Huang et 
al. (2007), and the decrease observed at day 14 may then be associated 
with the early differentiation stage. It is possible that the presence of both the 
osteogenic cell culture medium and the dissolution products of bioactive 
glasses may have affected the pattern of growth in osteoprogenitor cells, 
potentially inducing their differentiation. 
6.3.4 Analysis of RT-qPCR data 
Abundant research work has been published about the stimulatory effect of 
bioactive glasses on bone formation using various biological indicators of 
osteogenesis, demonstrating that there is a growing body of evidence 
supporting their potential use in bone regeneration applications. 
Xynos et al. (2000a) reported higher levels of alkaline phosphatase activity 
and osteocalcin synthesis on human osteoblasts cultured directly on discs of 
45S5 bioglass, suggesting that the ionic dissolution products released by the 
material may be able to influence cell cycle and control the differentiated cell 
population. Cells that were not capable of achieving a completely 
differentiated osteocyte phenotype were eliminated by apoptosis. The shift in 
cell population observed by Xynos et al. (2000a) toward mature osteoblasts 
occurred in a few hours and led to the formation of mineralised bone nodules 
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without the addition of bone growth factors. Xynos et al. (2000b) also 
reported a significant increase in the production of insulin-like growth factor II 
(IGF-II) by human osteoblasts after their exposure to dissolution products of 
45S5 bioglass. IGF-II is a potent growth factor, very abundant in bone, which 
induces osteoblast proliferation. Therefore, it was suggested that the 
stimulatory effect of bioactive glass dissolution products on osteoblast 
proliferation may have been mediated by IGF-II. Later work by Xynos et al. 
(2001) also led to the discovery that critical concentrations of soluble silica 
and calcium cations were able to activate or up-regulate seven families of 
genes in human osteoblasts involved in proliferation and differentiation. 
Various studies have been performed investigating this topic, as reviewed by 
Hench (2009), confirming the results of Xynos et al. (2001) in cells from 
several sources (i.e. embryonic stem cells, foetal cells and adult primary 
cells). 
Regarding the study of the osteogenic effect on rat MSCs, Radin et al. 
(2005) reported that the presence of 45S5 bioglass resulted in increased 
levels of alkaline phosphatase activity cultured both in direct contact with the 
samples and apart from them, suggesting that the glasses had a stimulatory 
effect on the osteoblastic differentiation of the cells. Yao et al. (2005) also 
reported an increased expression of alkaline phosphatase, osteocalcin and 
bone sialoprotein in RNA extracted from rat MSCs exposed to the dissolution 
products released from poly(lactide-co-glycolide) microspheres containing 
45S5 bioglass particles. Reilly et al. (2007) compared the effect of bioactive 
glasses on both human and rat MSCs, and reported that human MSCs 
generally produced significantly lower levels of alkaline phosphatase activity 
than rat MSCs when exposed to bioactive glasses. No differences were 
observed in human MSCs cultured in 45S5 bioglass and cell culture plastic 
and no consistent effects were observed in response to bioactive glass 
dissolution, suggesting that the beneficial effects of bioactive glass on bone 
regeneration may not be mediated by an accelerated differentiation of MSCs. 
Alkaline phosphatase activity was also reported by Gentleman et al. (2010), 
observing that it increased in a human osteosarcoma cell line in response to 
their exposition to strontium-substituted bioactive glasses. 
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The differentiation of MSCs into osteoblasts is initially characterised by the 
expression of different osteospecific genes. The genes selected for this study 
were: runt-related transcription factor 2 gene (Runx2), alkaline phosphatase 
gene (Alpl), Type I collagen gene (Col1a1), bone gamma-carboxyglutamate 
(gla) protein gene (Bglap), secreted phosphoprotein 1 gene (Spp1) and bone 
morphogenetic protein 2 gene (Bmp2). Alkaline phosphatase activity has 
usually been considered as one the early markers of osteogenesis and was 
one of the first to be identified. Runx2 has been identified as the major 
transcription factor controlling osteoblast commitment and differentiation, 
being expressed by MSCs at the onset of skeletal development and by 
osteoblasts during their differentiation. It regulates the expression of other 
genes such as Col1a1, Spp1 and Bglap. Finally, Bmp2 promotes Runx2 
expression in mesenchymal osteoprogenitor and osteoblastic cells. (Marie, 
2008). Therefore, it is possible to establish the sequence of genetic events in 
which these genes are involved during the osteoblast differentiation of 
MSCs, as shown in Figure 6.2. 
 
Figure 6.2. Schematic diagram representing the sequence of genetic events in the osteoblast 
differentiation of mesenchymal stromal cells, involving the genes Bmp2, Runx2, Alpl, Col1a1, 
Spp1 and Bglap. Adapted from Marie (2008) and Safadi et al. (2009). 
Results from the real-time quantitative PCR analyses (Figure 5.31 to Figure 
5.36) suggested that the dissolution of bioactive glass particles stimulated 
the up-regulation of six genes involved in the osteogenic differentiation of 
MSCs. The expression of Bmp2 increased in the presence of bioactive glass 
from day 1 in both standard cell culture medium and osteogenic cell culture 
medium conditions, suggesting that the presence of bioactive glass and the 
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ionic dissolution products stimulated the sequence of events shown above 
from the beginning point. The expression of Runx2 was also up-regulated 
from day 1 in both media conditions, increasing gradually until it peaked at 
day 6. This occurred as expected for this gene if the process of osteoblast 
differentiation had already started, suggesting that the gene was stimulated 
due to the higher expression of Bmp2. 
The study of Alpl, Col1a1, Spp1 and Bglap showed that the expression of 
these genes was up-regulated from day 1 and generally increased their 
levels of expression with time, as expected to occur. However, there were 
differences between the two media conditions. The results suggested that 
the presence of both the osteogenic factors and the bioactive glasses had a 
more pronounced effect on the expression than the glasses on their own. 
Alpl, Col1a1 and Bglap peaked at an earlier time point in osteogenic 
medium, and Spp1 showed more consistently higher levels of expression 
from day 1. The general decline observed in all genes at day 14 may be due 
to the lower concentrations of the cations in dissolution as the glass powders 
were depleted after several cycles of media change. Although the addition of 
new bioactive glass particles to the samples may have resulted in generally 
higher levels of expression and it may be an interesting study to perform, it 
was considered that this experimental arrangement was appropriate as it 
was more similar to the potential conditions in vivo. It would not be generally 
feasible to introduce fresh bioactive glass to a scaffold after implantation in 
vivo. 
These results also suggested that the strontium-substituted glasses may not 
always have a clear enhancing effect over the stimulation already induced by 
the unmodified glass. Statistically significant differences between Sr0 and 
Sr50 or between Sr0 and Sr100 bioactive glasses were observed for all the 
genes at different time points in both cell culture medium conditions, with the 
largest number of significant differences observed for Sr0 vs. Sr100. 
Although this may imply a potential stimulatory effect of strontium, the results 
were not consistent throughout the whole study and it is difficult to draw clear 
conclusions from this. The greatest stimulating effect of strontium appeared 
to be on Col1a1, Alpl and Bglap genes, while in other cases the levels of 
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expression were similar for the three glasses or, even, Sr0 was more 
stimulating than Sr50 or Sr100. 
Isaac et al. (2011) reported the up-regulation of various osteoblast genetic 
markers in foetal calvarial bone cells exposed to strontium-substituted 
bioactive glasses fabricated through the sol-gel route, some of which were 
the same as those analysed in this study. The expression of genes related to 
extracellular bone matrix proteins (i.e. Col1a1, Alpl, Bglap) and osteoblastic 
transcription factors (i.e. Runx2) were observed to increase in both studies, 
suggesting a stimulatory effect of the bioactive glasses. Additionally, Col1a1, 
Alpl and Bglap showed a clearer up-regulation in the case of samples 
exposed to bioactive glass compositions with greater proportions of strontium 
substitution. However, there are significant differences between the work of 
Isaac et al. (2011) and this study that need to be discussed, as they may 
have a considerable impact in the results. Issac et al. (2011) used 
osteoblastic cells obtained from calvarial bones of mouse foetuses, which 
were cultured in osteogenic cell culture medium from the time of isolation. It 
is reasonable to presume that the pattern of genetic expression in response 
to external stimuli may not be the same in undifferentiated primary cells 
isolated from adult animals than in differentiated osteoblasts obtained from 
foetuses. Furthermore, the particles of strontium-substituted bioactive glass 
used were pre-incubated, a step which may potentially reduce its effect on 
the cells compared with non-pre-incubated particles. As previously 
discussed, pre-incubation of bioactive glasses may be used to reduce their 
potential cytotoxicity as the initial dissolution and change in pH will occur 
before exposure to cells. Additionally, pre-incubation in fully supplemented 
cell culture medium will result in the adsorption of proteins on the glass 
surface, forming a layer which is important to allow adequate cell attachment, 
proliferation and differentiation on the material. This was an understandable 
step in the case of Isaac et al. (2011), as the cells were cultured in direct 
contact with the glass particles. However, in this study the cells were 
exposed to the dissolution products and this step was not considered as 
required. The substitution of calcium by strontium in the glasses used by 
Isaac et al. (2011) was also performed on a weight basis rather than on a 
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molar basis, which may have resulted in reduced glass solubility and 
bioactivity. 
More recently, Zhang et al. (2013) investigated the effect of the dissolution 
products of strontium-incorporated mesoporous bioactive glass scaffolds on 
the differentiation of rat bone marrow MSCs. The cell culture medium used 
was similar to one of the culture conditions in this study, which did not 
include any osteogenic factors such as ascorbic acid. The expression of 
Runx2, Alpl, Bglap and Col1a1 genes was up-regulated in comparison with 
the control samples, which were MSCs exposed to the dissolution products 
of bioactive glass with no strontium. Additionally, the expression of Runx2, 
Bglap and Col1a1 increased from day 7 to day 14, while the levels of Alpl 
decreased. In the study discussed in this report it was observed that the 
expression of these genes in standard cell culture conditions peaked at day 6 
and decreased by day 14. However, as previously mentioned, the content of 
strontium in the media was not regularly replenished, so it may be expected 
to observe a reduced effect. Finally, the presence of strontium resulted in 
greater expression levels in Alpl, Col1a1 and Bglap, but not in Runx2. 
In conclusion, results from this study suggested an enhancing effect of 
strontium cations released by the dissolution of bioactive glasses on the 
expression of Alpl, Col1a1 and Bglap genes. This is supported by results 
reported by Isaac et al. (2011) and Zhang et al. (2013), and may result in the 
stimulation of the differentiation of rat bone marrow MSCs into osteoblasts. 
The response of human MSCs should also be investigated, since it has been 
shown that bioactive glasses may have a decreased effect compared to rat 
MSCs (Reilly et al., 2007). 
Interestingly, when the expression levels in the osteogenic cell culture 
medium conditions were represented in relation to the expression levels in 
the control samples in the standard cell culture medium conditions (Figure 
5.37, Figure 5.38 and Figure 5.39), two distinct patterns of expression could 
be identified: firstly, the expression of Runx2, Alpl, Bglap and Bmp2 gradually 
increased through time, peaking at day 14; and secondly, Col1a1 and Spp1 
presented two peaks of expression, at day 1 and 6. This may potentially be 
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associated with the time sequence of gene expression in the process of 
osteoblast differentiation and with the way in which the proteins derived from 
the genes are used by the cell. 
Finally, it is significant to consider that, although the measurement of the 
variation of mRNA expression is an important indicator of cell differentiation, 
this is not the definitive approach to show how the process is operating. For 
example, a study of the osteoblast differentiation of human MSCs by Foster 
et al. (2005) did not show any clear concordance between the changes in the 
levels of gene expression and protein expression, except for alkaline 
phosphatase. Therefore, it may be recommendable to combine the mRNA 
isolation and analysis with proteomic techniques that may help to develop a 
clearer image of the mechanisms of cellular response to bioactive glass. 
6.3.5 Conclusions from the study of osteogenic effect of strontium-
substituted bioactive glass 
The population of rat MSCs used in the study was first characterised by 
detecting the expression of molecular surface markers CD44, CD45 and 
CD90 using FACS analysis. The results suggested that 29.2% of the whole 
population of cells were actual multipotent MSCs, expressing both CD44 and 
CD90, and not expressing CD45. However, a literature survey showed that 
CD44 may not be the most appropriate marker as it has shown varying levels 
of expression in different experiments and is expressed in several other cell 
types. Therefore, it was recommended to select an alternative surface 
molecular marker in the identification of a population of rat MSCs. 
The cytotoxicity of the dissolution of Sr0, Sr50 and Sr100 bioactive glasses 
on MSCs generally increased with the amount of glass powder used and with 
the proportion of strontium substitution in the glass composition, potentially 
due to a more severe effect on pH variation caused by the increased 
solubility of the glasses. However, Sr50 bioactive glass showed a less 
marked cytotoxic effect than Sr0 bioactive glass, suggesting a potential 
stimulatory effect of strontium on the MSCs that may be sufficient to 
neutralise the detrimental effect caused by the increased solubility of the 
glass. 
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Six genes associated with the process of osteoblastic differentiation of MSCs 
were up-regulated in response to the dissolution of Sr0, Sr50 and Sr100 
bioactive glass powders, both in standard cell culture medium and 
osteogenic cell culture medium conditions. The level of expression of the 
genes generally increased with time, displaying different patterns depending 
on the time sequence of gene expression in the process of osteoblastic 
differentiation. The final decrease observed at day 14 may be due to a 
severely reduced concentration of the cations in dissolution due to the 
depletion of the glasses after several cycles of media change. 
The strontium-substituted bioactive glasses generally stimulated gene 
expression up to levels similar to the unmodified glass. Greater stimulation 
was only observed at some time points and for some genes, mainly Col1a1, 
Alpl and Bglap. The results were not consistent throughout the whole study 
and, therefore, no definitive conclusions may be drawn on the reportedly 
superior ability of strontium-substituted bioactive glasses to enhance new 
bone formation compared with the unmodified parent compositions at this 
moment. 
In conclusion, the results suggested that the particles of non-pre-incubated 
bioactive glass are able to stimulate the osteoblast differentiation of MSCs by 
up-regulating the expression of genes involved in the differentiation process, 
implying their potential to promote bone tissue formation and to be used as 
part of a novel electrospun composite material in bone tissue engineering 
applications. 
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7 Conclusions 
The aim of this project was to design and fabricate an electrospun composite 
material combining PCL and particles of strontium-substituted bioactive glass 
and to evaluate its potential use as a scaffold for bone tissue engineering. To 
fulfil this purpose a series of objectives were established (See Aim and 
objectives) and a full programme of experimental work was planned and 
performed. 
The conclusions of that work are as follow: 
1) Three bioactive glass compositions, in which calcium was substituted 
by strontium in proportions of 0, 50 and 100% on a molar basis, were 
successfully fabricated. The characterisation of the bioactive glasses 
demonstrated that the strontium substitution had a well-defined effect 
on several material properties. These variations affect the way the 
glass works as a component of a composite material and the 
interactions of the composite material with cells and tissues in vitro 
and, potentially, in vivo. Increasing the content of strontium in the 
glass composition resulted in: 
a. An expansion of the glass network due to the larger strontium 
cation, which was observed as a progressive movement of the 
broad peak in the XRD spectra toward smaller values of angle 
2θ. 
b. A reduction in glass transition temperature due to the 
expansion and weakening of the glass network, resulting in an 
increase of the working range of the glasses. This suggested a 
potential use of strontium-substituted glasses in applications 
that require the shaping and sintering of the glasses through a 
viscous flow process and where the unmodified glasses are not 
adequate due to crystallisation. 
c. A linear increase of glass density due to the greater mass of 
the strontium cation, and a linear decrease of oxygen density 
due to the expanded and less rigidly bonded glass network in 
the modified glasses. 
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d. A linear increase of glass solubility due to the expansion of the 
glass network, potentially increasing glass bioactivity. 
2) Glass dissolution began on the surface of the material, as 
demonstrated through SEM and EDS studies, resulting in 
compositional changes in agreement with what is expected from 
bioactive glasses. 
3) Electrospun composite materials made of PCL and particles of 
strontium-substituted bioactive glass were successfully fabricated. 
The solution of 10 wt% PCL dissolved in a blend of DCM and DMF 
with ratio 90:10 v/v and with glass particles added following a 10:1 
PCL:glass weight ratio produced the most regular fibres and the 
smallest amount of detectable defects in the electrospun materials. 
The composite fibres exhibited regions with irregular morphologies 
and expanded diameters where the bioactive glass particles were 
incorporated within the polymeric fibres, as demonstrated by EDS 
analysis. The surface of the fibres was porous, suggesting an 
increased surface area and, consequently, an improved capability to 
absorb water and to release the ionic dissolution products to the 
environment. 
4) The dissolution of the bioactive glass particles and the subsequent 
release of their ionic dissolution products occurred rapidly after 
immersion in aqueous media, as demonstrated by rapid increases in 
environmental pH. 
5) Interactions between PCL and bioactive glass particles in the 
composite materials may occur as a consequence of glass 
dissolution, resulting in a faster stabilisation of environmental pH 
around neutral values. A potential mechanism for this effect may be 
associated with an accelerated degradation of PCL due to the severe 
alkalinisation created by the dissolution of the bioactive glass particles 
and the subsequent release of the acidic degradation products. It is 
suggested that this effect may be used to regulate the initial increase 
of pH induced by glass dissolution, which may be harmful to cells and 
tissues after implantation. 
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6) Two methods to add bioactive glass particles on the surface of the 
electrospun fibres were developed and tested. The ‘filtering method’ 
proved to be the most effective, achieving efficiencies between 80% 
and 90% when using suspensions of glass particles of concentration 
0.25% w/v and higher. 
7) The electrospun composite materials generally presented good levels 
of in vitro biocompatibility, comparable to materials made of only 
electrospun PCL. However, the addition of more than 0.05 mg of 
additional surface bioactive glass particles using the ‘filtering method’ 
resulted in a significant increase of material cytotoxicity. 
8) The dissolution of strontium-substituted bioactive glass powders 
exhibited a cytotoxic effect on rat MSCs. Amounts larger than 20 mg 
were considered as cytotoxic, inducing a significantly negative effect 
on cell viability. Sr50 was the least cytotoxic bioactive glass 
composition, possibly caused by the potentially stimulatory effect of 
MSCs by strontium which balanced the detrimental effect of the 
increased glass solubility. This also suggested that bioactive glass 
compositions containing both calcium and strontium may be more 
effective stimulating osteoprogenitor cells than glasses containing only 
calcium or strontium. 
9) The dissolution of strontium-substituted bioactive glass particles 
resulted in the up-regulation of six genes associated with the process 
of osteoblastic differentiation of rat MSCs in both standard and 
osteogenic cell culture medium conditions, suggesting a stimulatory 
effect of strontium in the differentiation process and in the formation of 
new bone tissue. This also implied the potential of these glass 
compositions to be used as part of composite materials for bone 
tissue regeneration. 
10) Strontium-substituted bioactive glasses generally stimulated gene 
expression at levels which were similar to those stimulated by the 
unmodified glass composition. In some cases (i.e. Col1a1, Alpl and 
Bglap genes) significantly higher levels of expression were observed. 
However, it is not possible to draw definitive conclusions about the 
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enhancing effect of strontium at this point as the results were not 
consistent throughout the whole study. 
To summarise, electrospun composite materials made of PCL and particles 
of strontium-substituted bioactive glass were successfully designed and 
fabricated, exhibiting good in vitro biocompatibility and the release of glass 
dissolution products to the surrounding environment. The observed 
stimulatory effect of strontium-substituted bioactive glass dissolution on 
MSCs showed that these glasses are promising materials for bone tissue 
regeneration applications, potentially encouraging the formation of new bone 
tissue. Hence, the potential of the electrospun composite materials to be 
used as scaffolds in bone tissue engineering applications was confirmed. 
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8 Further work 
The data presented in this report have demonstrated the potential of 
electrospun composite materials made of PCL and strontium-substituted 
bioactive glass to be used as scaffolds in bone tissue engineering. However, 
additional work needs to be done to expand our knowledge regarding the 
manufacturing process, the properties of the materials and the response of 
cells and tissues. 
The following research activities are suggested as a continuation of the work 
presented in this thesis: 
1) The manufacturing of the electrospun materials may be further 
improved by controlling important environmental parameters such as 
the temperature and the atmospheric humidity at which the process is 
performed. Noteworthy differences were sometimes observed as the 
temperature in the laboratory varied between seasons, and although it 
was possible to keep the temperature in the laboratory relatively 
constant using central heating and air conditioning, it did not allow for 
a fine control. This may be achieved by designing a special chamber 
which isolates the syringe and collecting plate from the external 
environment and which possesses systems that regulate these 
parameters within the enclosed space. It is expected that this work 
may require considerable effort and repeating the optimisation study 
of the electrospinning parameters will be necessary. 
2) Based on reports by O’Donnell et al. (2010), a bioactive glass 
composition exhibiting a 10% substitution of calcium by strontium (i.e. 
46.13 mol% SiO2 – 24.35 mol% Na2O – 24.22 mol% CaO – 2.69 
mol% SrO – 2.60 mol% P2O5) presented the highest levels of cell 
proliferation after human osteosarcoma cells were exposed to their 
dissolution products. It would be interesting to study the cytotoxic and 
osteogenic effect of this glass composition on MSCs, as a previous 
step considering its inclusion in the electrospun composite materials. 
3) The solubility studies of electrospun composite materials may be 
repeated under different experimental conditions to study the potential 
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interaction between the bioactive glass particles and the polymer. The 
samples may be immersed in simulated body fluids to expose them to 
a medium more similar to physiological conditions. The content of 
bioactive glass particles in the samples may also be increased to 
observe if it results in larger variations of pH and to study how the 
composite materials respond. The release of ions in dissolution over 
time may be studied using techniques such as inductively coupled 
plasma optical emission spectroscopy. 
4) The ‘filtering’ method to add glass particles on the surface of the 
electrospun samples may benefit from further optimisation to increase 
particle attachment to the fibres. For example, this may be achieved 
by modifying the polymeric surface using plasma treatment. This 
would induce the creation of carboxyl groups on the surface of PCL, 
leading to increased hydrophilicity and the potential formation of 
electrostatic bonds with cationic groups on the particles of bioactive 
glass (i.e. Ca2+, Sr2+). 
5) The growth of HA crystals on the electrospun samples may be studied 
by immersion in simulated body fluids over a period of several weeks, 
to observe its effect in the structure of the material, its degradation 
and its cytotoxicity. 
6) The concentrations of the ions released in the dissolution of the 
bioactive glass powders used in the study of MSCs viability could be 
measured. Then, solutions of cell culture medium containing those 
concentrations could be prepared and tested on the cells in order to 
see if they would induce a similar cytotoxic effect. 
7) The study of the effect of strontium-substituted bioactive glass on the 
osteoblastic differentiation of MSCs may be repeated to see if the 
results are similar to what has already been reported. Additionally, it 
would be interesting to extract the protein content from the cells to 
establish if the gene up-regulation can be linked to an increased 
synthesis of the associated proteins and enzymes. 
8) Finally, MSCs may be cultured directly on samples of the electrospun 
composite materials over a period of several weeks to study cellular 
differentiation and the production of extracellular matrix using diverse 
Further work 
200 
 
biochemical and histological methods. For example, an alkaline 
phosphatase assay may be used to measure its activity in the 
samples and alizarin red staining may be used to assess calcium 
deposition. 
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